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ABSTRACT 
Presently, there are more adults than children with congenital heart disease. 
Although this represents an outstanding achievement of medical management, 
mostly through improved surgical techniques, numerous clinical problems plague 
these adult survivors. This thesis investigates some of the more important issues 
faced by one of the commonest groups of CHD survivors, adults with repaired 
tetralogy of Fallot. 
 
Persistent issues of importance include; optimising timing of pulmonary valve 
replacement late after tetralogy repair; elucidating the determinants of exercise 
capacity; and outlining structure-function correlates using newly available 
technologies. Taken together, these questions are important to provide a greater 
understanding of clinical issues and to aid in generating solutions to these problems. 
 
A significant amount of uncertainty surrounds the indicators for pulmonary valve 
replacement in adult patients with repaired tetralogy of Fallot. Regional bodies such 
as the American Heart Association, the American College of Cardiology and the 
European Society of Cardiology have produced guidelines as to when the pulmonary 
valve should be implanted. However, the indicators provided in these documents are 
somewhat non-specific and lack consensus. In any case, monitoring of ventricular 
structure and function in pre-pulmonary valve replacement patients remains 
important. Chapter 5 reports that a significant degree of right ventricular dilatation 
occurs over a relatively short period of time. We found that right ventricular volume 
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increased from slightly below to marginally above a commonly used indicator for 
pulmonary valve replacement over just 2 years. Importantly, Chapter 7 found that 
pre-surgical right ventricular outflow tract volume correlated negatively with post-
surgical right ventricular function and exercise capacity. Furthermore, higher right 
ventricular muscular corpus volume before surgery was associated with lower 
improvement in global right ventricular volume after surgery. Global right ventricular 
volume is commonly weighted heavily as an indicator for pulmonary valve 
replacement. However, based on the results of Chapter 7, assessing regional right 
ventricular volumes may provide additional insights in the decision of when to 
surgically intervene. In light of the above mentioned results, regular monitoring of 
right ventricular volume via cardiac MRI with delineation of the right ventricular 
outflow tract and muscular corpus may be warranted.  
 
Although previous reports suggest decreased exercise capacity in adults with 
repaired tetralogy of Fallot, we found exercise capacity to be near-normal in our 
cohort. Chapters 3 and 4 describe a normal metabolic response to exercise, and 
even though peak exercise reached a marginally lower level than predicted in a 
normal healthy population, our cohort exhibited significantly higher exercise capacity 
than previous research. Exercise capacity was, in part, maintained by increased right 
ventricular mass measured at rest and decreased pulmonary regurgitant fraction 
during exercise; Chapter 6 reports increased biventricular outputs and ejection 
fractions and decreased pulmonary regurgitant fraction as exercise intensity 
increased. Right ventricular mass and right ventricular mass to volume ratio were 
found to be positively correlated with peak exercise capacity in Chapter 3. We found 
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that with each 10 grams of increased right ventricular mass, peak work was 8 Watts 
higher.  It seems, an adequate level of musculature and appropriate compliance of 
the right ventricle may be important in providing sufficient forward flow of blood into 
the pulmonary circuit and, in turn, maintaining exercise capacity. 
 
Long-term survival in adult repaired tetralogy of Fallot has improved appreciably over 
time. However, the significant risk of sudden cardiac death remains of concern. To 
the best of our knowledge, Chapter 8 provides the first description of the causes of 
death in this cohort. We found that presumed arrhythmia leads to sudden cardiac 
death in two-thirds of cases. This is an important finding and may suggest that this 
patient cohort requires closer scrutiny in regards to arrhythmia detection and 
monitoring in both the clinical and research settings. This is clearly an important area 
for further detailed investigation. 
 
In total, the studies within this thesis provides insight into some of the persistent 
issues faced by adults with repaired tetralogy of Fallot and may prove valuable in 
clinical decision making in this patient group. 
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CHAPTER ONE 
 
INTRODUCTION 
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1.1 MORPHOLOGY 
 
1.1.1 UNREPAIRED TETRALOGY OF FALLOT 
Niels Stensen, a Danish anatomist and naturalist, provided the first case report of 
tetralogy of Fallot (TOF) in 1671.1 However, a more complete anatomical description 
was not presented until 1784 by William Hunter who eloquently wrote: “...the 
passage from the right ventricle into the pulmonary artery, which should have 
admitted a finger, was not so wide as a goose quill; and there was a hole in the 
partition of the two ventricles, large enough to pass the thumb from one to the other. 
The greatest part of the blood in the right ventricle was driven with that of the left 
ventricle into the aorta, or great artery, and so lost all the advantage which it ought to 
have had from breathing”.2 Numerous case studies followed but it was not until 
Etienne-Louis Fallot’s 1888 paper L’anatomie pathologique de la maladie bleu3 when 
it was recognised that TOF is one malformation of the subpulmonary infundibulum 
and pulmonary valve not a random occurrence of four unrelated anomolies. Fallot 
himself did not coin the phrase ‘tetralogy of Fallot’, rather, in the interests of brevity, it 
was popularised by Maude Abbott in 1924.4 
 
Four anatomical features are always present in TOF; a ventricular septal defect 
(VSD), an overriding aorta resulting from a rightward deviation of the aortic valve 
with biventricular origin of its leaflets, subpulmonary infundibular stenosis, and 
subsequent right ventricular hypertrophy. However, a spectrum of morphology exists 
in terms of the borders of the VSD, the extent of aortic override and variations in 
subpulmonary infundibular anatomy. At one end of the spectrum, severe pulmonary 
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obstruction can result in the most common TOF variant; pulmonary atresia with VSD 
(see 1.1.2). On the other hand, TOF can be hard to distinguish from VSD with 
overriding aorta and minimal pulmonary stenosis. Despite the variability in cardiac 
anatomy, anterocephalad deviation of the outlet septum and hypertrophy of the 
septoparietal trabeculations forming a narrowed path to the pulmonary valve 
represent the defining anatomical features of this condition. Essentially, TOF is one 
abnormality arising from a malformed infundibulum. In the most common form of 
TOF, to which the studies of this thesis are mostly dedicated, the outflow tract from 
the right ventricle is patent at birth, the heart has normal segmental anatomical 
structure and major internal cardiac abnormalities, other than the aforementioned 
tetrad of defects, are not present. 
 
Figure 1.1. The anatomy of unrepaired tetralogy of Fallot. (Reproduced with 
permission from Thomas et al. Circulation 2007; 115: 1933-1947) 
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Ventricular septal defect 
The VSD is normally large and non-restrictive which facilitates bidirectional shunting. 
The interventricular communication can be described as perimembranous in around 
80 percent of Caucasian patients due to a fibrous continuity between the tricuspid 
and aortic valve leaflets, which form the postero-inferior border, and incorporates the 
interventricular part of the membranous septum. Twenty percent of Caucasian TOF 
patients have a VSD where the postero-inferior margin of the defect is muscular. In 
this case the septomarginal trabeculation is continuous with the ventriculo-
infundibular fold and forms the muscular region.5 
 
Overriding aorta 
The anterocephalad deviation of the outlet septum leads to a doubly committed 
aortic valve. The degree of aortic override varies considerably and could be 
diagnosed as double outlet right ventricle when severe. In the presence of 
substantial subpulmonary outflow tract obstruction, right to left shunting 
predominates and results in deoxygenated blood being passed through the 
malformed aortic valve into the systemic circulation. The associated chronic volume 
overload has been linked to aortic root dilatation in adult repaired TOF.6, 7 
 
Infundibular stenosis 
The subpulmonary outflow tract obstruction is a result of hypertrophied septoparietal 
trabeculations in addition to anterocephalad deviation of the outlet septum. The 
muscular nature of this region facilitates a mutable entity subject to influence by 
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factors such as catecholamines which can result in increased obstruction and 
hypercyanotic spells.8 
 
Areas of stenosis may continue more distally in the right ventricular outflow tract, and 
further still, into the pulmonary arteries. The pulmonary valve can be hypoplastic with 
dysfunctional bi-leaflets. Furthermore, the pulmonary trunk and pulmonary arteries 
can be underdeveloped with areas of focal stenosis.5 
 
1.1.2 TETRALOGY OF FALLOT VARIANTS 
Although TOF variants are not the focus of this thesis, it is worth briefly detailing their 
anatomy to enable a more complete understanding of the morphological and related 
pathophysiological dissimilarities between these conditions and the rationale behind 
excluding these patients from some of our studies. Although some variants may 
seem similar anatomically and haemodynamically in a surgically repaired adult 
patient, we believe differences in such factors in utero and during pre-repair infancy 
will result in heterogeneous pathophysiology and justifies exclusion. 
  
Pulmonary atresia with ventricular septal defect 
Pulmonary atresia with VSD results from an advanced level of anterocephalad 
deviation of the outlet septum. However, in rare cases the pulmonary valve is 
imperforate as opposed to severely stenosed. Pulmonary blood flow is maintained 
through confluent left and right pulmonary arteries via a patent ductus arteriosus in 
around half of all cases. In the remainder of patients, where the pulmonary arteries 
are confluent, multiple aorto-pulmonary collateral arteries supply blood to the 
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pulmonary circuit. When the pulmonary arteries are discontinuous or absent, 
pulmonary blood supply is preserved via multiple collateral arteries in isolation or in 
combination with an arterial duct. 
 
Management of pulmonary atresia with VSD is complicated by the fact that collateral 
arteries have a tendency to stenose over time and pulmonary hypertension may 
develop due to unrestricted flow. 
 
Tetralogy of Fallot with absent pulmonary valve 
Rudimentary circular leaflets at the ventriculo-pulmonary junction in addition to a 
malformed outlet septum results in an absent pulmonary valve and is observed in 
around 5 percent of TOF cases.9 The resultant free pulmonary regurgitation in foetal 
life causes right ventricular and pulmonary artery volume overload and subsequent 
dilation. Compression of the airways by dilated pulmonary arteries can cause 
inspiratory and expiratory stridor in extreme cases. Focal narrowing of the ventriculo-
pulmonary junction and compression/obstruction of the airways leads often to 
hypoxaemia in these patients.10 
 
Double outlet right ventricle – “tetralogy type” 
One variant of double outlet right ventricle is characterised by a marked aortic 
override resulting in an aorta which is more committed to the right ventricle than to 
the left. Although physiologically similar to TOF, surgical management must be 
altered to allow for the fact that left ventricular outflow tract obstruction may result 
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from traditional VSD repair. A longer patch may be necessary to avoid such a 
situation.11 
 
1.1.3 ASSOCIATED ANATOMIC ANOMALIES 
Anatomic anomalies associated with TOF frequently occur and are not considered 
variants. The most common anatomic anomalies are: variation in origin and/or 
course of coronary arteries; hypoplasia or stenoses of the pulmonary arteries; patent 
oval fossa; major aortopulmonary collateral arteries; aortic arch anomalies; 
secondary muscular inlet VSD; right-sided aortic arch. Approximately 2 percent of 
patients with TOF also have an atrioventricular septal defect.9 Pre surgery 
pathophysiology and management are similar, however, surgical management is 
altered to suit the more complex anatomy. 
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1.2 EPIDEMIOLOGY AND GENETICS 
 
TOF occurs in one in every 3600 live births and represents approximately 10% of all 
congenital heart disease, making it the most common cyanotic congenital 
malformation.12 Marginally more males than females are born with TOF.13 Australian 
data presents a similar situation with 3.2 TOF cases per 10,000 births, with males 
being slightly over represented in the group.14 Importantly, due to significant 
improvements in treatment, there are now more adults than children with congenital 
heart disease.15 
 
The precise cause of TOF is unknown and although its occurrence is difficult to 
predict, recurrence in a family is around 3%.16 However, microdeletion of the q11 
region of chromosome 22 has been shown to be present in up to 25% of patients 
suggesting a strong genetic substrate to the formation of TOF.17 Di George 
syndrome and velocardiofacial syndrome, which have 22q11 deletions, are often 
associated and diagnosed with TOF.18, 19 When patients with these syndromes are 
omitted, the prevalence of 22q11 microdeletions has been estimated to be 
approximately 6%.20 Importantly, late-onset neuropsychiatriac disorders are also 
associated with 22q11 deletion with schizophrenia occurring in around 25% in such 
patients, necessitating appropriate monitoring.21 Other chromosomal abnormalities, 
including trisomy 13, 18 and 21, can also occur in as many as 13% of TOF patients. 
Because of the potential presence of the aforementioned chromosomal deletions, 
fluorescent in-situ hybridisation may be warranted in all patients diagnosed with 
TOF. 
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A number of risk factors for the development of TOF during pregnancy have been 
identified, including uncontrolled diabetes, phenylketonuria and first trimester retinoic 
acid ingestion.22 
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1.3 DIAGNOSIS OF TETRALOGY OF FALLOT 
 
1.3.1 ANTENATAL DIAGNOSIS 
Antenatal diagnosis of TOF is possible via a foetal echocardiogram in those patients 
with suspicion of a positive diagnosis; known chromosomal abnormalities or extra-
cardiac malformations. Primarily because the presence of poor prognostic indicators 
warrants referral for echocardiography, prenatal diagnosis results in poorer long-term 
outcomes than postnatal diagnosis.23 In any case, only around half of TOF cases are 
detected during foetal echocardiography.23 When foetal diagnosis is possible it 
permits greater avoidance of dangerous cyanosis via maintenance of ductal patency 
through early prostaglandin administration. 
 
1.3.2 POSTNATAL DIAGNOSIS 
Clinical presentation 
The most prominent sign is cyanosis, which appears some time after birth. The 
degree and initial appearance of cyanosis depends upon the degree of pulmonary 
stenosis. Mild pulmonary stenosis results in no cyanosis and is described as 
acyanotic TOF. Cyanosis appears several months after birth when moderate 
pulmonary stenosis is present. In the case of severe pulmonary stenosis, cyanosis is 
also severe and occurs early in infancy.12 Cyanosis is evident on the lips and nail 
beds but is not associated with clubbing in modern times due to early surgical 
repair.16 
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Hypercyanotic spells, brought on by crying, defecating, feeding or dehydration, which 
agitates the dynamic infundibular outflow tract causing obstruction, are common 
amongst TOF patients with the onset being at around 3-6 months of age. These 
spells are characterised by an abrupt and severe decrease in oxygen saturation, 
hyperpnoea, dyspnoea and lethargy. Episodes are usually transient and resolve 
within 30 minutes. However, in severe spells greater levels of cyanosis can occur  
resulting in syncope, convulsions, even myocardial and/or cerebral ischaemia or 
death.12 
 
A single and loud second heart sound may be present in patients with TOF. 
Furthermore, a systolic murmur associated with the degree of RV outflow tract 
obstruction will also be audible. A less prominent murmur will be present in patients 
with severe obstruction and only a small amount of regurgitant flow but is associated 
with a greater degree of cyanosis. Blood flow across the VSD is generally not 
audible due to non-turbulent blood flow across the communication. 
 
Diagnostic techniques 
Chest radiography, electrocardiography and echocardiography are the frontline 
diagnosis tools. If the clinical presentation suggests the lesion may be present, a 
chest radiograph and ECG should be performed. Echocardiography can 
subsequently confirm the diagnosis with a thorough assessment of intracardiac 
anatomy. 
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Typical radiographic appearance includes a normal sized heart with a boot shaped 
appearance due a lifted apex, caused by right ventricular enlargement, and 
concavity in the main pulmonary artery area.16 Upon ECG examination, right sided 
dominance will produce right axis deviation, tall R waves in V4 and V1 leads and a 
large S wave in lead V6 with a sinus origin of the rhythm.24 Even though this ECG 
appearance is not unusual for a newborn, in a normal child this will resolve, whereas 
in a TOF patient it will persist beyond infancy and even into adulthood.16 
Echocardiography can then be used to make a definitive diagnosis and assess the 
degree of severity of associated abnormalities; right ventricular outflow tract 
obstruction; pulmonary artery morphology; supplementary sources of pulmonary 
blood flow; ventricular septal defect and aortic override; and associated anatomic 
anomalies. 
 
Cardiac magnetic resonance imaging (MRI) can be used when echocardiography 
provides inadequate imaging of stenotic or hypoplastic pulmonary arteries, major 
aortopulmonary collateral arteries or anomalies of the aorta and/or coronary 
arteries.24 
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1.4 MANAGEMENT OF TETRALOGY OF FALLOT 
 
The management of TOF has developed considerably over the years. Before the 
advent of surgical intervention, long-term prognosis was invariably poor. Presently, 
survival into adulthood is the norm, rather than a rare exception, due to the evolution 
of surgical techniques and a considerable body of research exists validating such 
approaches. 
 
1.4.1 SURGICAL INTERVENTIONS IN CHILDHOOD 
 
The age at which complete repair of TOF is performed has steadily declined over 
time. The current approach is generally either neonatal complete repair or neonatal 
palliation with a systemic to pulmonary shunt followed by a complete repair at the 
age of 4 to 6 months. Previously, a two-stage approach was almost uniformly used 
with complete repair being performed beyond infancy, which was the case for a 
number of the older participants of studies within this thesis. Performing a complete 
neonatal repair can provide immediate reduction in right ventricular pressure and 
volume overload, reduce the possibility of aortopulmonary shunt related stenoses in 
the branch pulmonary arteries, alleviate family anxiety, reduce the length of cyanosis 
and the risk of hypercyanotic spells, enhance overall growth and development, and 
decrease the likelihood of reintervention in the first year of life.16, 25 Conversely, there 
may be the risk of negative neurodevelopmental outcomes in neonates exposed to 
cardiopulmonary bypass26-28 and there is an association with larger transannular 
patching in neonatal complete repair.29, 30 Since both approaches have low peri-
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operative mortality29, 30 and comparative long-term outcome data is lacking, 
institutional preference is usually the prime determinant in the approach used. 
Commonly used relative indications for primary shunt procedures include left anterior 
descending coronary artery arising from a right coronary artery that crosses the right 
ventricular outflow tract, associated non-cardiac anomalies, and severely hypoplastic 
pulmonary arteries.31 In any case, the palliative and reparative surgical procedures 
used in tetralogy of Fallot management are outlined below. 
 
1.4.1.1 Palliative Procedures 
Palliative procedures for the relief of cyanosis in TOF began in the early 1940s when 
Helen Taussig noted that patients with a patent ductus arteriosus did better than 
those with a closed duct, who almost universally died.32 In partnership with Alfred 
Blalock, the concept of keeping this duct open led first to animal experiments33 and 
later to the human implementation of an end-to-side anastomosis of the left 
subclavian artery to the left pulmonary artery (Blalock-Taussig shunt or BT shunt) in 
1944.34 By 1951, 779 BT shunts had been performed by Blalock and his team. 
Ninety-nine of these patients died after surgery, however, 50 per cent were still alive 
after 20 years.35 
 
A number of variations to the BT shunt have been developed; the Potts shunt 
involves an anastomosis between the descending aorta and left pulmonary artery, 
however, these shunts have subsequently ceased to be utilised due to difficulty in 
closure during complete repair;36 the Waterston shunt implements an ascending 
aorta to pulmonary artery anastomosis and is technically easy to perform and 
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subsequently to close;37 a Cooley shunt utilises an ascending aorta to right 
pulmonary artery shunt.38 
 
Figure 1.2. Classic Blalock-Taussig, modified Blalock-Taussig, Waterston and Potts 
shunts (Reproduced with permission from Thomas et al. Circulation 2007; 115: 
1933-1947) 
 
 
 
A modified BT shunt was developed in 1962 to lower the risk of thrombosis 
associated with the peripheral nature of the original shunt design. The modified 
procedure involves the use of a prosthetic tube graft made of polytetrafluoroethylene 
(PTFE) between the subclavian artery and pulmonary artery.39 In current practice, 
either a modified BT shunt via a median sternotomy/posterolateral thoracotomy or an 
ascending aorta to main pulmonary artery shunt via a median sternotomy are mostly 
used. 
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Establishing a modified BT shunt improves pulmonary blood flow, increases growth 
of the pulmonary arteries, can reduce the use of transannular patching during 
complete repair40-42 and is associated with very low hospital mortality.43 However, 
shunt narrowing is common43 and there are small risks of excess pulmonary blood 
flow, pulmonary hypertension and heart failure; although these negative outcomes 
can be minimised by use of small diameter PFTE shunts.40 
 
1.4.1.2 Reparative Procedures 
Complete repair of TOF began in several centres in the mid 1950s after the 
development of sound cardiopulmonary bypass circuit practices. These early 
procedures were performed via median sternotomy and longitudinal or transverse 
ventriculotomy. Where present, shunts were closed prior to cardiopulmonary bypass 
being established. Infundibular resection was then performed and ventricular septal 
defect was closure followed using a pericardial or prosthetic patch. A transannular 
patch was utilised when the pulmonary annulus required augmentation. Preservation 
of the pulmonary valve was considered desirable where achievable. Complications 
during this period included low post-operative cardiac output, inadequate system 
perfusion, pulmonary dysfunction, coronary air embolism, poor myocardial protection 
and coronary artery damage.44-53 
 
In the infancy of these complete repair procedures post-operative mortality was up to 
60% but reduced to 7-14% by the mid 1960s as surgical techniques developed. Age 
less than 5 years at complete repair, transannular patch use, prior Potts shunt, 
severity of cyanosis, and in some centres, previous systemic to pulmonary artery 
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shunt, were found to be associated with higher mortality risk.44-53 Results from follow-
up studies resulted in the widespread practice of performing shunts in children less 
than 5 years of age and aiming for complete repair in symptomatic patients between 
8-12 years of age. Initial shunt placement was thought to develop the pulmonary 
bed, which would allow a more successful subsequent complete repair.54 
 
During the 1970s complete TOF repair began to be performed on increasingly 
younger patients. Follow-up studies during this period found that performing surgical 
repair as early as 1 month led to improved mortality and negligible heart 
block/neurological sequelae. Furthermore, the presence of a prior shunt may hamper 
right ventricular outflow tract growth. However, greater transannular patch use was 
required, which has negative late outcomes such as pulmonary regurgitation.55-58 
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Figure 1.3. Complete repair of tetralogy of Fallot (Reproduced with permission from 
Thomas et al. Circulation 2007; 115: 1933-1947) 
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Long-term follow-up studies of complete repair patients from the 1950s and 1960s 
found that ventriculotomy and transannular patch placement was largely responsible 
for right ventricular dysfunction, decreased exercise tolerance, arrhythmia and 
sudden cardiac death.59-62 In an attempt to alleviate these negative outcomes, 
surgeons now commonly utilise a transatrial or transatrial-transpulmonary approach 
with sparing of the pulmonary valve. Complete neonatal primary repair results in 
early survival rates are presently 98-100%.63-65 However, the majority of patients 
recruited to studies within this thesis were born in the late 1980s and early 1990s 
and almost solely underwent an early (<4 years of age) median sternotomy, shunt 
ligation (if present), right ventricular outflow tract incision, infundibular resection, 
ventricular septal defect closure with a Teflon patch and transannular patch 
augmentation of the outflow tract. This surgical approach is associated with higher 
levels of pulmonary regurgitation than transatrial or transatrial-transpulmonary 
techniques,29 however, long-term data is currently lacking comparing eras. 
 
1.4.2 LATE PROCEDURES 
 
1.4.2.1 Pulmonary Valve Replacement 
In most cases, chronic pulmonary regurgitation develops after complete TOF repair, 
resulting from surgical disruption of the pulmonary valve and right ventricular outflow 
tract. Previous studies have suggested pulmonary regurgitation results in 
progressive right ventricular dilatation, exercise incapacity, arrhythmia and sudden 
cardiac death.60, 66 Pulmonary valve replacement (PVR) is increasingly utilised in this 
patient cohort to reduce pulmonary insufficiency and remodel the right ventricle. 
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However, optimal timing of such valve implantation is an area of much uncertainty.  
The beneficial effects of PVR detailed below, need to be balanced with the risk of 
reoperation due to the limited lifespan of implanted valves of around 10 years.67 
 
PVR techniques include utilising Gore-tex bivalves, homograft conduits and various 
other conduits (bovine jugular, Dacron porcine, stentless porcine). However the vast 
majority of patients within this thesis received a stented prosthesis, specifically, a 
Medtronic Mosaic porcine valve. This approach is favoured within our institution and 
elsewhere as it provides superior durability to homografts68-70 and allows future 
percutaneous pulmonary valve replacement. 
 
The American College of Cardiology/American Heart Association Guidelines state 
that pulmonary valve replacement is reasonable in patients with severe pulmonary 
regurgitation and at least one of the following: symptoms; decreased exercise 
tolerance; moderate to severe right ventricular dysfunction; moderate to severe right 
ventricular enlargement; development of symptomatic or sustained atrial and/or 
ventricular arrhythmias; moderate to severe tricuspid regurgitation.71 The European 
Society of Cardiology Guidelines are in close agreement but add right ventricular 
outflow tract obstruction with right ventricular systolic pressure >80 mmHg (tricuspid 
regurgitation velocity on echocardiography >4.3 m/s) as a conjoint indicator for 
pulmonary valve replacement along with severe pulmonary regurgitation.72 In clinical 
practice, the degree of right ventricular dilatation is highly weighted in the decision of 
when to operate. Several studies have attempted to elucidate the degree to which 
the right ventricle may be allowed to dilate whilst still achieving normalisation of right 
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ventricular volumes after PVR. Indexed right ventricular end-diastolic volume 
(RVEDVi) cut points between 150 mL/m2 and 170 mL/m2 have been identified.73-75 
However, the validity of these findings may be called into question with some studies 
recruiting a low number of patients and/or utilising echocardiography rather than 
cardiac MRI in the assessment of ventricular volumes and function. Nevertheless, 
the lower end of this range is more commonly used by clinicians as an indication for 
PVR.  
 
Geva (2013) recently proposed the indications for PVR in repaired TOF patients 
shown in Table 1.1.76 These indications essentially summarise the need to monitor 
right ventricular size and function, pulmonary regurgitation and the burden of 
arrhythmia. Importantly, factors other than RVEDVi are given equal weighting as 
indications for PVR. Furthermore, the distinction made between symptomatic and 
asymptomatic patients is valuable since the threshold for intervention is lowered in 
those experiencing symptoms such as exercise intolerance, dyspnoea and syncope. 
Unfortunately for clinicians, there are no clear-cut answers on when to request PVR 
late after TOF repair and the key question remains whether or not to operate on an 
asymptomatic patient with a borderline size right ventricle. 
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Table 1.1. Proposed indications for PVR in patients with repaired TOF with moderate 
to severe pulmonary regurgitation (regurgitant fraction ≥25%) 
1. Asymptomatic patients with ≥2 of the following criteria: 
a. RV end-diastolic volume index >150 mL/m2 or z score >4. In 
patients whose body surface area falls outside published normal 
data: RV/LV end-diastolic volume ratio >2 77, 78 
b. RV end-systolic volume index >80 mL/m2 74, 79 
c. RV ejection fraction <47% 79-81 
d. LV ejection fraction <55% 79-81 
e. Large RVOT aneurysm 82, 83 
f. QRS duration >160 ms 79 
g. Sustained tachyarrhythmia related to right-sided heart volume 
load 84 
h. Other haemodynamically significant abnormalities: 71 
• RVOT obstruction with RV systolic pressure ≥0.7 
systemic  
• Severe branch pulmonary artery stenosis (<30% flow to 
affected lung) not amenable to transcathether therapy 
• Greater than or equal to moderate tricuspid regurgitation 
• Left-to-right shunt from residual atrial or ventricular septal 
defects with pulmonary-to-systemic flow ratio ≥1.5 
• Severe aortic regurgitation 
2. Symptomatic patients fulfilling ≥1 of the quantitative criteria detailed 
above. Examples of symptoms and signs include: 
a. Exercise intolerance not explained by extracardiac causes (eg, 
lung disease, musculoskeletal anomalies, genetic anomalies, 
obesity), with documentation by exercise testing with metabolic 
cart (≤70% predicted peak VO2 for age and sex not explained by 
chronotropic incompetence) 
b. Signs and symptoms of heart failure (eg, dyspnoea with mild effort 
or at rest not explained by extracardiac causes, peripheral 
oedema) 71 
c. Syncope attributable to arrhythmia 
3. Special considerations: 
a. Because of higher risk of adverse clinical outcomes inpatients 
who underwent TOF repair at ≥3 years of age, PVR may be 
considered if they fulfil ≥1 of the quantitative criteria in section 1 81 
b. Women with severe pulmonary regurgitation and RV dilatation or 
dysfunction may be at risk for pregnancy related complication. 
Although no evidence is available to support benefit from pre 
prepregnancy PVR, the procedure may be considered if fulfilling 
≥1 of the quantitative criteria in section 1 85 
Source: Geva (2013)76 
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Although the optimal timing of PVR remains difficult, there is more certainty that the 
procedure results in considerable short and medium-term benefit to TOF patients. A 
recent meta-analysis86 concluded from pool data of 48 included studies that post 
operative mortality was low (30-day mortality 0.87%; 5-year mortality 2.2%), the 5-
year PVR redo was 4.9%, RVEDVi decreased by 63 mL/m2, pulmonary regurgitant 
fraction reduced by 39%, left ventricular ejection fraction marginally increased 
(1.8%), QRS duration slightly decreased (-2.9 ms), and NYHA class improved (-0.9). 
Right ventricular ejection fraction only improved by 1% when not corrected for 
change in right ventricular volume, however, corrected right ventricular ejection 
fraction improved by 21%. Although there has been universal agreement on 
improvements in right ventricular volumes, pulmonary regurgitant fraction and NYHA 
class, some variation has been noted in the change in right ventricular ejection 
fraction, left ventricular volumes, left ventricular ejection fraction and QRS 
duration.73, 74, 77-79, 87-102 Furthermore, despite universal reporting reduced right 
ventricular volumes, the degree to which this reduction is due to outflow tract 
excision as opposed to muscular corpus remodelling has not been adequately 
investigated. 
 
Few studies have documented the effects of PVR on exercise capacity. Poor 
baseline exercise capacity is ubiquitous in studies to date, however, only 2 studies 
have shown a significant improvement in exercise performance; Warner et al 
(2003)69 found that maximum workload and percentage of predicted peak oxygen 
consumption significantly improved in a subset of 6 patients, 36.7 months post PVR; 
Frigiola et al (2008)77 reported a significant decrease in ventilatory response to 
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carbon dioxide production (VE/VCO2) in 57 patients, 12 months after PVR. Other 
studies conducted to date have not found an improvement in maximal or submaximal 
exercise performance as a result of PVR.96, 99, 103 The lack of improvement in 
exercise performance after PVR raises the question of whether deteriorating 
exercise capacity is a valid indicator for such surgery. However, it may be possible 
that patients with deteriorating exercise capacity experience the greatest benefit from 
PVR. Such subgroup analyses are important to develop sound indicators for surgical 
intervention. 
 
Despite recent efforts to study the effects of PVR, several questions remain 
unanswered and clinically important; little is known of the long-term effects of PVR, 
despite the importance of such information; the role of formal exercise testing in 
surgery timing decisions is not clear since there is a lack of correlation between 
symptoms, ventricular volume and exercise capacity; and the effects of PVR on 
cardiac function during exercise is poorly understood. Portions of this thesis attempt 
to answer some of these questions. 
 
1.4.2.2 Percutaneous Pulmonary Valve Replacement 
Although not discussed further in this thesis, it is worth noting that percutaneous 
approaches to placing a pulmonary valve have been developed in recent times with 
good early results.104, 105 Periprocedural mortality, late mortality and freedom from 
reoperation has been reported to be low.106 The main advantage of the procedure is 
the avoidance of serial sternotomies and the associated risks. However, the 
procedure is limited to those patients with a suitable conduit size and geometry; the 
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Medtronic Melody valve can be placed in conduits up to 22mm in diameter and the 
Edwards Sapien Valve up to 29mm in diameter. Therefore, patients with 
transannular patch repair are unsuitable for percutaneous pulmonary valve 
implantation as a first procedure to ameliorate late pulmonary regurgitation. Once a 
pulmonary valve of suitable diameter has been surgically implanted a percutaneous 
procedure may follow in the case of subsequent surgical valve failure. With current 
tendencies to perform valve sparing repairs and technological developments in 
percutaneous valves, future patients may be able to undergo this procedure without 
previous surgical valve implantation. 
 
Rare but serious complications of percutaneous pulmonary valve implantation 
include coronary artery compression, stent fracture, stent embolisation,107 and valve 
failure, which can often be resolved by placement of a second valve.108 
 
1.4.3 MONITORING DISEASE PROGRESSION 
 
1.4.3.1 Echocardiography 
Echocardiography is a common tool in the diagnosis and follow up of TOF patients. 
This imaging modality is portable, cost-effective, and can be particularly useful in 
assessing measurements such as right ventricular or pulmonary artery systolic 
pressure. However, difficulty is encountered when attempting to acquire adequate 
images of right-sided structures and distal vasculature. Furthermore, 
echocardiography is very operator dependent.109 Therefore, echocardiography is a 
useful imaging modality for TOF patients in certain situations only. Cardiac MRI can 
Chapter 1 Introduction 
 
26 
 
be more useful in assessing right ventricular volumes and function due to its superior 
ability to image the right heart. 
 
1.4.3.2 Cardiac Magnetic Resonance Imaging 
Cardiac MRI is currently the reference method for non-invasively assess pulmonary 
regurgitation, ventricular volume and ventricular function.110 Although pulmonary 
regurgitation can be evaluated via echocardiography and has good agreement with 
cardiac MRI, a full assessment pulmonary valvular flow, right ventricular morphology 
and function is far superior using the latter due to greater visualisation of the right 
heart and lack of geometrical assumptions. Evaluation of akinetic regions and/or 
areas of scarring in the right ventricular outflow tract are also possible, which is 
important in the assessment of arrhythmia risk. Furthermore, right ventricular outflow 
tract and pulmonary arterial tree anatomy can be thoroughly evaluated along with the 
relationship of the great vessels to the coronary circuit, which aids in determining 
whether patients are suitable for percutaneous pulmonary valve replacement. 
 
Serial cardiac MRI evaluations allow clinicians to monitor progress and greatly aids 
in the decision of when to intervene with PVR in order to reduce pulmonary 
regurgitation and right ventricular volume. In those patients who have undergone 
PVR procedures, cardiac MRI allows a full assessment of post procedural valvular 
and ventricular function. Cardiac MRI follow-up is approximately 24 months in pre-
PVR, clinically stable patients with only moderate pulmonary regurgitation and 
moderate right ventricular dilatation. Despite more than a decade of cardiac MRI 
collection across many centres internationally, little is known regarding the temporal 
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changes in ventricular volume and function in TOF patients. Elucidation of such data 
would allow recommendations on timing of clinical follow-up and permit greater 
planning of future interventions. 
 
Section 2.1 contains a description of technical aspects of cardiac MRI as it applies to 
the assessment of TOF. 
 
1.4.3.3 Measurements of Exercise Capacity 
Exercise capacity has previously been shown to be impaired in adults with repaired 
TOF60, 61, 83, 111, 112 (detailed in section 1.6.2). The degree of exercise intolerance and 
temporal changes in peak and submaximal exercise capacity are commonly used as 
indicators of clinical status. The American College of Cardiology/American Heart 
Association Guidelines recommend periodic cardiopulmonary exercise testing 
(CPET) to monitor exercise capacity and assess the risk of exercise induced 
arrhythmias. These guidelines further state that PVR is reasonable in patients with 
decreasing exercise capacity. However, the interval required between CPETs and 
what constitutes “decreasing exercise capacity” are left to the clinician’s discretion. 
Nevertheless, maximal oxygen consumption, VE/VCO2 slope and NYHA functional 
class have been identified as independent predictors of death or hospitalisation,113 
which indicates that monitoring peak and submaximal exercise capacity has at least 
some prognostic information and is a worthwhile procedure for monitoring 
progression of clinical status and risk stratification. However, specific rates of decline 
or cut off values have not been identified and, therefore, the CPET is currently a 
useful but imprecise tool. Knowledge of cardiac function during exercise may prove 
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to have more utility in assessing the clinical status of TOF patients. In this regard, the 
emerging technique of collecting cardiac magnetic resonance images of the 
exercising heart may provide valuable insights into cardiac function under stress and 
important prognostic information for this patient cohort. 
Chapter 1 Introduction 
 
29 
 
1.5 PATHOPHYSIOLOGY OF TETRALOGY OF FALLOT 
 
As detailed in sections 1.1.1 and 1.1.3, there is some heterogeneity within patients 
diagnosed with TOF. Specifically, there may be variation in the degree of aortic over-
ride, the size and nature of any ventricular septal defect, the degree of infundibular 
stenosis and the presence and severity of any associated anatomic anomolies. 
However, a generalised picture of the pathophysiology of TOF may be created. 
 
1.5.1 PRE REPAIR 
 
Before any palliative procedures are undertaken, cyanosis and hypoxaemia are 
commonly present. The VSD is usually large and non-restrictive, which creates a 
situation of equalised pressure between the left and right ventricles. The amount of 
pulmonary stenosis and right ventricular pressure establishes the level of pulmonary 
blood flow. Total systemic vascular resistance and venous return determine left 
ventricular systolic and aortic pressures. Infants may exhibit normal oxygen 
saturation and no cyanosis if they possess mild pulmonary stenosis and 
consequently the shunt through the VSD is left-to-right. This situation is commonly 
termed pink, acyanotic or precyanotic TOF. Generally, right-to-left shunting 
subsequently occurs as a result of increasing infundibular obstruction and cyanosis 
develops. Situations which increase venous return and decrease total peripheral 
resistance precipitate cyanosis; crying, cold temperatures or bathing. The amount of 
aortic override is not a determinant in the degree of cyanosis. Rather, cyanosis 
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worsens as pulmonary blood flow is further compromised by increased obstruction in 
the right ventricular outflow tract.12 
During cyanotic spells, a vicious cycle develops where an increased right-to-left 
shunt results in aortic oxygen desaturation, consequently systemic hypoxia and 
metabolic acidosis occur. Subsequent respiratory centre is stimulation causes 
hypernoea and catecholamine release, which increases infundibular stenosis and 
increases venous return with resultant deepening cyanosis. Furthermore, 
hypercapnia and respiratory acidosis occur as a result of decreased pulmonary 
blood flow and contribute to worsening hypoxaemia. 
 
Squatting can help to relieve cyanotic spells and is a common position to find an 
infant with TOF. Systemic venous return and vascular resistance are increased in 
this position and result in decreased right ventricular outflow tract obstruction. 
Therefore, decreasing right-to-left shunting and increasing pulmonary blood flow.12 
 
Chronic cyanosis may result in polycythemia and/or multiple aorto-pulmonary 
collateral arteries. The former can result in increased risk of cerebrovascular 
accidents114 and the latter can cause late complications after total surgical repair. 
 
1.5.2 POST COMPLETE REPAIR 
 
As described in section 1.4.1.2, complete repair of TOF results in relief of pulmonary 
stenosis and elimination of the right-to-left shunt. As a result, pulmonary blood flow 
increases and cyanosis is relieved.115 The patient is commonly now left with free 
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pulmonary regurgitation, however, the pulmonary regurgitant fraction is rarely more 
than 40%.116 The degree of pulmonary regurgitation is limited since pulmonary 
forward flow occurs even without the contribution of the right ventricle, in a similar 
fashion to the Fontan circulation. This is due to the effects of inspiration on thoracic 
cavity pressure, ejection of blood from the left ventricle creating a negative pressure 
gradient across the pulmonary vascular circuit and right atrial contraction. Further, 
resistance in the pulmonary microvasculature is low and a short distance from the 
right ventricle. Consequently, right ventricular contraction propels blood through the 
low resistance pulmonary arterial circulation into the low-pressure pulmonary veins. 
Since there is no reversal of gradient, no impetus for back flow through the 
pulmonary circuit exists. However, pulmonary regurgitation can be exacerbated by 
such factors as branch pulmonary artery stenosis, annulus size of the pulmonary 
valve, pulmonary arterial compliance and pulmonary microvasculature function.117 
 
Although well tolerated for many years after complete surgical repair, the chronic 
volume overload created by pulmonary regurgitation leads to progressive right 
ventricular dilatation.117, 118 The magnitude of the right ventricular response depends 
upon the quantity and period of pulmonary regurgitation119 and the nature of the right 
heart and pulmonary vascular circuit. Deterioration in right ventricular volumes and 
function is apparent in patients with at least moderate pulmonic regurgitation.120 
However, temporal changes in pulmonary regurgitation, right ventricular size and 
function are poorly understood. 
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Bove et al. (1983)121 provided early insights into the effects of long-standing 
pulmonary insufficiency on right ventricular function. They assessed 20 patients, 9 
years after total repair of TOF using echocardiography, radionuclide ventriculography 
and 24 hour holter monitoring. It was reported that patients with clinically significant 
pulmonary regurgitation had significantly higher right to left ventricular end-diastolic 
ratio and lower right and left ventricular ejection fractions. Further early studies 
confirmed the findings of Bove et al.122-124 Typical of the era though, age at repair 
was towards the end of the first decade of life, which restricts the relevance of these 
results to modern cohorts who typically undergo repair in infancy. More recent 
studies, however, have established the association between chronic pulmonary 
regurgitation and impaired right ventricular function.118, 120, 125-131 Koestenberger et al. 
(2011),131 for example, found that right ventricular ejection fraction was strongly 
correlated with severity of pulmonary regurgitation. 
 
Chronic pulmonary regurgitation in the setting of right ventricular outflow tract 
aneurysm or akinesis has been suggested to be the main cause of right ventricular 
failure late after TOF repair.130 Transannular patch repairs are strongly associated 
with an aneurismal and akinetic right ventricular outflow tract have also been 
associated with higher pulmonary regurgitant fractions125 and sustained ventricular 
tachycardia.132, 133 Furthermore, fibrosis as a result of surgical intervention is 
common in the right ventricular outflow tract and has been found to be related to 
ventricular dysfunction, decreased exercise tolerance and increased levels of atrial 
natriuretic peptide.134, 135  
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Regional wall motion abnormalities, including in the right ventricular outflow tract, 
have commonly been identified late after TOF repair. Vogel et al. (2001)136 reported 
right ventricular free wall reversed myocardial velocity in diastole in 48 of 74 patients 
studied. Of the 48 patients, 22 exhibited reversed systolic myocardial velocities in the 
right ventricular free wall and 19 patients had reverse diastolic myocardial velocity in 
the septum. QRS, QT and JT duration was found to be significantly longer in those 
patients with reversed myocardial velocity as compared to those with myocardial 
contractility. Weidemannn et al. (2002)137 further confirmed the association between 
right ventricular deformation abnormalities and prolonged QRS duration. Enhanced 
quantification of regional function was developed by Menteer et al (2005)138, which 
utilises MRI myocardial tissue tagging. 
 
Subsequent studies have utilised similar techniques in combination with late 
gadolinium enhancement to identify the presence of ventricular fibrosis and it’s 
association with regional function abnormalities.83, 128, 134 Wald et al (2009)83 found 
that global right ventricular ejection fraction was positively correlated to right 
ventricular outflow tract ejection fraction and negatively correlated to right ventricular 
outflow tract dyskinesia and right ventricular outflow tract late gadolinium 
enhancement. Babu-Narayan et al. (2006)134 found greater levels of ventricular 
fibrosis in areas of previous myocardial insult and suggested patients who previously 
underwent extensive right ventricular outflow tract reconstruction with greater 
transannular patch use were more likely to exhibit late gadolinium enhancement in 
this region; 99% of the 92 patients included in this study exhibited indications of right 
ventricular outflow tract fibrosis. Miura et al. (1992)124 provided early evidence that 
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surgical approach to TOF repair can have significant long term implications, with 
transpulmonary-transatrial repaired patients exhibiting better global right ventricular 
function and less regional wall motion abnormalities as compared to patients who 
had undergone a transventricular repair. Overall, the right ventricular outflow tract is 
an important area to consider when for choosing surgical technique, assessing risk, 
monitoring clinical status and selection of patients for late surgical procedures. 
 
The existence of right ventricular diastolic dysfunction late after TOF repair is 
common.139-145 In restrictive right ventricular physiology, blood flow from right atrial 
contraction travels directly into the pulmonary circuit via the passive right heart as 
indicated by antegrade flow in the main pulmonary aretery late in diastole.140, 143, 144 
The clinical implications of right ventricular diastolic function are unclear. Gatzoulis et 
al (1995)140 reported increased exercise capacity and less right ventricular dilatation 
in those patients with restrictive physiology when compared to those patients without 
restrictive physiology. Helbing et al (1996),141 however, found the opposite, with 
impaired exercise capacity associated with the presence of restrictive right 
ventricular physiology. Nevertheless, it is apparent that patients with right ventricular 
diastolic dysfunction have a lower chronic pulmonary regurgitant load.117 
 
Tricuspid regurgitation is a small but significant contributing factor towards right 
ventricular dysfunction, which occurs in around 32% of repaired TOF cases and 
develops as a result of annular dilatation, secondary to right ventricular expansion, 
and/or valvular injury during complete repair.117 Tricuspid regurgitation can 
exacerbate right ventricular dilatation and cause right atrial enlargment. 
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Reports of left ventricular function in adult repaired TOF are variable. An early study 
conducted by Jarmankani et al. (1972)146 concluded that patients left ventricular 
ejection fraction remained suppressed at a mean of 2.5 years post corrective 
surgery. Age at repair was not reported but presumably complete repair was 
performed significantly later than infancy, as opposed to the current practice of early 
correction. However, Gatzoulis et al. (2000)129 reported normal left ventricular 
ejection fraction in 95 adult repaired TOF patients, 18 years after repair with a mean 
age at repair of 12.6 ± 10.5 years. It is clear, however, that the presence of left 
ventricular dysfunction is related to major adverse clinical events. Knauth et al. 
(2008)80 studied 88 adult repaired TOF patients utilising cardiac MRI and found that 
patients who suffered major adverse outcomes had significantly lower left ventricular 
ejection fraction. Ghai et al. (2002)147 also reported that left ventricular dysfunction is 
a risk factor for sudden cardiac death in TOF patients late after repair. 
It seems reasonable, then, that abnormal interactions between the right and left 
ventricle are likely in the setting of the volume overloaded right heart.  Oosterhof et al 
(2006) compared 32 repaired TOF patients (age of repair: 6 years) with 10 
pulmonary stenosis patients (age at repair: 4 years ; p=NS) at a mean of 24 years 
after repair and found that TOF patients had significantly lower left ventricular 
ejection fractions. This suggests that the volume loaded right ventricle has an 
important impact on the left ventricle. In fact, a correlation between right and left 
ventricular ejection fractions has been demonstrated on numerous occasions.81, 130, 
148 Possible explanations include mutual myocardial fibres,149-151 electromechanical 
dyssynchrony,152 and geometrical interaction between chambers due to limited 
pericardial space.153 
Chapter 1 Introduction 
 
36 
 
Further late consequences of pulmonary regurgitation and subsequent right 
ventricular dilatation are discussed in section 1.6. 
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1.6 LATE OUTCOMES 
 
 
1.6.2 EXERCISE CAPACITY 
 
Exercise capacity has widely been reported to be suppressed late after the repair of 
tetralogy of Fallot. 60, 112, 134, 140, 141, 154-162 Fredriksen et al.159 found a peak oxygen 
consumption (VO2peak) of 21 mL/kg/min and a peak heart rate of 149 beats per 
minute during cycle ergometry in 494 patients at a mean age of 32 years. Similarly, 
Samman et al.160 reported reduced VO2peak of 22 mL/kg/min (66% predicted) and 
peak heart rate of 146 beats per minute in ninety-nine 34 year old TOF patients. 
Babu-Narayan et al.134 reported marginally higher maximal oxygen uptake during 
cardiopulmonary exercise test of 27 mL/kg/min (80% predicted) in 92 adults with 
repaired tetralogy of Fallot. However, Babu-Narayan’s study utilised a treadmill 
protocol, thus increasing VO2peak by use of a larger muscle mass compared to 
bicycle ergometry. Maximal exercise capacity has also been shown to decrease over 
time. Kipps et al.161 described a reduction in VO2peak from 27 mL/kg/min (78% 
predicted) to 25 mL/kg/min (73% predicted) over a 2.8 year period in 179 repaired 
TOF patients with a mean age of 24 years at initial visit. 
 
Pulmonary regurgitation has been associated with impaired exercise capacity.60, 157 
Carvalho et al.60 reported a significant negative correlation between pulmonary 
regurgitant fraction and both exercise duration and peak heart rate. Furthermore, 
patients with VO2peak less than 85% predicted had a significantly higher degree of 
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pulmonary insufficiency than those patients above 85% predicted VO2peak. Norgard 
et al.157 demonstrated significantly decreased VO2peak in patients with at least 
moderate pulmonary regurgitation as compared to patients with mild pulmonary 
regurgitation. However, when pulmonary regurgitation is alleviated via pulmonary 
valve replacement, either surgically or percutaneously, improved exercise capacity is 
not commonly observed.73, 77, 89, 96, 102, 163-168 
 
Reduced exercise capacity in adult repaired TOF could logically be thought to be 
associated with right ventricular dysfunction, however, evidence in this area is 
equivocal. Correlation studies have not consistently shown an association between 
right ventricular ejection fraction and peak or submaximal exercise capacity.60, 169, 170 
However, Geva et al.81 retrospectively analysed cardiac MRI data and clinical status 
of 100 repaired TOF patients and reported that reduced right ventricular ejection 
fraction was associated with poorer clinical status, as assessed by New York Heart 
Association functional class. Furthermore, regional dysfunction has been shown to 
be associated with reduced exercise capacity. Wald et al.83 used 3-dimensional 
models of the right ventricle, reconstructed from cardiac MRIs in 62 TOF patients, 
and found that right ventricular outflow tract ejection fraction was independently 
predictive of peak exercise capacity, whereas global right ventricular ejection fraction 
was not. Babu-Narayan et al.134 added further evidence that regional rather than 
global right ventricular dysfunction is associated with exercise incapacity. Babu-
Narayan restrospectively analysed late gadolinium enhancement score from cardiac 
MRIs in 92 repaired TOF patients. Overall, regional dysfunction was noted in areas 
of scar and patients with above mean late gadolinium enhancement score were 
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found to have lower peak exercise capacity. Scarring was particularly noted in 
regions of previous surgical insult such as the outflow tract (99%), interventricular 
septum (98%), inferior right ventricular insertion point (79%) and areas of 
trabeculated myocardium (24%). 
 
Chrontropic incompetence has been widely reported to be present in repaired 
TOF.134, 171-173 Diller et al.171 retrospectively analysed CPET results from 727 adult 
congenital heart disease patients between 1999 and 2005. Fifty-two per cent of 
repaired TOF patients exhibited chronotropic incompetence, defined as a 
chronotropic index (measured heart rate reserve/predicted heart rate reserve) less 
than 0.8. Wessel et al.111 reported reduced heart rates compared to controls at each 
stage and at maximal exercise during treadmill exercise using the Bruce protocol. 
However, resting heart rates were not different from controls. Interestingly, although 
reduced peak heart rate is likely to be related to reduced VO2peak, reduced 
submaximal heart rates have been shown to be unrelated to submaximal VO2.174 
Vagal tone during exercise has been shown to be normal in repaired TOF,61 
however, abnormalities in autonomic reflexes have been suggested as a possible 
mechanism of chronotropic incompetence. Ohuchi et al.173 concluded that blunted 
heart rate response to exercise is at least partly related to impaired cardiac 
autonomic activity. Davos et al.172 found globally impaired autonomic response to 
exercise with reduced baroreceptor sensitivity and heart rate variability. Both Ohuchi 
and Davos related impaired autonomic function to previous cardiac surgery, in 
particular, right ventricular outflow tract reconstruction. 
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Respiratory abnormalities in repaired TOF patients may also have a significant 
impact on exercise capacity. The presence of branch pulmonary artery stenoses has 
been suggested to have a negative impact on maximal oxygen consumption due to 
pulmonary blood flow maldistribution, ventilation-perfusion mismatch and inefficient 
gas exchange.61, 175 Improved VO2peak after balloon angioplasty of stenosed branch 
pulmonary arteries adds further weight to this assertion.176 Further possible 
respiratory influences on maximal exercise capacity are decreased respiratory vital 
capacity and increased ventilatory frequency.156, 157  
 
Exercise incapacity in adult repaired TOF patients could to some extent be explained 
by physical inactivity. General advice to limit vigorous physical activity by medical 
practitioners may lead to patients approaching exercise with caution; viewing it as a 
potentially dangerous pursuit. Previous research has confirmed that physical activity 
levels are low and, importantly, that physical training results in improved exercise 
capacity in TOF patients.177 
As a predictive tool, cardiopulmonary exercise testing has proven to be very useful in 
the setting of adult repaired tetralogy of Fallot. Diller et al.171 found that peak heart 
rate is predictive of survival. Giardini et al.113 reported that VO2peak, the slope of 
ventilation per unit of carbon dioxide production and New York Heart Association 
functional class are all independently predictive of death and hospitalization. Pre-
surgical cardiopulmonary exercise test results are also predictive of outcome. Babu-
Narayan et al.178 showed that pre pulmonary valve replacement VO2peak is a strong 
predictor of early post-surgery mortality. 
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1.6.1 ARRHYTHMIA, SURVIVAL AND SUDDEN CARDIAC DEATH 
 
As outlined in section 1.4.1.2, surgical repair techniques have significantly changed 
over the past several decades, which have resulted in improved survival rates.179 
Transannular patch use has been associated with poor outcomes, as described 
above, however, conflicting results have been reported regarding the degree and 
type of patching on survival rates.66, 180 Regardless, survival has universally been 
described as excellent for many decades. Early studies by Katz et al. (1982)181(an 8-
year actuarial survival rate of 96% in 414 patients repaired between 1967 and 1977), 
Rosenthal et al. (1984)182(95% cumulative survival 25 years postoperatively) and 
Nollert et al. (1997)183(a 36-year acturarial survival rate of 96% and normal life 
expectancy in 658 patients repaired between 1958 and 1977) reported encouraging 
results. More recently, Hickey et al. (2009)180 predicted a 40-year survival of 88% for 
patients repaired in 1985, which matches the era of repair for most of the patients 
included in this thesis. 
 
Despite encouraging survival rates, the burden of arrhythmia in adult repaired TOF 
patients is high. A recent multi-institutional study84 recruited 556 patients from 11 
centres and found that 43% had a sustained arrhythmia or an arrhythmia related 
intervention and 20% had an atrial tachyarrhythmia. Right atrial enlargement, 
hypertension and number of cardiac surgeries were associated with intraatrial re-
entrant tachycardia. Whereas, atrial fibrillation was associated with older age, 
decreased left ventricular ejection fraction, left atrial dilatation and number of cardiac 
surgeries. Ventricular arrhythmia was present in 15% of patients and was associated 
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with QRS duration, left ventricular dysfunction and number of cardiac surgeries. It is 
apparent that the left side of the heart plays an important role in arrhythmogenesis. 
 
The burden of arrhythmia in adult repaired TOF patients increases with age. The 
incidence of atrial and ventricular arrhythmias is low for the first 10 to 15 years after 
reparative surgery, followed by an increase thereafter.66, 84, 184 Although the overall 
burden of arrhythmia increases steadily with age, there are some differences in 
progression between subtypes. Atrial fibrillation is uncommon and less prevalent 
than intraatrial re-entrant tachycardia before 45 years of age. However, beyond this 
age the incidence of atrial fibrillation dramatically increases and becomes more 
common than intraatrial re-entrant tachycardia.84 The development of atrial fibrillation 
also tends to arise at an earlier age in TOF patients than in the normal population 
(>45 vs >65 years of age, respectively) and has a prevalence of 30% in patients over 
55 years of age.84, 185 All atrial tachyarrhythmias are more common in patients who 
underwent palliation before corrective surgery.66 
 
Ventricular arrhythmias have a high prevalence of 15% in adult repaired TOF 
patients, with ventricular tachycardia representing the vast majority of these cases.62, 
66, 84, 186 Pulmonary regurgitation leads to progressive right ventricular dilatation has 
been suggested as the main haemodynamic lesion resulting in sustained ventricular 
tachycardia and sudden cardiac death.66 QRS duration is lengthened by right 
ventricular dilatation and is strongly correlated with sustained ventricular 
tachycardia.59, 62, 66, 84, 187 Furthermore, QRS duration has been identified as an 
independent risk factor for malignant ventricular arrhythmias and sudden cardiac 
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death.59 Increased number of previous cardiac surgeries has also been suggested 
as a risk factor for ventricular arrhythmias,62, 84, 187 presumably via arrhythmogenic 
ventricular fibrosis at former incision sites.134 
 
Some studies have suggested pulmonary valve replacement results in decreased 
QRS duration188 and others have reported no change.97, 132 One study suggested 
QRS duration decreases after such surgery but steadily increases thereafter.189 
Meta-analyses have not provided clarification in this regard, with conflicting results 
as to whether pulmonary valve replacement decreases QRS duration in adult 
repaired TOF patients.86, 164 More importantly, the long-term effects of pulmonary 
valve replacement on ventricular tachycardia and sudden cardiac death are also 
uncertain.97, 132  
 
Little is known about the incidence and causes of sudden cardiac death. However, 
several studies have identified risk factors for ventricular tachycardia and sudden 
cardiac death (see Table 1.2).59, 66, 132, 147, 190-194 The highest risk patients have a 
clinical profile that includes having undergone multiple surgeries, an increased QRS 
duration, left ventricular systolic or diastolic dysfunction and age greater than 20 
years.84 
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Table 1.2 Risk factors for ventricular tachycardia and sudden cardiac death (Source: 
Villifane 2013195) 
 
• Older age at repair 
• Previous palliative shunts 
• Older age 
• Repeated syncope 
• Pulmonary regurgitation 
• Residual pulmonary stenosis 
• Severe right ventricular dilatation 
• Poor right ventricular function 
• Poor left ventricular function 
• Frequent ventricular ectopic beats on Holter monitoring or exercise test 
• QRS >180ms 
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2.1 ETHICS APPROVALS 
 
Ethics approval was granted for each of the studies within this thesis by the Sydney 
Local Health District Ethics Review Committee (RPAH Zone). Chapter 8 required 
additional approval from the Victorian Department of Justice Ethics Committee for 
access to the National Coronial Information System. Informed written consent was 
obtained from participants for each study other than Chapter 8, where access to 
coronial information was approved without individual consent. 
 
2.2 CARDIAC MAGNETIC RESONANCE IMAGING 
 
All magnetic resonance imaging was performed using a single 1.5T MR scanner 
(Philips Acheiva; Philips, Best, The Netherlands). 
 
2.2.1 ASSESSMENT OF RESTING VENTRICULAR VOLUMES AND FUNCTION 
USING STANDARD CINE MAGNETIC RESONANCE IMAGING 
 
Short axis, vertical long axis and 4-chamber views of both ventricles and outflow 
tracts were acquired over 9-12 slices utilising retrospectively gated steady-state free 
precession (b-FFE) cine MRI images. Imaging parameters acquired during a single 
breath hold were: TR=3.2 ms; TE=1.6 ms; flip angle=78˚; slice thickness=8 mm; 
matrix=192x256; field of view-300-380 mm; and temporal resolution=40 ms. 
Assessment of ventricular volumes and function using short axis cine images were 
Chapter 2 General Methods 
 
47 
 
manually traced along the endocardial border at end-diastole and end-systole using 
OSIRIX open source medical imaging software (32Bit v3.9.x). Simpson’s rule was 
used to calculate end-diastolic and end-systolic volumes for both ventricles; ejection 
fractions were calculated from these volumes.  
 
Regional analysis of the RV volumes in systole and diastole was then performed, 
where the RV was divided in the fibrous RVOT and RVMC components. The 
delineation of these segments was based on the following criteria. The fibrous RVOT 
was contoured from the pulmonary valve leaflets superiorly, to the fibrous to 
muscular transition zone with in the RVOT anteriorly based on delayed enhancement 
studies. Posteriorly the fibrous RVOT was contoured to include volume until the 
superior aspect of the interventrcular septum. An arbitrary line was contoured 
between the lower anterior and posterior landmarks to define the lower border zone 
of the fibrous RVOT. Fibrous RVOT measurements were independently analysed in 
all subjects by two observers with an intraclass correlation coefficient of 0.977 for 
end-systolic measurements and 0.923 for end diastolic measurements. 
 
2.2.2 RESTING MAGNETIC RESONANCE FLOW CALCULATION 
Pulmonary artery and aortic flow data were acquired during a breath-hold using a 
phase-sensitive (Venc set at 200 cm/sec and adjusted to avoid aliasing), gradient-
echo sequence (TR, <5 ms; TE, <3 ms; flip angle, 15˚; slice thickness, 7 mm; field of 
view =300-380 mm matrix, 256x240, temporal resolution=30 ms). Imaging planes 
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were standardised as the main pulmonary artery midpoint and aortic sino-tubular 
junction. Through plane flow data was acquired utilising retrospective cardiac gating. 
Phase contrast images were used to obtain arterial blood flow via semiautomatic 
vessel edge-detection algorithm (View Forum, Phillips system) with manual operator 
correction. Pulmonary artery net forward flow (mL) and PR fraction (%) were 
calculated as total forward pulmonary flow minus retrograde pulmonary flow, and 
percent retrograde pulmonary flow over total pulmonary flow, respectively. Similar 
calculations were used to determine aortic and tricuspid forward flow and regurgitant 
fraction. 
 
2.2.3 MAGNETIC RESONANCE ANGIOGRAPHY 
Pulmonary artery morphology was assessed with a dedicated magnetic resonance 
angiography sequence (MRA). Administration of intravenous contrast (0.2 mmol/kg 
of gadolinium pentatate, Magnevist) was triggered visually and was acquired in a 15 
second breath-hold. The 2-phased MRA was performed with a T1 weighted spoiled 
gradient echo sequence. The following imaging parameters were used: TR = 7 ms; 
TE = 3.5 ms; flip angle = 30o; matrix = 256 x 192; field of view = 480 mm; slice 
thickness = 3 mm, zip 2. 
 
2.2.4 LATE GADOLINIUM ENHANCEMENT: SCAR/FIBROSIS IMAGING 
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Scar imaging within the myocardium was performed with segmented phase-sensitive 
inversion recovery sequences (image parameters: TR=2xRR interval; TE=3.4 ms; 
flip angle=25˚; slice thickness=10mm; matrix=144x256; field of view=300-380 mm, 
acquired during a single breath-hold) 10 min post-administration of intravenous 
contrast (0.2 mmol/kg of gadolinium pentatate, Magnevist). Imaging included the 
entire short axis and long-axis planes of the left ventricle and right ventricle. 
 
2.2.5 EXERCISE CARDIAC MAGNETIC RESONANCE IMAGING PROTOCOL 
 
Cardiac function and flows were assessed using real-time free breathing magnetic 
resonance imaging at rest, 30% heart rate reserve (Level 1) and 60% heart rate 
reserve (Level 2). Target exercising heart rates were determined using the following 
calculation: target heart rate = resting heart rate + ([maximum heart rate – resting 
heart rate] x either 0.3 or 0.6). Maximal heart rate was obtained at peak exercise 
during the CPET described below. 
Increase in heart rate was achieved using a custom built, MRI compatible step-style 
ergometer, which utilised fluid filled chambers to create resistance. Study 
participants were placed in the supine position with an approximately 45 degree 
bend at their knees to allow stepping exercise without contacting the MR tunnel. A 5 
channel cardiac receive coil and vector-cardiogram leads were placed on the 
subject’s chest. During exercise, participants were verbally instructed to either 
increase or decrease their cadence to reach and then maintain the desired heart 
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rate. Once the heart rate had reached a plateau (typically after 1 to 2 minutes of 
exercise) at the target rate, imaging commenced. 
 
Localiser and calibration scans were performed at the outset before the following 
real-time magnetic resonance images were captured at rest, Level 1 and Level 2: 4-
chamber cine; short-axis cine stack (4 slices); aortic flow; and pulmonary artery flow. 
Real-time imaging parameters were: TR=4 ms; TE=1.4 ms; flip angle=60 ˚; slice 
thickness=8 mm; matrix=192x192; field of view 380 mm; and temporal resolution 
corresponding to 92ms. 100 temporal dynamics were obtained at each slice with 
corresponding velocity encoding (Venc 150-300cm/s, adjusted to avoid aliasing). 
Imaging planes were selected and flow calculations were performed as described 
above. Ejection fractions at rest and during exercise were obtained from real-time 4-
chamber cine images utilising OSIRIX software (32Bit v3.9.x) to trace the 
endocardial border during end-diastole and end-systole, as described above and 
previously validated.196 All real-time data was collected in less than 60 seconds from 
commencement of imaging protocol. 
 
2.3 CARDIOPULMONARY EXERCISE TESTING 
 
An electronically braked bicycle ergometer (Lode Corival; Lode BV, Groningen, The 
Netherlands) was used to perform progressive, maximal exercise tests. Ramped 
protocols were individually determined, as described by Jones et al (1985).197 A 
period of at least 2 minutes low resistance pedalling followed maximal exertion whilst 
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heart rate, blood pressure and ECG morphology was monitored. Breath by breath 
expiratory gas analysis (VMax229; SensorMedics; Yorba Linda, California) and ECG 
monitoring (Cardiosoft, version 6.51, GE Healthcare, Waukesha, Wisconsin) were 
performed. Blood pressure was periodically measured and oxygen saturation 
measurements (Radical, Massimo Corp, Irvine, USA) were also obtained 
continuously. Work rate, heart rate, blood pressure, oxygen consumption, carbon 
dioxide production, ventilation, oxygen saturation and ECG morphology continuously 
collected during the testing period. 
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3.1 INTRODUCTION 
Exercise capacity has widely been reported to be impaired in adults with repaired 
tetralogy of Fallot (TOF).60, 112, 134, 140, 142, 159, 162 However, the relationship between 
exercise capacity and right ventricular (RV) structure and function has been only 
poorly characterised. Cardiac MRI parameters have exhibited weak relationships 
with peak exercise ability in previous research. 60, 83, 169, 170 Exercise capacity must 
be, however, at least partially related to the capability of the RV to produce forward 
flow. The contractile performance of the RV is to some extent determined by RV 
mass, which is not currently used in clinical decision making, such as the timing of 
pulmonary valve replacement.  
We aimed to determine whether RV mass is correlated with exercise capacity and 
could therefore provide a useful marker of clinical status and potentially future 
outcomes, in repaired tetralogy patients. 
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3.2 METHODS 
 
3.2.1 STUDY POPULATION 
Between September 2008 and February 2013, a total of 82 patients with TOF or 
tetralogy-type pulmonary atresia with ventricular septal defect (PAVSD) were 
prospectively recruited to undertake cardiopulmonary exercise testing and cardiac 
MRI, having been referred to our adult congenital heart service for assessment (table 
1). Ethics approval was obtained from the Royal Prince Alfred Hospital Human 
Research Ethics Committee, Sydney, and all participants gave informed consent. 
 
3.2.2 CARDIAC MRI PROTOCOL 
Cardiac magnetic resonance imaging was performed as described in General 
Methods sections 2.2.1 – 2.2.3. In addition, end-diastolic traces of the right 
ventricular epicardial border, again using OSIRIX open source medical imaging 
software (32Bit v5.2), allowed calculation of RV mass. Reproducibility was assessed 
by repeating RV mass measurements by a second observer in 10 patients; the 
intraclass correlation coefficient was found to be 0.935. 
 
3.2.3 CARDIOPULMONARY EXERCISE TESTING 
Cardiopulmonary exercise testing was performed as described in General Methods 
section 2.3. 
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3.2.4 STATISTICAL METHODS 
Continuous variables are presented as mean ± SD. Pearson’s correlation and 
multivariable linear regression were used to assess associations between measures 
of cardiac structure by MRI and exercise capacity. Peak work was our primary 
outcome measure, and RV mass was our prespecified primary variable of interest. 
Multivariable models were adjusted for age and gender, with subsequent models 
additionally adjusting for other measures of cardiac structure and function as detailed 
in the results. Body surface area (BSA) was defined as 0.016667 x weight0.5 x 
height0.5,198 and the ratio of RV mass to BSA was also analysed. IBM SPSS 
Statistics (version 21.0; IBM Corp., Somers, NY) was used for statistical analyses. 
Statistical significance was inferred at two-sided P value <0.05.
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3.3 RESULTS 
3.3.1 PARTICIPANT CHARACTERISTICS 
Table 1 shows patient characteristics. Eighty-two patients (age at evaluation 26 ± 10 
years; mean age at repair 2.5 ± 2.8 years; 23.3 ± 7.9 years since repair; 53 males) 
were included in this study. The majority of patients had a primary diagnosis of TOF 
(n=73; 89%) with a fewer number having a primary diagnosis of PA VSD (n=9, 11%). 
Complete repair was performed using a transannular patch in 74 patients (90%), 
whereas a homograft was used in 3 patients (4%) and a valve sparing repair was 
performed in 2 patients (2%). Surgical data was not available for 3 patients due to 
the procedure being performed outside Australia and missing medical records.  
 
3.3.2 CARDIAC MRI RESULTS 
Table 2 shows cardiac MRI results. RV dilatation was observed (RVEDVi 153 ± 43.9 
mL/m2; RVESVi 77.3 ± 31.2 mL/m2) and pulmonary regurgitation was moderate to 
severe (pulmonary regurgitant fraction [PRF]: 33 ± 14%). LVESVi was elevated (34.2 
± 11.3 mL/m2), however, LVEDVi was not abnormal (81.4 ± 14.7 mL/m2). Maintained 
LV and RV stroke volumes (LV SV 84.9 ± 19.8 mL; RV SV 135.4 ± 37.9 mL) and 
ejection fractions (LV EF 58.8 ± 7.7%; RV EF 50.5 ± 7.3%) were observed. Right 
ventricular outflow tract obstruction was assessed via the most recent echo using 
standardised AHA/ACC criteria71 and was noted in 12 patients (mild: 5 [6%]; mild-
moderate: 4 [5%]; moderate: 1 [1%]; moderate-severe: 2 [2%]). 
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3.3.3 CARDIOPULMONARY EXERCISE TEST RESULTS 
Table 3 shows cardiopulmonary exercise test results. Overall, exercise capacity was 
near-normal. Peak work was 88 ± 17% of predicted (172 ± 53 watts), VO2peak was 84 
± 17% predicted (32 ± 8 mL/kg/min) and peak heart rate was 90 ± 9% predicted (171 
± 16 bpm). Anaerobic threshold was above 60% of maximal exercise capacity when 
measured as a percentage of peak work (work at anaerobic threshold: 105 ± 35 
watts; percentage of peak work: 62 ± 10) and peak oxygen uptake (VO2 at 
anaerobic threshold: 21.5 ± 5.6 mL/kg/min; percentage of peak: VO2 69 ± 12). The 
respiratory exchange ratio was 1.25 ± 0.12. 
 
3.3.4 CORRELATIONS 
In univariate analysis, RV mass (r=0.45, p<0.001), RV mass to RVEDV ratio 
(r=0.286, p=0.009) and RV mass to BSA ratio (r=0.28, p=0.01) were all positively 
correlated with peak work (see figures 1 and 2). The association of RV mass with 
peak work was such that for each 10 gram higher RV mass, peak work was 8 watts 
higher. 
 
RV and LV cardiac output and stroke volumes also correlated with peak work (RV 
SV: r=0.396, p<0.001; RV CO: r=0.313, p=0.004; LV SV: r=0.642, p<0.001; LV CO: 
r=0.56, p<0.001). Significant positive correlations were observed between RV CO 
and LV CO (r=0.672, p<0.001), RV EF and LV EF (r=0.618, p<0.001), and RV SV 
and LV SV (r=0.547, p<0.001). The correlation between peak work and RVEDVi, 
RVESVi and PRF was not statistically significant (p>0.05 for each correlation). 
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VE/VCO2 positively correlated with RVEDVi, RVESVi, PRF and negatively correlated 
with RVEF at anaerobic threshold (RVEDVi: r=0.305, p=0.005; RVESVi: r=0.383, 
p<0.001; PRF: r=0.316, p=0.005; RVEF: r=-0.342, p=0.002) and at peak exercise 
(RVEDVi: r=0.349, p=0.001; RVESVi: r=0.448, p=<0.001; PRF: r=0.260, p=0.021; 
RVEF: r=-0.453, p<0.001). 
 
In multivariable linear regression adjusted for age and sex, RV mass remained 
significantly correlated with peak work. This association was independent of all other 
tested cardiac MRI variables (see Figure 3). Similar results were found when these 
analyses were performed with RV mass to RVEDV ratio and RV mass to BSA ratio, 
rather than RV mass. 
 
The above relationships were unaltered when the same analyses were performed 
excluding those 9 patients with underlying PA-VSD or the 8 patients with more than 
mild RV outflow tract obstruction. 
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Table 3.1. Patient characteristics 
Participants (n)     82 
Age (years)   26 ± 10 
Males (n)    53 (65%) 
Primary diagnosis    
 TOF   73 
 PAVSD   9 
Primary repair    
 
Transannular 
patch  74 
 Homograft  3 
 Valve sparing  2 
 Surgical data not available 3 
Age at TOF repair   2.5 ± 2.8 
Years since repair     23.3 ± 7.9 
TOF, tetralogy of Fallot; PA VSD, pulmonary atresia with ventricular septal defect. 
 
Table 3.2. Cardiac MRI results 
Indexed left ventricular end-diastolic volume (mL/m2)   81.4 ± 14.7 
Indexed left ventricular end-systolic volume (mL/m2)  34.2 ± 11.3 
Left ventricular stroke volume (mL)  84.9 ± 19.8 
Left ventricular ejection fraction (%)  58.8 ± 7.7 
Left ventricular cardiac output (L/min)  6.1 ± 1.6 
Indexed right ventricular end-diastolic volume (mL/m2)  153 ± 43.9 
Indexed right ventricular end-systolic volume (mL/m2)  77.3 ± 31.2 
Right ventricular stroke volume (mL)  135.4 ± 37.9 
Right ventricular ejection fraction (%)  50.5 ± 7.3 
Right ventricular cardiac output (L/min)  9.8 ± 3.3 
Pulmonary regurgitant fraction (%)   33.0 ± 14.2 
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Table 3.3. Cardiopulmonary exercise test results 
Peak work (watts) 172 ± 53 
     % predicted peak work 88 ± 17 
Work at anaerobic threshold (watts) 105 ± 35 
     % of peak work 62 ± 10 
VO2peak (ml/kg/min) 32 ± 8 
     % predicted VO2peak 84 ± 17 
anaerobic threshold VO2 as % of VO2peak 69 ± 12 
Peak heart rate (bpm) 171 ± 16 
     % predicted peak heart rate 90 ± 9 
Peak respiratory exchange ratio 1.25 ± 0.12 
VE/VCO2 at anerobic threshold 25.3 ± 3.1 
VE/VCO2 at peak 27.7 ± 4.1 
VO2peak, peak oxygen consumption; VE/VCO2, ratio of minute ventilation to carbon dioxide 
production. 
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Figure 3.1. Linear regression of peak work and RV mass 
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Figure 3.2. Linear regression of peak work and RV mass:RVEDV 
 
RV, right ventricle; RVEDV, right ventricular end-diastolic volume. 
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Figure 3.3. Association of RV mass with peak work, adjusted for RVEDVi, RVEF, PRF, LV 
CO and LV EF 
 
Partial residual plot showing the association between RV mass and peak work, adjusted for indexed 
right ventricular end-diastolic volume (RVEDVi), right ventricular ejection fraction (RVEF), pulmonary 
regurgitant fraction (PRF), left ventricular cardiac output (LV CO) and left ventricular ejection fraction 
(LV EF). For each 10 gram higher RV mass, peak work was 7.5 watts (95% CI 3.3, 1.2) higher. Y axis 
recalibrated to the mean. 
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3.4 DISCUSSION 
In this study, we have shown that RV mass, RV mass:RVEDV and RV mass:BSA 
positively correlated with peak exercise capacity, independent of traditional 
indicators of clinical status, in a group of adult repaired TOF patients with right 
ventricular dilatation, moderate to severe pulmonary regurgitation and near-normal 
exercise capacity. Furthermore, we have shown that PRF and RV dilatation result in 
altered respiratory dynamics during exercise as evidenced by positive correlations 
with VE/VCO2. 
 
Previous research has not provided any certainty in the relationship between cardiac 
MRI variables and peak exercise capacity. Meadows et al.170 retrospectively studied 
cardiac MRI and CPET data from 37 adult patients with repaired TOF and found that 
RV EF was positively and independently correlated with VO2peak, VO2 at anaerobic 
threshold and oxygen pulse. Furthermore, Wald et al.83 performed regional analysis 
of RV function in 62 adult repaired TOF patients and reported that although global 
RV EF was positively correlated with VO2peak, RV outflow tract EF was more strongly 
correlated on univariate analysis and independently correlated in multiple linear 
regression analysis with step-wise selection of variables. However, other previous 
studies have reported no correlation between RV EF and peak exercise capacity.60, 
169 The lack of correlation between RV EF and peak exercise capacity in the current 
study may be explained by lack of statistical power generated from a comparatively 
high overall exercise capacity in our cohort. However, this possible lack of statistical 
power means the positive correlation between RV mass and peak work is even more 
striking. 
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The strong positive and independent correlation between peak work and RV mass 
indicates the importance of an effective level of musculature in the subpulmonary 
ventricle. Furthermore, a positive correlation between peak work and RV 
mass:RVEDV highlights the important contribution of RV compliance towards peak 
exercise capacity. These findings support the notion that RV volume alone may be 
less important than RV mass and its ratio to ventricular volume in the ability to 
produce forward flow of blood into the pulmonary circuit and overall exercise 
capacity. However, these patients with increased RV mass may also have increased 
LV mass, which may have a similar impact on exercise capacity. The lack of 
correlation between exercise capacity and traditional indicators of clinical status 
further underpins the importance of our findings. RV mass has previously been 
shown to be elevated in TOF patients as compared to controls130, 169 and represents 
a compensatory response to haemodynamic insults. RV hypertrophy is mostly 
thought to be a negative adaptive process and is likely in response to long-standing 
pulmonary regurgitation, however, from the evidence presented in our study, this 
adaptation may result in positive effects on exercise capacity. However, there is 
likely a point at which increased RV mass may decrease the ability to produce 
forward flow out of the right ventricle as a result of decreased cavity size and RV 
mass:RVEDV. Futhermore, RV hypertrophy may be viewed as maladaptive in 
patients with RV outflow tract obstruction, which was relatively uncommon in our 
series.  Severe RVH could also potentially predispose to RV diastolic dysfunction, 
which was not formally assessed in the current study. 
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Not surprisingly, biventricular cardiac outputs and stroke volumes were positively 
correlated with peak work. Furthermore, substantial LV-RV interaction is evidenced 
by significant positive correlations between right and left ventricular systolic function. 
Clearly the right ventricle does not act in isolation and is heavily dependent on left 
ventricular function, and vice versa. This finding confirms previous research where 
significant ventricular-ventricular interaction has been reported.81, 127, 130, 148 It has 
been noted, however, that excessive RV hypertrophy can impinge on LV filling, 
which may have adverse effects on exercise capacity.199 
 
Although PRF has previously been reported to be correlated with peak exercise 
capacity,60, 157 when pulmonary regurgitation is alleviated via surgical insertion of a 
pulmonary valve, exercise capacity does not commonly improve.73, 77, 89, 96, 102, 163-168 
RVEDVi also does not seem to be directly related to peak exercise capacity. 
However, both PRF and RVEDVi were negatively correlated with VE/VCO2 indicating 
altered respiratory dynamics during exercise. Altered pulmonary artery anatomy has 
previously been implicated in distorted pulmonary blood flow distribution, ventilation-
perfusion mismatch and inadequate respiratory gas exchange,61, 175 and may 
therefore play a role in the development of exercise incapacity. However, it should 
be noted that VE/VCO2 is not a measure of either submaximal or maximal exercise 
capacity. Rather an elevated VE/VCO2 simply indicates an altered respiratory 
response to a given level of carbon dioxide production. 
 
3.4.1 STUDY LIMITATIONS 
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The main limitation of the present study was that our cohort of adult repaired TOF 
patients demonstrated near normal exercise capacity, compared to previously 
reported groups. Caution therefore needs to be taken before generalising these 
results to the greater TOF population Furthermore, it is possible that correlation 
between certain cardiac MRI and exercise variables were not present due to a lack 
of statistical power as a result, even though ours is a large study for this question. 
Analysis of RV mass is not commonly performed. However, with robust analysis 
protocols, we have performed these measurements with good reproducibility. Finally, 
this was a single centre study only.
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3.5 CONCLUSIONS 
In adult repaired TOF patients with moderate-severe pulmonary regurgitation and RV 
dilatation, RV mass is positively correlated with peak work output during CPET. This 
association is independent of other cardiac MRI variables. Importantly, traditional 
cardiac MRI indicators of clinical status are not significantly correlated with peak or 
submaximal exercise capacity. RV mass may provide a novel marker of clinical 
progress amongst this patient cohort. 
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EXERCISE CAPACITY AND STROKE VOLUME ARE 
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4.1 INTRODUCTION 
 
Pulmonary regurgitation (PR) is very common late after TOF repair in childhood due 
to the frequent need to open the right ventricular outflow tract across the pulmonary 
valve as part of the repair.117 Chronic exposure of the right ventricle (RV) to a 
regurgitant load may lead to progressive RV dilatation, and has been associated with 
adverse events such as increased symptoms, arrhythmia and death.66, 81, 115, 183, 200 
Potential causes of RV dysfunction in adults with repaired TOF include abnormalities 
of the temporal pattern of RV mechanical activation.201 Although PVR is an effective 
way of reducing the volume load on the RV, there is no proof from prospective 
studies that it reduces the risk for adverse outcomes, such as sudden cardiac death, 
sustained ventricular arrhythmias or heart failure.73, 74, 77, 78, 97, 102 The timing of PVR, 
however, is an area of uncertainty. The European Society of Cardiology (ESC), the 
American College of Cardiology (ACC)/American Heart Association (AHA) and the 
Canadian Cardiovascular Society (CCS) have currently published guidelines for PVR 
in adults with repaired TOF.15, 71, 72 Severe PR, together with symptoms and/or 
moderate to severe RV enlargement, are suggested as indicators for PVR. However, 
there is some uncertainty regarding the definition of moderate to severe RV 
enlargement. Based on work conducted by Therrien et al.,73 the CCS guidelines 
suggest an RVEDVi of 170 ml/m2 as an indicator for PVR, as dilatation beyond this is 
unlikely to result in normalisation of RV dimensions post-PVR. Alternatively, the ESC 
includes progressive RV dilatation in indications for intervention after repair of TOF, 
and refers to Oosterhof et al.74 when stating that RV size is unlikely to normalise after 
PVR when RVEDVi is allowed to dilate beyond 160 ml/m2. The ACC/AHA guidelines, 
however, do not indicate what constitutes moderate to severe RV enlargement. In 
practice, an RVEDVi of 150ml/m2 is a commonly used RV volume for recommending 
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PVR in adults with repaired TOF.75 As PVR has limited durability,67 deferring this 
surgery for as long as possible may reduce the number of surgical procedures 
needed over a patient’s lifetime. 
 
In this study, we sought to determine differences in cardiac structure, function and 
exercise capacity in such patients, above and below an RVEDVi of 150 ml/m2. 
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4.2 METHODS  
 
4.2.1 PATIENT POPULATION 
Between April 2009 and February 2010, a total of 55 consecutive patients with 
previously diagnosed TOF or pulmonary atresia with ventricular septal defect 
(PAVSD) were prospectively recruited after being referred to our adult congenital 
heart service for a cardiac MRI and CPET (Table 4.1). 
 
4.2.2 CARDIAC MRI PROTOCOL 
Cardiac magnetic resonance imaging was performed as described in General 
Methods sections 2.2.1 – 2.2.3. 
 
4.2.3 CARDIOPULMONARY EXERCISE TESTING 
Cardiopulmonary exercise testing was performed as described in General Methods 
section 2.3. 
 
4.2.4 STATISTICAL METHODS 
All data are presented as mean±SD or median and range. The patients were divided 
into two groups according to a prospectively defined cut-point for RVEDVi, at 150 
ml/m2. Secondary analyses were performed using RVEDVi cut-points of 160 ml/m2 
and 170 ml/m2. Statistical comparison of parametric data was performed with a 2-
tailed unpaired Student t test. Prespecified primary endpoints of interest were (1) for 
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MRI, the calculated LV cardiac output (as the best overall determinant of cardiac 
performance) and (2) for CPET, the maximum work achieved as a per cent of normal 
(control) values. All other non-primary comparisons were adjusted by the Hochberg 
modification of the Bonferroni correction.202 The relationship between dichotomous 
variables was tested with the χ2 test. A two-tailed p value <0.05 was considered 
statistically significant. Pearson’s correlation coefficient was used to assess relations 
between cardiac MRI and exercise parameters. Statistical analysis was performed 
with SPSS V.19 for Windows (SPSS). 
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4.3 RESULTS 
 
4.3.1 PATIENT POPULATION (n=55) 
Fifty-five patients (mean age at repair 2.3±1.9 years; age at evaluation 26.2±8.8 
years; range 15-49 years; 33 males) were included in this study. Demographic and 
surgical details are shown in Table 4.1. The primary diagnosis in the cohort was most 
frequently TOF (n=50; 91%) with a lesser number of PA-VSD (n=5; 9%). A 
transannular patch (TAP) repair was performed in 46 (84%) patients, while a 
homograft, valvectomy or valve-sparing repair was conducted in 2 (3.5%), 2 (3.5%) 
and 2 (3.5%) patients, respectively. Detailed operative data was not available for 
three patients due to missing medical records. Overall, the patients were assessed 
23.6±7.2 years after surgical repair. 
 
Subjects with RVEDVi of >150 ml/m2 (n=35) were later after initial repair (25.4±7.8 vs 
20.7±5.8 years; p=0.009) and were older at the time of evaluation (28.4±9.7 vs 
22.5±5.5 years; p=0.006). However, there was not a significant difference in primary 
diagnosis (>150 ml/m2; TOF n=33, PA VSD n=2 vs <150ml/m2; TOF n=17, PA VSD 
n=3; p=0.249), age at complete repair (2.5±2.1 years vs 2.0±1.5 years, p=0.344), 
type of primary repair (TAP n=31, homograft n=0, valvectomy n=1, valve sparing 
repair n=1 vs TAP n=15, homograft n=2, valvectomy n=1, valve sparing repair n=1; 
p=0.36), gender (p=0.09). 
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4.3.2 MRI RESULTS (n=55) 
For all subjects considered together, RV dilatation (RVEDVi 163±44 ml/m2; RVESVi 
84±37 ml/m2) and moderate to severe PR (PR fraction 38±10%; PR volume 53±23 
ml/beat) were observed (Table 4.2). Indexed LVEDVi was within the normal range 
(83±15 ml/m2), however, indexed LVESVi was elevated (36±11 ml/m2). Consistent 
with the RV dilatation, QRS duration was prolonged (143±29 ms) (Table 4.1), 
although the effect of LV parameters cannot be excluded. Biventricular indexed 
stroke volumes (SV) and EFs were maintained (RVSVi 79±17 ml/m2; LVSVi 47±8 
ml/m2; RVEF 50±7%; LVEF 58±7%). Fibrosis was rarely detected in the RV body 
(n=1), and more frequently in the RV outflow (n=38). 
 
4.3.3 CARDIOPULMONARY EXERCISE TEST RESULTS (n=55) 
Table 4.3 shows cardiopulmonary exercise test results. Peak work rate reached 
176±51 Watts, which represented 89±15% of that predicted. Peak oxygen 
consumption reached 85±15% of that predicted at 31±8 ml/kg/min. Peak heart rate 
achieved was 173±16 beats/min which was 92±8% of that predicted. Oxygen 
consumption at anaerobic threshold was 21±6 ml/kg/min which represents 68±12% 
of peak oxygen uptake. Ventilatory response to carbon dioxide (VE/VCO2) was 25±3 at 
anaerobic threshold and 28±4 at peak exercise. Percentage of predicted peak work 
achieved significantly correlated with LVEDVi (p=0.048). There were no other 
significant correlations between the variables shown in Table 4.4. 
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4.3.4 RVEDVI OF 160 ml/m2 AND 170 ml/m2 AS CUT-POINTS 
Secondary analyses were performed using RVEDVi cut-points of 160 ml/m2 and 170 
ml/m2. Comparing patients above and below an RVEDVi of 160 ml/m2, LVEDVi 
(p=0.003) and LVSVi (p=0.008) became significantly higher in the more dilated 
group. All LV parameters became insignificant between groups when an RVEDVi of 
170 ml/m2 was used as a cut-point. There were no significances between group 
differences in any exercise parameter, when either of these secondary cut-points 
was used. 
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4.4 DISCUSSION 
 
In this study, we have shown relatively normal submaximal and peak exercise 
parameters in a group of adult patients with repaired TOF, prospectively recruited 
from a single centre, with pulmonary regurgitation and right ventricular dilatation. 
When the group was divided into those above and below an RVEDVi of 150ml/m2, 
there was no significant difference in measured values of maximal exercise capacity. 
In fact, exercise capacity was at near-normal levels, even in the more dilated group, 
despite greater PR, RV dilatation and lower normal RVEF. This leaves the crucial 
decision of PVR timing less certain, in adult patients with repaired TOF. 
 
Over the entire cohort, measures of peak exercise capacity were higher than 
previously reported in similar groups of adult repaired TOF patients (VO2peak: 21.1-
27.6 ml/kg/min; per cent achieved of predicted VO2 peak: 51-78%; peak work: 109-
143 Watts; peak heart rate: 146-163 beats/min).77, 159, 161, 162, 170 Measures of 
ventricular function, age at evaluation, or age at TOF repair surgery do not explain 
the disparity in exercise capacity, as our results do not meaningfully differ from those 
of past research with respect to these parameters. 77, 159, 161, 162, 170 Relatively 
preserved heart rate responses, and/or an era effect may contribute to these 
favourable results. 
 
Chronotropic incompetence contributes to exercise intolerance and is related to long-
term outcomes in repaired TOF.171 Our cohort exhibited a substantially increased 
heart rate at peak exercise compared with previous similar studies, 77, 159, 161, 162, 170 
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and offers in part an explanation for the preserved exercise capacity we observed. It 
should be noted that none of the patients in our study had evidence of resting or 
exercise-induced arrhythmia. There is also the possibility of an era effect, with our 
data being collected on a young group of patients in a later time period (2008-2011), 
compared with previous studies. 77, 159, 161, 162, 170 In this regard, surgical technique, 
postoperative care and clinical management of patients may have differed from the 
previously published groups of patients. 
 
Since adults with repaired TOF patients have previously been shown to respond 
positively to a structured program of physical activity,177 higher levels of physical 
activity in our patient group may also be a plausible contributor to the high exercise 
capacity we observed. Previous studies have shown physical activity levels to be low 
in adult repaired TOF patients, where this data was generated from the northern 
hemisphere.177 It is possible that our patients (in Australia) were encouraged to 
participate in physical activity from a young age, and this may have had an impact in 
preserving and optimising their exercise capacity, however, such data were not 
routinely collected. More investigation into the opportunities provided, and the impact 
of shifting attitudes regarding physical activity in this group of patients certainly 
deserves additional detailed study. 
 
Our study demonstrates a lack of correlation between baseline RV volumes and 
peak exercise capacity in PR. This result is in keeping with previous studies which 
have similarly failed to show a relationship between RV dilatation and exercise 
capacity.170 Moreover, in the context of a dilated but not concentrically hypertrophied 
RV as a result of PR, LV systolic function is not impaired by ventricular interaction, as 
Chapter 4 Exercise Capacity and Stroke Volume are Preserved Even with Severely 
Dilated Right Ventricle, Late After Tetralogy Repair 
 
83 
may be the case of RV hypertrophy resulting from pulmonary stenosis.199 Since 
oxygen saturations and LV function are not compromised as the RV dilates, oxygen 
delivery to working muscles and exercise capacity would not be expected to 
decrease (unless the RV stroke volume fails). Our findings thus question the 
presumption that RV dilatation inevitably impairs exercise performance and forms an 
important piece of evidence as to why repaired TOF patients may not improve their 
exercise capacity after PVR. Although limited conclusions can be drawn from cross-
sectional data, it is worth noting that the more dilated group was significantly older 
than the less dilated group. There is currently no satisfactory data regarding the 
temporal patterns of RV dilatation. Our findings suggest that long-term monitoring of 
RV structure is warranted which would be best addressed by a large prospective 
study. 
 
Late after TOF repair, PR is known to be associated with RV dilatation and systolic 
dysfunction,203 which can result in heart failure, exercise intolerance, arrhythmia and 
death.66, 81, 115, 183, 200 The optimal timing of PVR in TOF patients is a point of 
contention, particularly in asymptomatic patients. The ESC, ACC/AHA and CCS have 
published guidelines for PVR late after TOF repair.15, 71, 72 There is general 
agreement that the decision for PVR involves consideration of the presence or 
absence of symptoms, the degree of PR, RV function, exercise capacity, arrhythmia 
and the degree of RV enlargement. There is, however, some disagreement about the 
volume to which the RV can be allowed to dilate prior to PVR, whilst still achieving 
beneficial remodelling post surgery. Threshold RVEDVi measurements of between 
150 ml/m2 and 170 ml/m2 have been suggested as points above which normalisation 
of RV dimension becomes unlikely.15, 71, 73-75, 78, 80 In order to minimise the number of 
lifetime procedures in these subjects with PR, developing more specific markers for 
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detecting adverse adaptive mechanisms to PR would be useful in assisting decision 
making concerning the timing of surgery. 
 
4.4.1 STUDY LIMITATIONS 
The observed similarities in RV systolic function between the two groups in this study 
may be explained to some extent, by resting cardiac MRI measurements being 
compared with exercise variables measured at a point of maximal exertion. Future 
studies may need to focus on assessment of cardiac function during exercise to 
elucidate parameters more relevant to the maximally functioning heart. Furthermore, 
longitudinal data relevant to the chronically dilating RV may be important in 
understanding the RV-adaptive mechanisms of PR. Also, we have not directly 
examined two other factors that might influence the timing of PVR for dilated RV; 
propensity to arrhythmia or ability of the RV to diminish in size postoperatively. These 
other factors require consideration in clinical decision making. 
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4.5 CONCLUSIONS 
 
We found peak exercise capacity to be higher than previously reported, and near-
normal in our cohort of adults with dilated RVs late after TOF repair. Contributors 
may include appropriate peak heart rate, good physical activity levels or an era 
effect. Furthermore, our patients exhibited near-normal exercise capacity and 
maintained biventricular systolic function, even in those with RVs dilated well beyond 
150 ml/m2. These results question the validity of using this marker of RV dilatation as 
the major basis for replacing the pulmonary valve in this setting.
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5.1 INTRODUCTION 
Long standing PR is a common occurrence after the repair of TOF due to pulmonary 
valve excision and/or the frequent use of transannular patch during initial repair of 
the right ventricular outflow tract. Exposure of the RV to a chronic regurgitant load 
leads to RV dilatation and has been associated with negative consequences such as 
exercise intolerance, arrhythmia and sudden cardiac death.60, 61, 66, 170, 204-206 
 
RV dilatation in the moderate to severe range is frequently observed in young adult 
life in repaired TOF patients, at which point replacement of the pulmonary valve is 
considered. PVR has been shown to be safe and effective in reducing PR, RV 
dilatation and QRS duration.69, 73, 74, 77, 102, 164, 165, 189 However, controversy surrounds 
the degree to which the RV should be “allowed to dilate” before the need for surgical 
intervention. Many centres advocate a conservative approach of performing surgery 
when RVEDVi reaches 150 mL/m2. However, there is some evidence that the RV 
can be allowed to dilate to as large as 170 mL/m2 73, 74 whilst still achieving 
normalisation of RV volume after PVR (RVEDVi ≤ 108 mL/m2 207). PVR timing is 
based on these RV volumetric cut-points, yet the progression of RV dilatation 
towards these milestones is poorly understood. Furthermore, the contributions of RV 
muscular corpus (RVMC) and RV outflow tract (RVOT) volumes in the temporal 
changes of global RV dilatation have yet to be investigated. Two recent reports have 
suggested only slow if any progression of RV volumes in this clinical context.89, 208 
We therefore sought to characterize temporal changes in global RV, RVOT and 
RVMC volumes in TOF patients, in our adult congenital heart disease cohort. 
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5.2 METHODS 
 
5.2.1 PATIENT POPULATION 
140 adult repaired TOF patients had undergone cardiac MRI in our imaging facility; 
69 subsequently underwent PVR or percutaneous pulmonary valve implantation. Of 
the remaining 71 patients who had not undergone surgical or percutaneous 
procedure to implant a pulmonary valve, 14 had 1 or more follow up cardiac MRIs. 
Data was used in these 14 patients referred for 2 clinically indicated cardiac MRIs, 
and if more than 2 scans had been undertaken, the greatest inter-MRI period was 
chosen. Overall, the inter-cardiac MRI period was 2.1 ± 1.0 years. 
 
5.2.2 CARDIAC MAGNETIC RESONANCE IMAGING PROTOCOL 
Cardiac magnetic resonance imaging was performed as described in General 
Methods sections 2.2.1 – 2.2.3. 
 
5.2.3 STATISTICAL METHODS 
All data are presented as mean ± SD. Statistical comparison of initial and follow up 
MRI data was performed with a 2-tailed paired Student t tests. The pre-specified 
primary study endpoint was change in RVEDVi. As other endpoints were inter-
related and the study was exploratory in nature, p-values were not adjusted for 
multiple comparisons. Pearson’s correlation coefficient was used to assess relations 
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between change in RVEDVi and other MRI variables. Inter-observer variability in 
RVOT volume analysis was assessed via interclass correlation. Statistical 
significance was inferred at a two-tailed p-value <0.05. Statistical analyses were 
performed with SPSS V.21 for Windows (SPSS). 
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5.3 RESULTS 
 
5.3.1 PATIENT POPULATION (N=14) 
Cardiac MRI data was included from 14 patients (age at evaluation 26 ± 11 years; 
mean age at repair 3.2 ± 2.9 years; 7 males). Patient demographics and surgical 
details are outlined in Table 5.1. TOF was the primary diagnosis and a trans-annular 
patch repair had been performed in all 14 patients. 
 
5.3.2 MRI RESULTS (N=14) 
MRI results are displayed in Table 5.2. Initially, the cohort had moderate RV 
dilatation (RVEDVi; 142 ± 19 mL/m2, RVESVi; 68 ± 17 mL/m2), moderate to severe 
PR (PR fraction; 33 ± 11%) and normal RV ejection fraction (RVEF; 53 ± 8%). 
Indexed LV end-diastolic volume (LVEDVi; 76 ± 10 mL/m2) and LV ejection fraction 
(LVEF; 61 ± 5%) were within normal ranges, however, LV end-systolic volume was 
mildly elevated (LVESVi; 30 ± 7 mL/m2). LV and RV stroke volumes were maintained 
(LVSV; 82 ± 15 mL, RVSV; 132 ± 21 mL). RVOT volume was 8.6 ± 4.6% of RV 
volume (indexed RVOT end-diastolic volume [RVOT EDVi]; 12 ± 7 mL/m2).  
 
After 2.1 ± 1.0 years, RVEDVi had increased significantly (to 151 ± 20 mL/m2, 
p=0.005; change=8.4 ± 9.3 mL/m2, range=-6 to 26 mL/m2; annual mL/m2 
increase=4.3 ± 4.6; annual percentage increase=3.1 ± 3.3%). RVESVi (77 ± 19 
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mL/m2, p=0.009) and RVMC indexed end-diastolic volume (RVMC EDVi; 138 ± 20 
mL/m2, p=0.014) also increased, and RVEF decreased (49 ± 7%, p=0.039). RVEDVi 
increased from below to above an RVEDVi of 150 mL/m2 in 3 patients (see Figure 
5.1).  No other RV or LV structural or functional measures significantly changed in 
the period between MRIs. 
 
Change in RVEDVi was significantly correlated with initial LVEDVi (r=-0.582, 
p=0.029), initial RVEDVi:LVEDVi (r=0.6, p=0.023) and change in RVMC EDVi 
(r=0.919, p<0.001) but not change in RVOT EDVi (r=0.182, p=0.552) (see Figure 
5.2). 
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Table 5.1. Cohort characteristics   
Participants (n)   14 
Age (years)   26 ± 11 
Males (n)   7 
Age at TOF repair (years)  3.2 ± 2.9 
Years between TOF repair and 1st MRI 23 ± 8 
TOF indicates tetralogy of Fallot  
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Table 5.2. Cardiac MRI values at initial and follow up MRI 
   MRI 1 MRI 2 Change 
RVEDVi (mL/m2)  142 ± 19 151 ± 20* 8.4 ± 9.3 
RVESVi (mL/m2)  68 ± 17 77 ± 19* 9.2 ± 11.3 
RVMC EDVi (mL/m2) 130 ± 19 138 ± 20* 7.6 ± 9.5 
RVOT EDVi (mL/m2) 12 ± 7 13 ± 6 0.4 ± 1.7 
RVSV (mL)  132 ± 21 132 ± 23 0.1 ± 13.8 
RVEF (%)   53 ± 8 49 ± 7* -3.6 ± 5.8 
RVCO (L)   9.0 ± 1.3 9.0 ± 1.6 0.0 ± 1.4 
PRF (%)   33 ± 11 33 ± 12 0.3 ± 4.4 
RV:LV ratio  1.9 ± 0.3 1.9 ± 0.3 0.0 ± 0.2 
LVEDVi (mL/m2)  76 ± 10 79 ± 11 3.0 ± 7.2 
LVESVi (mL/m2)  30 ± 7 31 ± 7 1.1 ± 5.7 
LVSV (mL)  82 ± 15 85 ± 15 3.3 ± 11.2 
LVEF (%)   61 ± 5 60 ± 5 -1.1 ± 4.4 
LVCO (L)     5.6 ± 0.6 5.8 ± 1.1 0.2 ± 1.1 
* indicates p<0.05; EDVi indicates indexed end-diastolic volume;  
ESVi, end-systolic volume; RVMC, RV muscular corpus; RVOT, RV 
outflow tract; SV, stroke volume; EF, ejection fraction; CO, cardiac 
output; PRF, pulmonary regurgitant fraction.  
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Figure 5.1. Right ventricular volume at first and second MRI 
 
RVEDVi indicates indexed right ventricular end-diastolic volume. 
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Figure 5.2. Correlation of change in RVEDVi with change in RVMC EDV 
 
 
 
RVEDVi indicates indexed right ventricular end-diastolic volume. 
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5.4 DISCUSSION 
 
In our cohort of adult repaired TOF patients with free PR, RV volumes significantly 
increased over 2 years, from 5% below the commonly used RVEDVi indicator for 
PVR of 150 mL/m2 to marginally above this cut-point. The observed RV dilatation 
was related to RVMC volume enlargement but not change in RVOT size, initial 
RVEDVi or initial PR fraction. In addition to RV dilatation, RVEF significantly 
decreased during the inter-MRI period. 
 
The natural history of RV dilatation in repaired TOF has not been thoroughly studied. 
Our results are in contrast to previous reports which did not show a significant 
increase in RV size or deterioration of RV function over a similar period of time.89, 208 
There was some variation in the degree of change in RV size, with 3 patients 
experiencing approximately up to 25 mL/m2 increase in RVEDVi and 3 patients 
exhibiting minimal change in serial RV volumes. The RV dilated moderately in the 
remaining 8 patients. This variation can, to some extent, be explained by the degree 
to which the RVMC dilated. We showed that those patients with greater RVMC 
dilatation experienced greater increase in global RV size. 
 
Progression of RV size is important in this setting, as it has significant implications 
for the timing of PVR and imaging follow up periods. Specifically, rapid RV dilatation 
may warrant early surgical intervention and short follow up periods. Early PVR may 
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have the advantage of preventing the potentially damaging effects of an enlarged 
RV.77, 209 However, reintervention due to limited valve lifespan 210, 211 requires 
consideration, particularly in asymptomatic patients. 
 
5.4.1 STUDY LIMITATIONS 
This study was limited by the small number of patients and the relatively short time 
frame over which they were followed. There is also the possibility of selection bias 
from patients with echocardiographic evidence of a dilating RV being referred for 
cardiac MRI. Larger, long-term prospective studies are required to better understand 
progression of RV dilatation and its determinants throughout the lifespan of TOF 
patients. 
 
5.5 CONCLUSIONS 
The RV continues to dilate in many patients with PR late after TOF repair, 
approximately 5-10% over 2 years. These data might inform a reasonable interval for 
serial MRI scanning, especially given the inaccuracy of cardiac ultrasound for 
precise measurements of RV volumes.
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6.1 INTRODUCTION 
We have recently demonstrated that patients with repaired TOF have near normal 
exercise capacity, even in the setting of severe RV dilatation and severe PR.212 
However, the mechanisms whereby cardiac output is augmented with exercise in 
this setting are poorly understood. 
 
Recently, real-time MRI techniques have been developed, to allow imaging of 
cardiac structures and blood flow during exercise.213, 214 A thorough appreciation of 
the biventricular response to exercise in adult repaired TOF may facilitate a more 
complete understanding of the onset and underlying causes of exercise-related 
symptoms. Furthermore, in patients who are asymptomatic and have normal or near-
normal exercise capacity the addition of real-time MRI imaging of the exercising 
heart may provide greater sensitivity in observing altered cardiac function, when 
compared to resting MRI alone. 
 
We thus studied ventricular function and cardiac flows during exercise in adults with 
repaired tetralogy of Fallot with moderate to severe pulmonary regurgitation and RV 
dilatation and correlate these measures with objective assessments of exercise 
capacity. 
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6.2 METHODS 
 
6.2.1 STUDY POPULATION 
Sixteen adult repaired tetralogy of Fallot patients were prospectively recruited to 
undergo clinically indicated resting cardiac MRI, cardiac MRI during exercise and a 
standard CPET. The exercise cardiac MRI and CPET were performed on the same 
day as the resting cardiac MRI in all but 2 cases, where they returned within a 
month. Patients were included in the study if they had TOF as a primary diagnosis 
(TOF variants were excluded), were older than 15 years, had an RVEDVi > 105 
mL/m2 and had a PR fraction > 20%. Eight healthy age and gender matched 
controls were also recruited for comparison. The control group underwent exercise 
cardiac MRI and CPET on the same day. Controls were included if they undertook 2 
or less structured exercise sessions per week. 
 
6.2.2 RESTING CARDIAC MRI PROTOCOL 
Cardiac magnetic resonance imaging was performed as described in General 
Methods sections 2.2.1 – 2.2.2. 
 
6.2.3 EXERCISE CARDIAC MRI PROTOCOL 
Cardiac magnetic resonance imaging was performed as described in General 
Methods section 2.2.4. 
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2.4 BICYCLE CARDIOPULMONARY EXERCISE TESTING PROTOCOL 
Bicycle cardiopulmonary exercise testing was performed as described in General 
Methods section 2.3. 
 
2.5 STATISTICAL METHODS 
All data are presented as mean ± SD. Statistical comparisons were performed with 
2-tailed paired Student t tests; paired samples t test for within group comparisons 
and independent samples t test for between group comparisons. Pearson’s 
correlation coefficient was used to assess relations between resting cardiac MRI, 
exercise cardiac MRI and CPET variables. A two-tailed p-value of <0.05 was used to 
infer statistical significance. Statistical analyses were performed with SPSS V.21 for 
Windows (SPSS). 
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6.3 RESULTS 
 
6.3.1 PARTICIPANT CHARACTERISTICS 
All TOF patients (n=16) had a transannular patch repair at a mean age of 2.2 ± 1.3. 
In TOF patients, height was 173 ± 9 cm, weight was 69 ± 15 kg and there were 10 
(63%) males. In the controls, group height was 180 ± 6 cm, weight was 77 ± 13 kg 
and there were 5 (63%) males. There were no statistically significant differences 
between the TOF and control groups in the above mentioned patient characteristics. 
  
6.3.2 RESTING CARDIAC MRI RESULTS 
Resting cardiac MRI results are shown in Table 6.1. Overall, the group had severely 
dilated RVs, moderate-severe PR fraction and lower-normal RVEF. 
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Table 6.1. Resting cardiac MRI results in TOF patients. 
Indexed left ventricular end-diastolic volume (mL/m2) 78 ± 11 
Indexed left ventricular end-systolic volume (mL/m2) 32 ± 9 
Left ventricular stroke volume (mL/beat) 83 ± 13 
Left ventricular ejection fraction (%) 59 ± 6 
Left ventricular cardiac output (L/min) 6.2 ± 1.0 
Indexed right ventricular end-diastolic volume (mL/m2) 149 ± 37 
Indexed right ventricular end-systolic volume (mL/m2) 73 ± 25 
Right ventricular stroke volume (mL/beat) 139 ± 40 
Right ventricular ejection fraction (%) 52 ± 7 
Right ventricular cardiac output (L/min) 10.4 ± 3.3 
Pulmonary regurgitant fraction (%) 35 ± 12 
Regurgitant volume (mL/beat) 46 ± 27 
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6.3.3 EXERCISE CARDIAC MRI RESULTS 
6.3.3.1 TOF patients vs Controls 
There were no significant differences in biventricular ejection fractions between TOF 
patients and controls, other than lower RVEF during Level 2 exercise in TOF patients 
(51 ± 10% vs 61 ± 9%, p=0.045). Aortic and pulmonary artery net forward flow as 
well as ventricular output were significantly lower in TOF patients than controls at 
rest (aortic net forward flow: 72 ± 14 vs 98 ± 12 mL/beat, p<0.001; pulmonary artery 
net forward flow: 72 ± 20 vs 93 ± 9 mL/beat, p=0.009; LV output: 5.6 ± 1.4 vs 6.9 ± 
1.5 L/min, p=0.042) and both levels of exercise ([Level 1: aortic net forward flow: 76 
± 14 vs 100 ± 14 mL/beat, p=0.001; pulmonary artery net forward flow: 74 ± 20 vs 96 
± 15 mL/beat, p=0.014; LV output: 7.7 ± 1.7 vs 10.1 ± 1.5 L/min, p=0.003; RV output: 
7.5 ± 2.2 vs 9.6 ± 1.7 L/min, p=0.028] [Level 2: aortic net forward flow: 75 ± 11 vs 
102 ± 19 mL/beat, p<0.001; pulmonary artery net forward flow: 69 ± 12 vs 95 ± 21 
mL/beat, p=0.01; LV output: 9.3 ± 1.9 vs 13.1 ± 1.9 L/min, p<0.001]), despite no 
difference in heart rate (Rest: 76 ± 10 vs 70 ± 10 beats per minute, p=0.22, Level 1: 
100 ± 10 vs 100 ± 5, p=0.735, Level 2: 123 ± 17 vs 127 ± 12, p=0.50) (see Figures 
6.1 and 6.2). 
 
6.3.3.2 Within group changes from rest to Level 2 during exercise cardiac MRI 
Biventricular cardiac output significantly increased during exercise in both TOF 
patients (RV output: 5.2 ± 1.6 to 8.5 ± 1.6 L/min, p<0.001; LV output: 5.3 ± 1.0 to 9.3 
± 1.9 L/min, p<0.001) and controls (RV output: 6.6 ± 1.4 to 11.9 ± 1.7 L/min, 
p<0.001; LV output: 6.9 ± 1.5 to 13.1 ± 1.9 L/min, p<0.001), despite no significant 
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increase in aortic (TOF: 70 ± 12 to 75 ± 11 mL/beat, p=0.152; control: 98 ± 12 to 102 
± 19 mL/beat, p=0.306) or pulmonary artery net forward flow (TOF: 70 ± 19 to 69 ± 
12 mL/beat, p=0.854; control: 93 ± 9 to 95 ± 21 mL/beat, p=0.648). TOF patients 
augmented forward flow out of the RV by significantly decreasing PR fraction (37 ± 
15 to 31 ± 15%, p=0.002) and increasing RVEF (44 ± 7 to 51 ± 10%, p=0.025) and 
heart rate (75 ± 10 to 123 ± 17 beats per minute, p<0.001). LVEF also significantly 
increased in TOF patients (47 ± 8 to 52 ± 11%, p=0.015).Controls increased 
biventricular output via a significant increase in biventricular ejection fractions 
(RVEF: 49 ± 7 to 61 ± 9%, p=0.003; LVEF: 51 ± 3 to 56 ± 5%, p=0.004) and heart 
rate (70 ± 11 vs 127 ± 12 beats per minute, p<0.001) (see Figures 6.1, 6.2 and 6.3). 
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Figure 6.1. Tetralogy of Fallot and Control exercise MRI results 
 
AoNFF: aortic net forward flow; PA NFF: pulmonary artery net forward flow; PRF: pulmonary 
regurgitant fraction; RVEF: right ventricular ejection fraction; HR: heart rate; TOF: tetralogy 
of Fallot. 
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Figure 6.2. Tetralogy of Fallot and Control exercise MRI results 
 
LVCO: left ventricular cardiac output; RVCO: right ventricular cardiac output; TOF: tetralogy 
of Fallot. 
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Figure 6.3. Right ventricular ejection fraction at rest, Level 1 and Level 2 in tetralogy of 
Fallot patients and Controls 
 
TOF: tetralogy of Fallot. 
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6.3.4 CARDIOPULMONARY EXERCISE TEST RESULTS 
Overall, TOF patients exhibited near-normal exercise capacity. VE/VCO2 (27 ± 3 vs 27 
± 3, p=0.921), percentage of peak work at anaerobic threshold (66 v 8 vs 72 ± 7%, 
p=0.108) and respiratory exchange ratio at peak exercise (1.22 ± 0.1 vs 1.26 ± 0.08, 
p=0.347) were not significantly different between TOF patients and controls. When 
compared to control data, however, TOF patients had significantly decreased 
submaximal and maximal exercise capacity (Peak work: 172 ± 47 Watts [83 ± 15% 
predicted] vs 295 ± 52 Watts [121 ± 15% predicted], p<0.001; VO2peak: 30 ± 9 
mL/kg/min [73 ± 15% predicted] vs 44 ± 9 mL/kg/min [100 ± 16% predicted], 
p=0.006). 
 
3.5 CORRELATIONS 
RVEF at Level 2 correlated positively with PR fraction at Level 2 (r=0.575, p=0.025) 
and anaerobic threshold as a percentage of peak oxygen consumption (r=0.564, 
p=0.029). Change in RVEF from rest to Level 2 also positively correlated with 
anaerobic threshold as a percentage of peak oxygen consumption (r=0.684, 
p=0.005). 
 
Resting cardiac MRI RVEDVi positively correlated with PR fraction at Level 2 
(r=0.523, p=0.046) but not RVEF during exercise. RV end-diastolic (rest: r=0.766, 
p=0.001; Level 1: r=0.820, p<0.001; Level 2: r=0.798, p<0.001) and end-systolic 
(rest: r=0.711, p=0.002; Level 1: r=0.694, p=0.003; Level 2: r=0.662, p=0.007) areas 
used to calculate real-time ejection fractions from four chamber images during 
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exercise cardiac MRI strongly correlated with resting cardiac MRI RVEDVi and 
indexed RV end-systolic volume,  respectively.
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6.4 DISCUSSION 
In repaired TOF patients with severe RV dilatation and moderate-severe PR, 
increasing exercise intensity during MRI resulted in increased heart rate, increased 
RVEF, increased biventricular cardiac output, decreased PR fraction and no change 
in biventricular net forward flow per beat. Maximal and submaximal exercise capacity 
during CPET were near-normal in TOF patients, suggesting that our observed 
cardiac responses to exercise provide a sufficient mechanism to maintain near-
normal exercise capacity in this patient cohort, despite the significant residual right 
heart abnormalities. 
 
In the healthy population, LV output increases during exercise in proportion to work 
rate in order to maintain adequate supply of oxygenated blood to working muscles. 
An increase in heart rate, stroke volume and ejection fraction leads to this increase 
in cardiac output.215 Our results in TOF patients and controls support these previous 
findings. Augmentation in RV forward flow during exercise is particularly important 
because of its relationship to LV preload and subsequent ejection into the systemic 
circulation. “Forward” RV output at rest is potentially compromised in TOF patients 
by regurgitation across the pulmonary valve. However, our results showed that PR 
fraction decreased as exercise intensity increased, which augmented net forward RV 
output. A likely explanation of the observed decrease in PR fraction during exercise 
may be reduced diastolic filling time, as heart rate increases. 
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Correlations between resting cardiac MRI RV volumes and functional outcomes have 
not previously been reported.170 In the present study, there were no relationships 
between resting cardiac MRI RVEDVi and submaximal or maximal exercise capacity. 
It is worth noting, however, that one patient with an RVEDVi of 270 mL/m2 failed to 
increase RVEF during exercise and exhibited the poorest exercise capacity on 
CPET, which may suggest negative functional consequences with extreme RV 
dilatation. 
 
The overarching narrative in TOF research describes an enlarged RV as impaired. 
However, we have presently and previously212 found that in our patients with 
severely dilated RVs and moderate-severe PR, exercise capacity is maintained at 
near-normal levels. This was achieved via increased RV output as a result of 
increasing heart rate, increasing RVEF and decreasing PR fraction. Furthermore, 
biventricular net forward flow and exercise capacity were not correlated to RV 
dilatation. Although our research has suggested functional outcomes may not be 
related to RV size, the possibility of malignant arrhythmia and sudden cardiac death 
in patients with severely dilated RVs necessitates careful consideration as to the 
degree to which the RV is allowed to dilate in adult repaired TOF patients before the 
pulmonary valve is replaced. Further research may reveal cardiac exercise MRI 
measures to be useful criteria for the optimal timing of pulmonary valve replacement 
in TOF. In particular, serial assessment of RVEF during exercise may provide 
invaluable insights into RV performance as the RV dilates and may eventually form 
part of clinical decision making. 
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6.4.1 STUDY LIMITATIONS 
Cardiac responses to exercise are somewhat altered in the supine position. Venous 
return is augmented when compared to the upright position and results in higher pre-
load and subsequent stroke volume. In fact, since stroke volume plateaus during 
exercise and it is at a higher level at rest in the supine position, it is not necessarily 
surprising that our measures of stroke volume did not increase. Calculating 
biventricular ejection fractions on exercise from four chamber cine images has 
previously been seen as a limitation. However, the accuracy of our measurements is 
supported by previous validation of this technique196 and strong correlation of 
retrospectively gated clinical cardiac MRI RVEDVi and indexed RV end-systolic 
volume with real-time four chamber end-diastolic and end-systolic volumes. Another 
limitation was that movement of subjects during exercise MRI and possible muscular 
fatigue at higher levels of exercise meant that we were unable to capture some of 
the data at maximal exercise. 
Chapter 6 Mechanisms of Maintained Exercise Capacity in Adults with Repaired Tetralogy of Fallot 
 
114 
6.5 CONCLUSIONS 
Exercise capacity was maintained at near-normal levels in TOF patients via 
increased RV output, which was facilitated by an increased heart rate, increased 
RVEF and no change in biventricular net forward flow per beat, as exercise intensity 
increased. PR fraction decreased secondary to decreased diastolic time with 
increased heart rate. It is apparent that adult repaired TOF patients with severely 
dilated RVs develop compensatory mechanisms to augment forward flow out of the 
enlarged ventricle, and therefore, maintain near-normal exercise capacity.
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RIGHT VENTRICULAR OUTFLOW TRACT ENLARGEMENT PRIOR 
TO PULMONARY VALVE REPLACEMENT IS ASSOCIATED WITH 
POORER STRUCTURAL AND FUNCTIONAL OUTCOMES, IN 
ADULTS WITH REPAIRED TETRALOGY OF FALLOT 
Chapter 7 Right Ventricular Outflow Tract Enlargement Prior to Pulmonary Valve 
Replacement is Associated with Poorer Structural and Functional Outcomes, in Adults with 
Repaired Tetralogy of Fallot 
 
116 
7.1 INTRODUCTION 
 
Trans-annular Patch repair of TOF leaves patients with PR which, in the long term, 
leads to RV dilatation, which in turn has been associated with exercise intolerance, 
arrhythmia, RV dysfunction and sudden cardiac death.60, 61, 66, 204-206 As such, PVR is 
a very common late procedure in young adults with repaired TOF and has been 
shown to be safe and effective in reducing pulmonary regurgitation, RV volume, 
QRS duration and improving exercise capacity.69, 73, 74, 77, 102, 164, 165, 189 However, 
these beneficial results need to be balanced against the risk associated with repeat 
PVR due to a limited lifespan of the implanted valve and the lack of conclusive 
evidence for improved survival.76, 195, 210, 216 Thus, the timing of PVR is of great 
importance and is a point of current conjecture.73-76, 78 
 
Previous reports have documented the effects of PVR in adults with impaired 
exercise capacity prior to PVR 69, 73, 74, 77, 102, 165 and have failed to consider regional 
aspects of RV structure in assessing the responses to PVR surgery. In particular, we 
were concerned that dilatation of the RVOT would not necessarily diminish after PVR 
(as opposed to likely diminution in size of the RVMC) and that residual enlargement 
of the RVOT would be associated with (i) failure to normalise RV volumes after PVR 
and (ii) failure of exercise capacity to improve. We therefore studied regional RV 
volumes and exercise capacity, in adults with PR after TOF repair, before and after 
clinically indicated PVR.  
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7.2 METHODS 
 
7.2.1 PATIENT POPULATION 
Between April 2009 and December 2012, a total of 18 repaired TOF patients referred 
to our adult congenital heart service for a cardiac MRI and CPET were prospectively 
recruited to undergo these assessments both before and approximately one year 
after surgical PVR (Table 7.1). 
 
7.2.2 CARDIOVASCULAR MRI PROTOCOL 
Cardiac magnetic resonance imaging was performed as described in General 
Methods sections 2.2.1 – 2.2.3. 
 
7.2.3 CARDIOPULMONARY EXERCISE TESTING 
Cardiopulmonary exercise testing was performed as described in General Methods 
section 2.3. 
 
7.2.3 STATISTICAL METHODS 
All data are presented as mean ± SD. Statistical comparison of pre and post-PVR 
data was performed with a 2-tailed paired Student t tests. Pearson’s correlation 
coefficient was used to assess relations between pre-PVR RVEDVi and post-PVR 
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changes in MRI and CPET variables. Interclass correlation was used to assess inter-
observer variability in RVOT volume analysis. Statistical significance was inferred at 
a two-tailed p-value <0.05. Statistical analyses were performed with SPSS V.21 for 
Windows (SPSS). 
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7.3 RESULTS 
 
7.3.1 PATIENT POPULATION (N=18) 
Eighteen patients (mean age at repair 2.0 ± 1.1 years; age at evaluation 25 ± 8 
years; 14 males) were studied. Demographic and surgical details are shown in Table 
7.1. All included patients had a primary diagnosis of TOF and had a trans-annular 
patch repair. A Medtronic Mosaic porcine valve was implanted in 15 patients (83%), 
a pulmonary homograft in 2 patients (11%) and an aortic homograft in 1 patient (6%). 
Overall, PVR surgery was performed 23 ± 7 years after initial TOF repair and the 
post-PVR assessment was performed 14 ± 3 months after the procedure. 
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Table 7.1. Cohort characteristics 
  
Participants (n)   18 
Age (years)   25 ± 8 
Males (n)   14 
Height (cm)   174 ± 8 
Weight (kg)   74 ± 14 
Age at TOF repair (years)  2 ± 1 
PVR details    
 Bioprosthesis (n)  15 
 Pulmonary homograft (n) 2 
 Aortic homograft (n) 1 
 Cross clamp time (min) 47 ± 18 
 Pulmonary artery augmentation (n) 10 
 Transventricular incision (n) 18 
Years between TOF repair and PVR 23 ± 7 
PVR indicates pulmonary valve replacement; TOF, 
tetralogy of Fallot   
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7.3.2 MRI RESULTS (N=18) 
MRI results are presented in Table 7.2. Pre-operatively, the group had severe RV 
dilatation (RVEDVi; 186.3 ± 32.3 mL/m2, RVESVi; 98.3 ± 30 mL/m2) and moderate to 
severe PR (PR fraction; 39.7 ± 5.7 %). LVESVi was elevated (34.9 ± 12 mL/m2), 
however, LVEDVi was within the normal range (84.7 ± 14.7 mL/m2). 
 
Changes observed after PVR are shown in Table 7.2. There were the expected 
significant reductions in RVEDVi (186.3 ± 32.3 vs 114.2 ± 19.7 mL/m2; p<0.001), 
RVESVi (98.3 ± 30 vs 61.9 ± 16.7 mL/m2; p<0.001), RV SV (p<0.001), RV CO 
(P<0.001), PR fraction (p<0.001), tricuspid regurgitant fraction (p=0.023) and RV to 
LV ratio (2.2 ± 0.4 vs 1.3 ± 0.2; p<0.001). There were no significant changes in LV 
structure or function as a result of PVR. 
 
Figure 7.1 shows pre and post-operative RVEDVi for each patient. All patients 
showed a decrease in RVEDVi after PVR, however, “normalisation” (RVEDVi ≤ 108 
mL/m2) 207 was only achieved in 7 of the 18 patients. The mean pre-PVR RVEDVi in 
the group that did normalise was 165 ± 19 mL/m2 and was 200 ± 33 mL/m2 in those 
who did not. The largest RV to achieve normalisation had a pre RVEDVi of 190 
mL/m2. 
 
Regional analysis of right ventricular outflow tract and right ventricular muscular 
corpus 
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Pre-PVR volumes and ejection fractions for the fibrous RVOT and RVMC are shown 
in Table 7.4. RVOT end-systolic volume (RVOT ESV; 36.7 ± 23.6 mL) was larger 
than RVOT end-diastolic volume (RVOT EDV; 30.6 ± 18.2 mL), indicating dyskinetic 
movement of this segment in systole. By contrast, the RVMC did contract, as 
expected (RVMC end-systolic volume [RVMC ESV]; 145.2 ± 48.4 mL, RVMC end-
diastolic volume [RVMC EDV]; 314.1 ± 60.8 mL). Due to RVOT expansion during RV 
contraction, RVOT ejection fraction measured during systole was “negative” (-23.8 ± 
37 %), whereas RVMC ejection fraction was positive (54.6 ± 7.7 %). 
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Table 7.2. Magnetic resonance imaging results 
       
  Pre Post P value Change 
Correlation of 
change with 
pre PVR 
RVEDVi P value 
LVEDVi (mL/m2) 84.7 ± 14.7 88.6 ± 16.9 0.159 3.9 ± 11.2 0.235 0.348 
LVESVi (mL/m2) 34.9 ± 12 36.9 ± 9.6 0.361 2.1 ± 9.3 -0.096 0.704 
LV SV (mL) 92.3 ± 17.1 98.8 ± 20.5 0.071 6.5 ± 14.3 0.467 0.051 
LV EF (%) 59.7 ± 7.6 58.6 ± 5.6 0.559 -1.1 ± 7.5 0.266 0.286 
LV CO (L/min) 6.7 ± 1.6 6.7 ± 1.8 0.981 0.01 ± 1.9 -0.293 0.238 
RVEDVi (mL/m2) 186.3 ± 32.3 114.2 ± 19.7 <0.001* -72.1 ± 20.4 -0.815* <0.001* 
RVESVi (mL/m2) 98.3 ± 30 61.9 ± 16.7 <0.001* -36.3 ± 19.2 0.395 0.361 
RV SV (mL) 162.2 ± 23.4 99.9 ± 16.7 <0.001* -62.3 ± 14.2 0.099 0.696 
RV EF (%) 48 ± 7.6 46.6 ± 7.2 0.272 -1.4 ± 5.2 0.420 0.232 
RV CO (L/min) 11.8 ± 2.7 6.8 ± 1.5 <0.001* -5.0 ± 2.6 -0.179 0.266 
Pulmonary regurgitant fraction (%) 39.7 ± 5.7 4.8 ± 3.6 <0.001* -34.8 ± 6.5 -0.483* 0.05* 
Tricuspid regurgitant fraction (%) 9.0 ± 8.6 4.8 ± 4.7 0.023* -4.2 ± 6.5 -0.228 0.378 
RV:LV ratio 2.2 ± 0.4 1.3 ± 0.2 <0.001* -0.93 ± 0.31 -0.104 0.505 
Weight (kg) 74.1 ± 13.8 76.8 ± 15 0.009* 2.7 ± 3.8 0.147 0.561 
* Indicates p≤0.05; EDVi, indexed end-diastolic volume; ESVi, indexed end-systolic volume; SV, stroke volume; EF, ejection  
fraction; CO, cardiac output.       
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Figure 7.1. Indexed right ventricular end-diastolic volume before and after pulmonary valve 
replacement. 
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7.3.3 CARDIOPULMONARY EXERCISE TEST RESULTS (N=18) 
Cardiopulmonary exercise test results are presented in Table 7.3. Pre-operatively, 
submaximal and peak exercise capacity was normal. Oxygen consumption (VO2) at 
anaerobic threshold as a percentage of VO2peak was 66.7 ± 13.7 %, VO2peak was 34.6 
± 9.8 mL/kg/min-1, percentage of predicted VO2peak achieved was 85.3 ± 15.0 %, 
peak work was 200.6 ± 52.2 Watts and percentage of predicted peak work achieved 
was 93.1 ± 16.2 %. VE/VCO2 was within normal range at anaerobic threshold (25.4 ± 
3.8) and at peak exercise (28.5 ± 4.8). There was no evidence of chronotropic 
incompetence in the patient group (peak heart rate; 175.9 ± 18.5 beats per minute, 
percentage of predicted peak heart rate achieved; 92 ± 10 %). 
 
Work at anaerobic threshold increased (118.9 ± 34.4 vs 132.9 ± 43.7 Watts, 
p=0.037) and respiratory exchange ratio at peak exercise (1.27 ± 0.11 vs 1.18 ± 
0.12, p=0.008) decreased at the post PVR assessment. No other submaximal or 
maximal cardiopulmonary exercise test measures were significantly different 
between pre and post-PVR assessments 
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Table 7.3. Cardiopulmonary exercise test results 
       
  Pre Post P value Change 
Correlation of 
change with 
pre PVR 
RVEDVi 
P 
value 
Work at anaerobic threshold as percentage of peak work (%) 60.0 ± 9.8 65.9 ± 12.2 0.068 5.9 ± 12.9 -0.119 0.639 
Work at anaerobic threshold (Watts) 118.9 ± 34.4 132.9 ± 43.7 0.037* 14 ± 26.2 -0.048 0.849 
Peak work (Watts) 200.6 ± 52.2 199.7 ± 47.1 0.741 -0.9 ± 11.2 0.075 0.769 
Percentage of predicted peak work achieved (%) 93.1 ± 16.2 91.2 ± 11.6 0.508 -1.9 ± 11.7 -0.454 0.058 
VO2 at anaerobic threshold as percentage of peak VO2 (%) 66.7 ± 13.7 68.1 ± 11.7 0.656 1.4 ± 13.1 -0.306 0.217 
VO2 at anaerobic threshold (mL/kg/min-1) 22.4 ± 6.11 23.7 ± 8.8 0.381 1.2 ± 5.9 -0.07 0.782 
Peak VO2 (mL/kg/min-1) 34.6 ± 9.8 34.3 ± 8.5 0.86 -0.2 ± 5.1 0.264 0.291 
Percentage of predicted peak VO2 achieved (%) 85.3 ± 15.0 88.9 ± 14.4 0.287 3.6 ± 13.9 0.117 0.643 
Respiratory exchange ratio at peak exercise 1.27 ± 0.11 1.18 ± 0.12 0.008* -0.1 ± 0.1 0.126 0.619 
VE/VCO2 at anaerobic threshold 25.4 ± 3.8 25.2 ± 2.3 0.66 -0.28 ± 2.6 -0.208 0.221 
VE/VCO2 at peak VO2 28.5 ± 4.8 29.4 ± 3.6 0.328 0.9 ± 4.0 -0.424 0.079 
Peak heart rate (Beats per minute) 175.9 ± 18.5 170.4 ± 10.8 0.137 -5.5 ± 14.9 -0.486* 0.041* 
Percentage of predicted peak heart rate achieved (%) 92 ± 10 89 ± 5 0.076 -3.5 ± 8.0 -0.377 0.123 
* Indicates p≤0.05; VO2, oxygen consumption; VE, ventilation; VCO2, carbon dioxide production    
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7.3.4 CORRELATIONS OF PRE-PVR RVEDVI WITH POST-PVR CHANGES 
Pre-PVR RVEDVi was found to correlate with the post-operative change in RVEDVi 
(see Figure 7.2, change=-72.1 ± 20.4 mL/m2, r=-0.815, p<0.001), change in PR 
fraction (change=-34.8 ± 6.5 %, r=-0.483, p=0.05) and change in peak heart rate 
(change=-5.5 ± 14.9 bpm, r=-0.486, p=0.041). Pre-PVR RVEDVi did not correlate 
with post-PVR change of any other MRI or CPET variable. 
 
7.3.5 CORRELATIONS OF PRE-PVR RVOT AND RVMC VOLUMES WITH POST-
PVR OUTCOMES 
Correlations between pre-PVR RVOT volumes and post-PVR measures are shown 
in Table 7.3 and Figures 7.3 and 7.4. RVOT EDV and RVOT ESV negatively 
correlated with post-PVR RV EF (r=-0.53, p=0.024 and r=-0.557, p=0.016, 
respectively), delta RV CO (r=-0.619, p=0.006 and r=-0.730, p=0.001, respectively), 
post-PVR VO2peak (r=-0.489, p=0.039 and r=-0.485, p=0.041, respectively) and delta 
VO2 at anaerobic threshold (r=-0.541, p=0.02 and r=-0.480, p=0.044, respectively). 
RVMC EDV and RVMC ESV were negatively correlated with delta RVEDVi (r=-
0.594, p=0.009 and r=-0.646, p=0.004, respectively) and delta RVESVi (r=-0.681, 
p=0.002 and r=-0.792 and p<0.001, respectively) but not with any functional 
parameters.
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Table 7.4. Pre-PVR RVOT and RVMC volumes and correlations with post-
PVR results         
 
Pre-PVR 
(mean ± SD)  
Post-
PVR 
RV EF 
Post-
PVR 
VO2 at 
AT 
Post-
PVR 
Peak 
VO2 
Delta 
RVEDVi Delta RVESVi 
Delta 
RV CO 
Delta % 
Predicted 
Peak Work 
Delta 
VO2 at 
AT 
RVOT EDV (mL) 30.6 ± 18.2  -0.53 -0.487 -0.489   -0.619  -0.541 
RVOT ESV (mL) 36.7 ± 23.6  -0.557  -0.485   -0.73  -0.48 
RVMC EDV (mL) 314.1 ± 60.8     -0.594 -0.681    
RVMC ESV (mL) 145.2 ± 48.4  -0.497   -0.646 -0.792    
RVOT EF (%)  -23.8 ± 37.0     0.52 0.505  0.556  
RVMC EF (%) 54.6 ± 7.7   0.563     0.494 0.69       
Only statistically significant (p<0.05) Pearson's correlation coefficients are displayed. RVOT indicates RV outflow tract; RVMC, RV  
muscular corpus; EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction.    
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Figure 7.2. Correlation of change in indexed right ventricular end-diastolic volume with pre-
pulmonary valve replacement indexed right ventricular end-diastolic volume. 
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Figure 7.3. Correlation of post-pulmonary valve replacement right ventricular ejection 
fraction with right ventricular outflow tract end-diastolic volume. 
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Figure 7.4. Correlation of post-pulmonary valve replacement peak oxygen consumption with 
right ventricular outflow tract end-diastolic volume. 
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7.4 DISCUSSION 
In repaired TOF patients with severely dilated RVs and severe PR, PVR resulted in 
smaller RVs and lower PR but did not significantly alter ejection fraction or exercise 
capacity. The largest pre-PVR RV to achieve “normalisation” (RVEDVI ≤ 108 mL/m2 
207) had a pre-operative RVEDVi of 190 mL/m2, although some smaller RVs failed to 
normalise. There was a strong negative correlation between pre-PVR RVEDVi and 
post-PVR change in RVEDVi. Importantly, the volume of the RVOT pre-PVR 
correlated negatively with RV function and exercise capacity, after PVR.  
 
Our results are in general agreement with past findings that PVR leads to decreased 
RV volumes but has little effect on overall ventricular function in adults with repaired 
TOF.69, 73, 74, 77, 102, 164, 165 To the best of our knowledge, all studies to date using 
cardiac MRI have observed a decrease in indexed RV volumes and PR fraction, in 
this situation.73, 74, 77, 102 One study showed an increase in RV ejection fraction,77 
whereas others have either shown no change or an increase in effective RV ejection 
fraction.73, 74, 102 A meta-analysis conducted by Cheung et al.164 confirmed that 
RVEDVi, RVESVi and PR fraction decrease as a result of PVR but RV ejection 
fraction does not change significantly. 
 
Despite the general consensus on the beneficial effects of PVR, when to perform the 
procedure is a point of much contention. Besides increasing RV volume, a decrease 
in RV ejection fraction, worsening maximal exercise capacity, deteriorating 
symptomatic status, RV hypertension, tricuspid regurgitation, branch pulmonary 
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arterial stenosis, sustained tachyarrhythmia, RV outflow tract aneurysm and 
decreased RV longitudinal curvature have all been suggested as important in the 
PVR timing decision. 76, 195, 217 However, the key in the ability to prognosticate is 
obtaining long-term outcome data, which is currently lacking. 
 
In the present study 7 of 18 patients achieved normalisation of their RVEDVi. In 
those patients who did normalise, a pre-PVR RVEDVi of 165 ± 19 mL/m2 was 
observed and in those who did not it was 200 ± 33 mL/m2. Although four patients 
achieved normalisation with a pre-PVR RVEDVi above 165 mL/m2, the group that 
failed to normalise had substantially larger RVs; only one patient was below a pre-
PVR RVEDVi above 165 mL/m2. There was also a strong correlation between pre-
PVR RVEDVi and post-PVR change in RVEDVi. We conclude that normalisation of 
RVEDVi is less likely to occur above a pre-PVR RVEDVi of 165 mL/m2.  Therefore, 
the widely used RVEDVi cut-point for PVR of 150mL/m2 likely provides an 
appropriately conservative indicator for PVR timing. 
 
We have now shown that larger pre-PVR RVOT size is associated with poorer post-
PVR RV function and exercise capacity. Furthermore, larger RVMC volumes are 
associated with less favourable improvement in RV volumes after PVR surgery. We 
believe delineation of RVMC and RVOT volumes adds value to pre operative cardiac 
MRI assessments and may aid in the selection of patients for PVR. Previously, Wald 
et al have highlighted the role of RVOT function in determining RV ejection fraction 
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and exercise capacity, in adults with repaired TOF (prior to PVR), consistent with our 
current observations.83 
 
Inadequate resection of the RVOT during PVR and may result sluggish RV systolic 
performance post-PVR. A large and dyskinetic RVOT does not actually contribute to 
effective RV forward flow. The RVOT may act as a reservoir, filling during systole 
and emptying back into the RV during diastole; as indicated by a negative RVOT 
ejection fraction. Alternatively, long-term exposure of the RV to a large and non-
contractile RVOT may have deleterious effects on RV function and subsequently 
exercise capacity, even when the RVOT has been adequately resected during PVR. 
Overall, it seems possible that conservative transannular patch use during initial TOF 
repair in infancy and aggressive RVOT resection at the time of PVR may have long-
term beneficial effects.218  
 
Warner et al. 69 reported a post-PVR increase in peak exercise capacity as indicated 
by improved peak work and percentage of predicted peak work achieved. These 
conclusions were drawn, however, from a subset of only 6 patients. Other studies 
have shown an improvement in submaximal, rather than peak, exercise capacity.77, 
165 Eyskens et al.165 showed an increase in ventilatory anaerobic threshold and 
Frigiola et al.77 reported a decrease in the VE/VCO2 slope. Overall, PVR does not 
seem to have a substantive and reproducible effect on exercise capacity.  
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The observed lack of improvement in peak or submaximal exercise capacity in our 
TOF patients is not surprising, given the high overall exercise performance and 
lower-normal RV ejection fraction of the cohort before undergoing PVR. In the 
absence of a training stimulus, an improvement in exercise capacity would not be 
expected in the setting of preserved ventricular function. Past studies showing 
improvements in exercise capacity may have done so by enrolling patients with more 
marked pre-operative exercise abnormalities.69, 77, 165 Furthermore, it may be 
methodologically unsound to compare cardiac function derived from supine MRI with 
CPET variables measured in the upright position, during maximal exertion. Future 
studies may need to incorporate exercise studies performed in the supine position. 
Real time MR scanning of the exercising heart could provide invaluable insights into 
the relationships between PVR, the RV, cardiac function and exercise capacity. 
 
7.4.1 STUDY LIMITATIONS 
Analysis of RVOT volume is a relatively novel technique but in our hands and with 
rigorous definition, could be measured with good reproducibility. This required the 
identification of highly reproducible landmarks, which could be consistently and 
clearly identified. Future imaging techniques such as using higher magnetic field 
strength and 4D flow may allow even greater delineation of anatomical structures 
within the right ventricle. Another limitation is the relatively small number of 
participants enrolled in the study, however using each patient as their own control 
allowed sufficient statistical power to study relationships between cardiac structure 
and function, in this clinical setting. 
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7.5 CONCLUSIONS 
After PVR in young adults with repaired TOF and severe PR with dilated RVs, RV 
volume reduction is greatest in those with the largest RVs preoperatively, and RV 
volume normalisation is rare with a pre-operative RV volume over 165 mL/m2. Larger 
pre-surgical RVOT volume was associated with poorer RV function and lower 
exercise capacity after PVR surgery. This observation may inform pre-operative 
patient selection as well as surgical technique; further studies are required to 
examine these possibilities. 
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8.1 INTRODUCTION 
 
Late outcomes in repaired tetralogy of Fallot have dramatically improved over recent 
decades resulting in an increased number of adult survivors.115, 182, 183, 219-221 A shift 
from ventriculotomy and trans-annular patch repairs towards a 
transatrial/transpulmonary approach has likely contributed significantly to this.222, 223 
However, these encouraging trends are accompanied by the rare but definite risk of 
malignant arrhythmia and sudden cardiac death.66, 224 
 
Chronic pulmonary regurgitation and QRS duration have been associated with 
arrhythmia and sudden cardiac death in adult tetralogy of Fallot.66 Although 
pulmonary valve replacement results in decreased pulmonary regurgitation and right 
ventricular volumes, evidence of post procedural risk reduction is lacking.164 Risk 
stratification, particularly identifying high-risk individuals for sudden cardiac death, 
remains problematic and an area of importance. Due to the paucity of data in this 
area, we aimed to define the causes and circumstances of adult tetralogy of Fallot 
deaths from coronial findings in Australia, over the past two decades. 
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8.2 METHODS 
8.2.1 DATA COLLECTION 
Coroners’ reports from all Australian states (1990-2011) were obtained where 
tetralogy of Fallot was a recorded diagnosis, in subjects aged ≥16 years, excluding 
deaths associated with heart surgery. Direct access to autopsy and police report files 
was possible in the most populous state, New South Wales. Access to autopsy and 
police report information was via the web-based National Coronial Information 
Service in other Australian states. The circumstances of death were obtained from 
police reports; macroscopic and histological findings were analysed from autopsy 
reports. 
 
8.2.1.1 Circumstances of Death 
We classified circumstances of death as being death during exertion or death at rest. 
Place of death was classified as at home; in hospital or elsewhere. 
 
8.2.1.2 Cause of Death 
All cause mortality was classified as sudden cardiac death; (unexpected likely 
cardiac death which occurred less than 24 hours after symptoms commenced) and 
non-sudden cardiac death; death from all causes other than sudden cardiac death. 
 
Right Ventricular Fibrosis was defined by the presence or absence of focal scarring 
(or collagenous deposits) seen on microscopy. Given that the microscopy specimens 
were focal sections of the myocardium and imaging was not performed, objective 
quantification of the overall fibrosis burden was unable to be determined. 
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8.2.2 DATA ANALYSIS 
Significance was assessed between the sudden cardiac death and non-sudden 
cardiac death groups using an independent samples student’s t test for continuous 
variables and the Chi squared test for dichotomous variables. Normality was 
assessed using the Kolmogorov-Smirnov test. The level of significance was set at 
2P≤0.05. In cases where circumstances or causes of death were uncertain, the data 
was treated as missing. Statistical analysis was performed using SPSS version 
19.0.0 (SPSS Inc., Chicago, IL, USA). 
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8.3 RESULTS 
Characteristics of the cohort identified are detailed in Table 8.1. Of the 23 decedents 
identified (mean age at death 36 ± 14 years), 17 were identified as having sudden 
cardiac death as their cause of death, 4 were classified as non-sudden cardiac death 
and cause of death was not able to be accurately determined in 2 cases. Using New 
South Wales prevalence estimates, this represents a death rate of approximately 1-
10 in 10000 cases (recognising the likely significant underestimation resulting from 
ascertaining coronial cases only). 
 
Death occurred at rest in 14 and on exertion in 5 cases; death was at home in 11, in 
hospital in 6 and outdoors in 6. Circumstance of death was not able to be determined 
in 4 cases. 14 decedents had had surgical repair, 3 were unrepaired, 1 had had a 
palliative shunt and status of surgical repair was not available in 5 patients. Only 2 
patients had a bioprosthetic pulmonary valve in place at autopsy. Suicide (n=1), 
pulmonary artery dissection (n=1), aortic root abscess secondary to staphylococcal 
endocarditis (n=1) and bleeding peptic ulcer (n=1) were the causes of death in the 
non-sudden cardiac death group. One decedent where cause of death was not able 
to be determined was a 25 year old female with prior craniotomy for cerebral 
abscess who exhibited a residual abscess on autopsy and was on anti-epileptic 
therapy. She presented with nausea, vomiting and hypotension, became syncopal 
and never regained consciousness despite haemodynamic improvement. The 
second patient was a 36 year old female who sustained a fall at home a week prior 
to death, developed progressive abdominal distension and did not seek treatment. 
She was found deceased by her mother. In the entire group, heart weight was 
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markedly above normal values (333 ± 166 grams above normal). Right ventricular 
fibrosis was documented in 17 of 23 cases (74%). 
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Table 8.1. Characteristics of decedents 
               Sudden cardiac death (n=17)        Non-sudden cardiac death (n=4) 
        mean ± SD n %   mean ± SD n % 
Age at death (years)   38.7 ± 15.9* 17   29.5 ± 3.3* 4  
Height (cm)    169 ± 11 15   161 ± 24 4  
Weight (kg)    72.3 ± 20.3 15   70.3 ± 24.7 4  
Heart weight (g)   640 ± 202 16   481 ± 171 4  
Heart weight compared to normal (g)  379 ± 170 15   221 ± 92 4  
Heart weight indexed to body surface area (g/m2) 357 ± 91.9 15   268 ± 42.2 4  
Males (n)     13 76   4 100 
RV fibrosis (n)    14 82   3 75 
Surgical details          
 Repaired (n)    10 59   3 75 
 Unrepaired (n)   2 12   1 25 
 Palliative repair (n)   1 6   0 0 
 Pulmonary valve replacement (n)  2 12   0 0 
Circumstances of death          
 Death occurred during exertion (n)  5 29   0 0 
 Death occurred at rest (n)   10 59   4 100 
Place of death          
 Home (n)    10† 59   1† 25 
 Hospital (n)    1† 6   3† 75 
  
Outdoors 
(n)       6† 35     0† 0 
*p<0.05 on independent samples t test. †p<0.05 on Chi Squared analysis. Circumstances of death were unknown in 2 cases.  
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8.4 DISCUSSION 
In this study, we have demonstrated that sudden cardiac death is the more frequent 
mode of death in adults with tetralogy of Fallot. Although only age at death and place 
of death were significantly different between the sudden cardiac death and non-
sudden cardiac death groups, there were trends towards larger hearts and more 
deaths during exercise in the sudden cardiac death group. We do acknowledge, 
however, the small number of non-sudden cardiac death patients in this series. 
 
The evolution of surgical technique in repair of tetralogy of Fallot over several 
decades has resulted in improved survival rates.115, 182, 183, 219-221 However, late 
outcomes of more recently adopted techniques, such as early complete repair with 
pulmonary valve sparing, have yet to be evaluated. Despite increasingly favourable 
survival rates, sudden cardiac death remains a significant concern late after tetralogy 
of Fallot repair.66, 224 In large, long-term follow up studies, the lifetime risk of sudden 
cardiac death has ranged from 2.0 to 8.3%.66, 115, 183, 200, 225 Gatzoulis et al.66 followed 
793 repaired tetralogy of Fallot patients and reported an 8.3% risk of sudden cardiac 
death, 35 years from repair. 
 
Although sudden cardiac death is the most common cause of death in adult repaired 
tetralogy of Fallot,66, 183 the annual incidence of these events has been reported to be 
low at 0.15%.200 Identifying high-risk patients who may require preventative 
measures is an area of importance and continuing research. Nollert et al.224 followed 
490 tetralogy of Fallot patients, repaired between 1958 and 1977, at a mean age of 
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8.6 ± 12.2 years. Higher pre-operative NYHA score, no previous palliation and 
increasing time from repair were found to be risk factors for sudden cardiac death 
224. Gatzoulis et al.66 documented QRS duration, QRS rate of change, pulmonary 
regurgitation and age at repair as risk factors for sudden cardiac death in those with 
tetralogy of Fallot repair at age 8.2 ± 8 years.66 Although certain risk factors have 
been identified, it is possible that these results are less relevant to the current young 
adult cohort of repaired tetralogy of Fallot patients who have undergone modern 
surgical techniques. 
 
Although the precise cause of sudden cardiac death is difficult to determine at 
autopsy, pre-existing ventricular and atrial arrhythmias as a result of tetralogy of 
Fallot repair and subsequent haemodynamic lesions are commonly implicated.66, 224 
Preventative measures include a move from ventriculotomy and trans-annular patch 
repairs towards a transatrial/transpulmonary approach, pulmonary valve replacement 
in the presence of severe right ventricular dilatation and the placement of 
implantable cardioverter defibrillators. The timing of pulmonary valve replacement 
and use of implantable cardioverter defibrillators remains an area of contention; 
however, their effectiveness in reducing arrhythmic events when appropriately 
deployed has a reasonable level of consensus.73, 74, 164, 187, 226-228 
 
The high occurrence of sudden cardiac death in our study cohort further emphasises 
the established risk of these devastating events in tetralogy of Fallot patients. Risk 
stratification remains an area of uncertainty and is vitally important for judgements 
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relating to preventative strategies. Further research is required to develop guidelines 
to allow greater clarity in clinical decision-making in this patient group. 
 
8.4.2 STUDY LIMITATIONS 
Our study was limited by obtaining coronial cases only, leading to a likely significant 
underestimation of tetralogy of Fallot deaths. Many cases may not have been 
referred to the coroner for investigation due to cause of death being presumed to be 
related to tetralogy of Fallot. A further limitation was the small numbers of non-
sudden cardiac death, which limits comparisons within the cohort. Nevertheless this 
is, to our knowledge, the largest autopsy series of adults with tetralogy of Fallot yet 
reported. 
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8.5 CONCLUSIONS 
Young adult death in tetralogy of Fallot patients has a wide variety of causes; 
presumed arrhythmia leading to sudden death accounts for approximately two-thirds 
of cases. Greater age at death and place of death were related to sudden cardiac 
death. There were also trends towards larger hearts and more deaths during 
exercise in the sudden cardiac death group.  Given the high incidence of sudden 
cardiac death, evolving surgical techniques and uncertainty surrounding risk 
stratification and preventative strategies, continuing research in this area is required.
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Significant improvements in surgical treatment and long-term management of TOF 
patients have lead to increasing numbers surviving into adulthood. In fact, there are 
now more adult TOF patients than children.15, 229 Despite improving survival rates, 
persistent issues such as ventricular dysfunction, exercise incapacity, need for late 
surgical intervention, arrhythmia management and sudden cardiac death have been 
reported this patient cohort and are poorly characterised. The studies within this 
thesis endeavour to address several aspects of these issues to provide improved 
insights into clinical management of adult repaired TOF patients. 
 
 
9.1 EXERCISE CAPACITY IN ADULTS WITH REPAIRED TETRALOGY OF 
FALLOT 
 
Despite previous research suggesting reduced exercise capacity in adults with 
repaired TOF, the studies within this thesis report near-normal exercise capacity in 
our patient cohort. Several explanations may be offered to explain this finding. 
Firstly, the patients included in these studies were asymptomatic and exhibited good 
overall clinical status.  Second, TOF patients have previously exhibited increased 
exercise capacity in response to physical training.177 Therefore, relatively higher 
physical activity compared to earlier reported cohorts may offer a further explanation 
(although we cannot make this conclusion since physical activity levels were not 
systematically recorded). Third, patients may have been more vigorously 
encouraged to reach peak effort during cardiopulmonary exercise testing. This 
assertion is supported by a relatively high mean peak respiratory exchange ratio of 
1.27. Anecdotally, it was perceived that virtually all patients provided a maximal 
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effort, which may not be the case in previous reports and can be the difference 
between a normal and a marginally sub-normal result. Fourth, our patients may have 
received different surgical and clinical care. For example, a mean age at repair 
below 2.5 years is relatively young and these procedures may have been performed 
in such a way as to impart less myocardial injury and potentially improved long-term 
function. Finally, we showed normal or near-normal ventricular function during rest 
and exercise. Chapter 4 reported normal biventricular ejection fractions and cardiac 
outputs during rest and normal heart rate at peak exercise. Chapter 6 described 
normal ventricular response to exercise, albeit at a marginally lower level than 
controls. 
 
Chapter 3 detailed the positive correlation between RV mass and peak exercise 
capacity, which highlights the importance of adequate musculature of the right 
ventricle in order for adequate blood to flow into the pulmonary circuit. Furthermore, 
the positive correlation between RV mass:RVEDV indicates that peak exercise 
capacity is heavily reliant on RV compliance. Importantly, traditional markers of 
clinical status exhibited no relationship with exercise capacity. RV mass may provide 
a novel marker of patient progress and may be worth considering in clinical decision 
making. 
 
Overall, the studies within this thesis highlight that adults with repaired TOF may not 
necessarily experience exercise incapacity to the extent previously reported. 
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9.2 VENTRICULAR STRUCTURE AND FUNCTION IN ADULTS WITH REPAIRED 
TETRALOGY OF FALLOT 
 
At rest, our cohort of TOF patients exhibited right ventricular dilatation, moderate to 
severe pulmonary regurgitation, normal left and right ventricular ejection fractions 
and normal left and right cardiac outputs. Although, the degree of right ventricular 
dilatation varied, mean levels had reached the clinical threshold where pulmonary 
valve replacement would be considered. Despite significant dilatation, the right 
ventricle was able to produce adequate forward flow into the pulmonary circuit. 
 
Chapter 3 showed that interaction between the left and right ventricle plays an 
important role in forward flow both into the systemic and pulmonary circuits. 
Undoubtedly, the right ventricle does not act alone and requires consideration in the 
setting of a biventricular symbiosis.  
 
Chapter 6 reported a normal ventricular response to exercise in adult repaired TOF 
patients. Interestingly, pulmonary regurgitant fraction reduced as exercise intensity 
increased, which augmented net right ventricular output. Presumably, reduced 
diastolic filling time and altered right ventricular compliance provides a likely 
explanation. 
 
The degree to which the right ventricle dilates over time is an important and 
previously unanswered question for clinicians. Chapter 5 detailed a significant 
increase in right ventricular volume from slightly below to marginally above the level 
at which pulmonary valve replacement is commonly considered over a 2 year period. 
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This finding highlights the possibility of rapid increases in right ventricular volume 
and the need for regular monitoring with the aid of cardiac MRI. 
 
9.3 PULMONARY VALVE REPLACEMENT IN ADULTS WITH REPAIRED 
TETRALOGY OF FALLOT 
 
The results presented in chapter 7 broadly supported previous findings; pulmonary 
valve replacement resulted in reduced right ventricular volumes and pulmonary 
regurgitation but did not change right ventricular ejection fraction or exercise 
capacity. Importantly though, pre-surgical right ventricular outflow tract volume 
negatively correlated with post-surgical right ventricular function and exercise 
capacity. Furthermore, higher pre-surgical right ventricular muscular corpus volume 
was associated with less improvement in global right ventricular volume after 
pulmonary valve replacement. These findings highlight the importance of delineating 
between transannular patch and muscular corpus volumes in both clinical and 
research situations. Furthermore, our results support the current movement towards 
valve-sparing repairs in infants with TOF. In adult TOF patients who have undergone 
a transannular patch repair, monitoring right ventricular muscular corpus volume 
rather than global RV volume may be more important in terms of post-surgical 
outcomes. 
 
The timing of pulmonary valve replacement remains a vexing problem. Our findings 
further support a conservative approach of using an indexed right ventricular end-
diastolic volume of 150 mL/m2 as an indicator for this procedure. 
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9.4 CAUSES OF DEATH IN ADULTS WITH REPAIRED TETRALOGY OF FALLOT 
 
Despite significant improvements in long-term survival, sudden cardiac death 
remains an area of concern in adult repaired TOF. To the best of our knowledge, 
Chapter 8 provides the first description of the causes of death in this patient cohort. 
Presumed arrhythmia lead to sudden cardiac death in approximately two-thirds of 
cases. Arrhythmogenic causes of sudden cardiac death are poorly understood and 
are an area for further detailed research. 
 
9.6 FUTURE DIRECTIONS 
 
Large, long-term prospective studies detailing the progression of ventricular structure 
and function, symptomatic status, arrhythmia and exercise capacity would allow a 
better understanding of the pathophysiologic development of TOF over time. To 
date, little is known in this regard. 
 
Long-term outcomes after pulmonary valve replacement would also be useful in the 
assessment of surgical timing and approaches. Randomised controlled trials would 
be particularly useful in determining optimal timing of pulmonary valve replacement, 
however, such studies would likely need to be multicentric to have sufficient and 
clinically relevant power. Nevertheless, the importance of such timing decision 
warrants closer scrutiny and coordinated efforts between adult congenital heart 
disease centres may prove especially useful in this area of research. 
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Important emerging imaging techniques may play an important role in determining 
relationships between cardiac structure and function. Cardiac MRI 4D flow is a 
significant development and provides the opportunity to better understand intra-
cardiac and great vessel flow patterns. The development of faster and higher 
resolution cardiac MRI sequences along with MRI compatible breath-by-breath 
expiratory gas analysis and more advanced MRI compatible ergometers will allow 
greater examination ventricular dynamics and the contributors to reduced exercise 
capacity in adult repaired TOF. Furthermore, the relationships between exercise 
capacity and ventricular structure and function during peak exercise may soon be 
able to be examined using these techniques. 
 
After consideration of the results contained within this thesis, one of the more 
important areas for future research may be to elucidate the causes, frequency and 
pathophysiology of arrhythmia in adult repaired TOF. Large, multi-centre studies 
would be useful in examining the complex interplay between ventricular volumes, 
myocyte function and neural activation.
References 
 
155 
REFERENCES 
 
1. Stensen N. Embrio monstro affinis parisiis dissectum. Acta Med Philos Hafniensa. 1671-
72;1:202-203 
2. Hunter W. Medical observations and inquiries. London: Private publication. 1784:417-419 
3. Fallot ELA. Contribution a l'anatomie pathologique de la maladie bleu (cyanose cardiaque). 
Marseille Medical. 1888;25:77-93 
4. Abbott ME, Dawson, W.T. The clinical classification of congenital cardiac disease, with 
remarks upon its pathological anatomy, diagnosis and treatment. Int Clin. 1924;4:156-188 
5. Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. 
2005;15 Suppl 1:38-47 
6. Chowdhury UK, Mishra AK, Ray R, Kalaivani M, Reddy SM, Venugopal P. Histopathologic 
changes in ascending aorta and risk factors related to histopathologic conditions and aortic 
dilatation in patients with tetralogy of fallot. J Thorac Cardiovasc Surg. 2008;135:69-77, 77 
e61-11 
7. Tan JL, Gatzoulis MA, Ho SY. Aortic root disease in tetralogy of fallot. Curr Opin Cardiol. 
2006;21:569-572 
8. Kothari SS. Mechanism of cyanotic spells in tetralogy of fallot--the missing link? Int J Cardiol. 
1992;37:1-5 
9. Alsoufi B, Williams WG, Hua Z, Cai S, Karamlou T, Chan CC, Coles JG, Van Arsdell GS, 
Caldarone CA. Surgical outcomes in the treatment of patients with tetralogy of fallot and 
absent pulmonary valve. Eur J Cardiothorac Surg. 2007;31:354-359; discussion 359 
10. Nichols DG, Ungerleider RM, Spevall PJ. Critical heart disease in infants and children. 
Philadelphia: Mosby; 2006. 
11. Karl TR. Atrioventricular septal defect with tetralogy of fallot or double-outlet right ventricle: 
Surgical considerations. Semin Thorac Cardiovasc Surg. 1997;9:26-34 
12. Shinebourne EA, Anderson RH. Fallot's tetralogy. In: Anderson RH, Baker EJ, Macartney FJ, 
Rigby ML, Shinebourne EA, Tynan M, eds. Paediatric cardiology. London: Churchill 
Livingstone; 2002:1213-1250. 
13. Gatzoulis M, Webb G, Piers EF, Daubeney MA. Diagnosis and management of adult 
congenital heart disease. London: Churchill Livingstone; 2010. 
14. Abeywardana S, Sullivan EA, Australian Institute of Health and Welfare. Congenital 
anomalies in australia 2002-2003. Sydney: Australian Institute of Health and Welfare 
National Perinatal Statistics Unit; 2008. 
15. Silversides CK, Kiess M, Beauchesne L, Bradley T, Connelly M, Niwa K, Mulder B, Webb G, 
Colman J, Therrien J. Canadian cardiovascular society 2009 consensus conference on the 
management of adults with congenital heart disease: Outflow tract obstruction, coarctation 
of the aorta, tetralogy of fallot, ebstein anomaly and marfan's syndrome. Can J Cardiol. 
2010;26:e80-97 
16. Bailliard F, Anderson RH. Tetralogy of fallot. Orphanet J Rare Dis. 2009;4:2 
17. Webber SA, Hatchwell E, Barber JC, Daubeney PE, Crolla JA, Salmon AP, Keeton BR, Temple 
IK, Dennis NR. Importance of microdeletions of chromosomal region 22q11 as a cause of 
selected malformations of the ventricular outflow tracts and aortic arch: A three-year 
prospective study. The Journal of pediatrics. 1996;129:26-32 
18. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, McDonald-McGinn D, Chien 
P, Feuer J, Zackai EH, Emanuel BS, Driscoll DA. Frequency of 22q11 deletions in patients with 
conotruncal defects. J Am Coll Cardiol. 1998;32:492-498 
19. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, 
Wong LY, Elixson EM, Mahle WT, Campbell RM. A population-based study of the 22q11.2 
References 
 
156 
deletion: Phenotype, incidence, and contribution to major birth defects in the population. 
Pediatrics. 2003;112:101-107 
20. Gioli-Pereira L, Pereira AC, Bergara D, Mesquita S, Lopes AA, Krieger JE. Frequency of 
22q11.2 microdeletion in sporadic non-syndromic tetralogy of fallot cases. Int J Cardiol. 
2008;126:374-378 
21. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, Gatzoulis MA. Clinical 
features of 78 adults with 22q11 deletion syndrome. American journal of medical genetics. 
Part A. 2005;138:307-313 
22. Allen HD, Clark EB, Gutgessell HP. Moss and adam's heart disease in infants, children and 
adolescents. 2001 
23. Chew C, Halliday JL, Riley MM, Penny DJ. Population-based study of antenatal detection of 
congenital heart disease by ultrasound examination. Ultrasound in obstetrics & gynecology : 
the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 
2007;29:619-624 
24. Momma K. Tetralogy of fallot and truncus arteriosus. In: Crawford MH, DiMarco JP, Paulus 
WJ, eds. Cardiology. Philadelphia: Mosby; 2004:1289-1298. 
25. Castaneda AR. Classical repair of tetralogy of fallot: Timing, technique, and results. Semin 
Thorac Cardiovasc Surg. 1990;2:70-75 
26. Fallon P, Aparicio JM, Elliott MJ, Kirkham FJ. Incidence of neurological complications of 
surgery for congenital heart disease. Archives of disease in childhood. 1995;72:418-422 
27. Limperopoulos C, Majnemer A, Shevell MI, Rohlicek C, Rosenblatt B, Tchervenkov C, Darwish 
HZ. Predictors of developmental disabilities after open heart surgery in young children with 
congenital heart defects. The Journal of pediatrics. 2002;141:51-58 
28. Miller G, Tesman JR, Ramer JC, Baylen BG, Myers JL. Outcome after open-heart surgery in 
infants and children. Journal of child neurology. 1996;11:49-53 
29. Stewart RD, Backer CL, Young L, Mavroudis C. Tetralogy of fallot: Results of a pulmonary 
valve-sparing strategy. Ann Thorac Surg. 2005;80:1431-1438; discussion 1438-1439 
30. Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of fallot in the neonate: Results in 
the modern era. Ann Surg. 2000;232:508-514 
31. Starr JP. Tetralogy of fallot: Yesterday and today. World J Surg. 2010;34:658-668 
32. Stoney WS. A short history of cardiac surgery. In: Pioneers of cardiac surgery. Nashville: 
Vanderbilt University Press; 2008. 
33. Blalock A. Effects of an artificial ductus arteriosus on experimental cyanosis and anoxemia. 
Archives of surgery. 1946;52:247-252 
34. Blalock A, Taussig HB. Landmark article may 19, 1945: The surgical treatment of 
malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. By 
alfred blalock and helen b. Taussig. Jama. 1984;251:2123-2138 
35. Taussig HB. Neuhauser lecture: Tetralogy of fallot: Early history and late results. AJR. 
American journal of roentgenology. 1979;133:422-431 
36. Daniel FJ, Clarke CP, Richardson JP, Westlake GW, Jones PG. An evaluation of potts' 
aortopulmonary shunt for palliation of cyanotic heart disease. Thorax. 1976;31:394-397 
37. Pickering D, Trusler GA, Lipton I, Keith JD. Waterston anastomosis. Comparison of results of 
operation berfore and after age 6 months. Thorax. 1971;26:457-459 
38. Cooley DA, Hallman GL. Intrapericardial aortic-right pulmonary arterial anastomosis. Surgery, 
gynecology & obstetrics. 1966;122:1084-1086 
39. Klinner W, Pasini M, Schaudig A. [anastomosis between systemic and pulmonary arteries 
with the aid of plastic prostheses in cyanotic heart diseases]. Thoraxchirurgie. 1962;10:68-75 
40. Calder AL, Chan NS, Clarkson PM, Kerr AR, Neutze JM. Progress of patients with pulmonary 
atresia after systemic to pulmonary arterial shunts. Ann Thorac Surg. 1991;51:401-407 
References 
 
157 
41. McKay R, de Leval MR, Rees P, Taylor JF, Macartney FJ, Stark J. Postoperative angiographic 
assessment of modified blalock-taussig shunts using expanded polytetrafluoroethylene 
(gore-tex). Ann Thorac Surg. 1980;30:137-145 
42. Sabri MR, Sholler G, Hawker R, Nunn G. Branch pulmonary artery growth after blalock-
taussig shunts in tetralogy of fallot and pulmonary atresia with ventricular septal defect: A 
retrospective, echocardiographic study. Pediatr Cardiol. 1999;20:358-363 
43. Gladman G, McCrindle BW, Williams WG, Freedom RM, Benson LN. The modified blalock-
taussig shunt: Clinical impact and morbidity in fallot's tetralogy in the current era. J Thorac 
Cardiovasc Surg. 1997;114:25-30 
44. Gerbode F, Osborn JJ, Kerth WJ, O'Brien MF. Complete correction of tetralogy of fallot. 
Western journal of surgery, obstetrics, and gynecology. 1964;72:1-5 
45. Ebert PA, Sabiston DC, Jr. Surgical management of the tetralogy of fallot: Influence of a 
previous systemic-pulmonary anastomosis on the results of open correction. Ann Surg. 
1967;165:806-813 
46. Goldman BS, Mustard WT, Trusler GS. Total correction of tetralogy of fallot. Review of ten 
years' experience. Br Heart J. 1968;30:563-568 
47. Wolf MD, Landtman B, Neill CA, Taussig HB. Total correction of tetralogy of fallot. I. Follow-
up study of 104 cases. Circulation. 1965;31:385-393 
48. Kirklin JW, Wallace RB, McGoon DC, DuShane JW. Early and late results after intracardiac 
repair of tetralogy of fallot. 5-year review of 337 patients. Ann Surg. 1965;162:578-589 
49. Kirklin JW, Payne WS, Theye RA, Dushane JW. Factors affecting survival after open operation 
for tetralogy of fallot. Ann Surg. 1960;152:485-493 
50. Kirklin JW, Devloo RA. Hypothermic perfusion and circulatory arrest for surgical correction of 
tetralogy of fallot with previously constructed potts' anastomosis. Diseases of the chest. 
1961;39:87-91 
51. Kirklin JW, Payne WS. Surgical treatment for tetralogy of fallot after previous anastomosis of 
systemic to pulmonary artery. Surgery, gynecology & obstetrics. 1960;110:707-713 
52. Kirklin JW, Ellis FH, Jr., Mc GD, Dushane JW, Swan HJ. Surgical treatment for the tetralogy of 
fallot by open intracardiac repair. The Journal of thoracic surgery. 1959;37:22-51 
53. Kirklin JW, Donald DE, Harshbarger HG, Hetzel PS, Patrick RT, Swan HJ, Wood EH. Studies in 
extracorporeal circulation. I. Applicability of gibbon-type pump-oxygenator to human 
intracardiac surgery: 40 cases. Ann Surg. 1956;144:2-8 
54. Malm JR, Bowman FO, Jr., Jameson AG, Ellis K, Blumenthal S. Current concepts in treatment 
of tetralogy of fallot. Diseases of the chest. 1964;45:86-89 
55. Di Donato RM, Jonas RA, Lang P, Rome JJ, Mayer JE, Jr., Castaneda AR. Neonatal repair of 
tetralogy of fallot with and without pulmonary atresia. J Thorac Cardiovasc Surg. 
1991;101:126-137 
56. Pacifico AD, Bargeron LM, Jr., Kirklin JW. Primary total correction of tetralogy of fallot in 
children less than four years of age. Circulation. 1973;48:1085-1091 
57. Barratt-Boyes BG, Neutze JM. Primary repair of tetralogy of fallot in infancy using profound 
hypothermia with circulatory arrest and limited cardiopulmonary bypass: A comparison with 
conventional two stage management. Ann Surg. 1973;178:406-411 
58. Bonchek LI, Starr A, Sunderland CO, Menashe VD. Natural history of tetralogy of fallot in 
infancy. Clinical classification and therapeutic implications. Circulation. 1973;48:392-397 
59. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy 
of fallot. Qrs prolongation relates to right ventricular size and predicts malignant ventricular 
arrhythmias and sudden death. Circulation. 1995;92:231-237 
60. Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after 
complete repair of tetralogy of fallot: Deleterious effects of residual pulmonary 
regurgitation. Br Heart J. 1992;67:470-473 
References 
 
158 
61. Wessel HU, Cunningham WJ, Paul MH, Bastanier CK, Muster AJ, Idriss FS. Exercise 
performance in tetralogy of fallot after intracardiac repair. J Thorac Cardiovasc Surg. 
1980;80:582-593 
62. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marcon F, Alexander ME, Walsh 
EP. Value of programmed ventricular stimulation after tetralogy of fallot repair: A 
multicenter study. Circulation. 2004;109:1994-2000 
63. Pigula FA, Khalil PN, Mayer JE, del Nido PJ, Jonas RA. Repair of tetralogy of fallot in neonates 
and young infants. Circulation. 1999;100:II157-161 
64. Sousa Uva M, Lacour-Gayet F, Komiya T, Serraf A, Bruniaux J, Touchot A, Roux D, Petit J, 
Planche C. Surgery for tetralogy of fallot at less than six months of age. J Thorac Cardiovasc 
Surg. 1994;107:1291-1300 
65. Hennein HA, Mosca RS, Urcelay G, Crowley DC, Bove EL. Intermediate results after complete 
repair of tetralogy of fallot in neonates. J Thorac Cardiovasc Surg. 1995;109:332-342, 344; 
discussion 342-333 
66. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, 
Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden 
cardiac death late after repair of tetralogy of fallot: A multicentre study. Lancet. 
2000;356:975-981 
67. Wells WJ, Arroyo H, Jr., Bremner RM, Wood J, Starnes VA. Homograft conduit failure in 
infants is not due to somatic outgrowth. J Thorac Cardiovasc Surg. 2002;124:88-96 
68. Fiore AC, Rodefeld M, Turrentine M, Vijay P, Reynolds T, Standeven J, Hill K, Bost J, 
Carpenter D, Tobin C, Brown JW. Pulmonary valve replacement: A comparison of three 
biological valves. Ann Thorac Surg. 2008;85:1712-1718; discussion 1718 
69. Warner KG, O'Brien PK, Rhodes J, Kaur A, Robinson DA, Payne DD. Expanding the indications 
for pulmonary valve replacement after repair of tetralogy of fallot. Ann Thorac Surg. 
2003;76:1066-1071; discussion 1071-1062 
70. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and 
aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc 
Surg. 1995;109:509-517; discussion 517-508 
71. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules 
JW, Graham Jr TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh 
EP, Webb GD. Acc/aha 2008 guidelines for the management of adults with congenital heart 
disease. J Am Coll Cardiol. 2008;52:1890-1947 
72. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, 
Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, 
Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E, Vahanian A, Auricchio A, Bax J, Ceconi 
C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, 
Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Swan L, Andreotti F, 
Beghetti M, Borggrefe M, Bozio A, Brecker S, Budts W, Hess J, Hirsch R, Jondeau G, Kokkonen 
J, Kozelj M, Kucukoglu S, Laan M, Lionis C, Metreveli I, Moons P, Pieper PG, Pilossoff V, 
Popelova J, Price S, Roos-Hesselink J, Uva MS, Tornos P, Trindade PT, Ukkonen H, Walker H, 
Webb GD, Westby J. Esc guidelines for the management of grown-up congenital heart 
disease (new version 2010). Eur Heart J. 2010;31:2915-2957 
73. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for 
pulmonary valve replacement in adults after tetralogy of fallot repair. Am J Cardiol. 
2005;95:779-782 
74. Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, Bouma 
BJ, Zwinderman AH, Hazekamp MG, de Roos A, Mulder BJ. Preoperative thresholds for 
pulmonary valve replacement in patients with corrected tetralogy of fallot using 
cardiovascular magnetic resonance. Circulation. 2007;116:545-551 
References 
 
159 
75. Dave HH, Buechel ER, Dodge-Khatami A, Kadner A, Rousson V, Bauersfeld U, Pretre R. Early 
insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular 
dimensions. Ann Thorac Surg. 2005;80:1615-1620; discussion 1620-1611 
76. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: The 
quest continues. Circulation. 2013;128:1855-1857 
77. Frigiola A, Tsang V, Bull C, Coats L, Khambadkone S, Derrick G, Mist B, Walker F, van Doorn C, 
Bonhoeffer P, Taylor AM. Biventricular response after pulmonary valve replacement for right 
ventricular outflow tract dysfunction: Is age a predictor of outcome? Circulation. 
2008;118:S182-190 
78. Buechel ER, Dave HH, Kellenberger CJ, Dodge-Khatami A, Pretre R, Berger F, Bauersfeld U. 
Remodelling of the right ventricle after early pulmonary valve replacement in children with 
repaired tetralogy of fallot: Assessment by cardiovascular magnetic resonance. Eur Heart J. 
2005;26:2721-2727 
79. Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, del Nido P. Randomized trial of 
pulmonary valve replacement with and without right ventricular remodeling surgery. 
Circulation. 2010;122:S201-208 
80. Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE, del Nido PJ, Geva T. 
Ventricular size and function assessed by cardiac mri predict major adverse clinical outcomes 
late after tetralogy of fallot repair. Heart. 2008;94:211-216 
81. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired 
clinical status in long-term survivors of tetralogy of fallot repair evaluated by magnetic 
resonance imaging. J Am Coll Cardiol. 2004;43:1068-1074 
82. Davlouros PA, Karatza AA, Gatzoulis MA, Shore DF. Timing and type of surgery for severe 
pulmonary regurgitation after repair of tetralogy of fallot. Int J Cardiol. 2004;97 Suppl 1:91-
101 
83. Wald RM, Haber I, Wald R, Valente AM, Powell AJ, Geva T. Effects of regional dysfunction 
and late gadolinium enhancement on global right ventricular function and exercise capacity 
in patients with repaired tetralogy of fallot. Circulation. 2009;119:1370-1377 
84. Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Kay J, Valente AM, Earing 
MG, Lui G, Gersony DR, Cook S, Ting JG, Nickolaus MJ, Webb G, Landzberg MJ, Broberg CS, 
Alliance for Adult Research in Congenital C. Arrhythmia burden in adults with surgically 
repaired tetralogy of fallot: A multi-institutional study. Circulation. 2010;122:868-875 
85. Egidy Assenza G, Cassater D, Landzberg M, Geva T, Schreier J, Graham D, Volpe M, Barker N, 
Economy K, Valente AM. The effects of pregnancy on right ventricular remodeling in women 
with repaired tetralogy of fallot. Int J Cardiol. 2013;168:1847-1852 
86. Ferraz Cavalcanti PE, Sa MP, Santos CA, Esmeraldo IM, de Escobar RR, de Menezes AM, de 
Azevedo OM, Jr., de Vasconcelos Silva FP, Lins RF, Lima Rde C. Pulmonary valve replacement 
after operative repair of tetralogy of fallot: Meta-analysis and meta-regression of 3,118 
patients from 48 studies. J Am Coll Cardiol. 2013;62:2227-2243 
87. Chalard A, Sanchez I, Gouton M, Henaine R, Salami FA, Ninet J, Douek PC, Di Filippo S, 
Boussel L. Effect of pulmonary valve replacement on left ventricular function in patients with 
tetralogy of fallot. Am J Cardiol. 2012;110:1828-1835 
88. Lee C, Kim YM, Lee CH, Kwak JG, Park CS, Song JY, Shim WS, Choi EY, Lee SY, Baek JS. 
Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary 
regurgitation after relief of right ventricular outflow tract obstruction: Implications for 
optimal timing of pulmonary valve replacement. J Am Coll Cardiol. 2012;60:1005-1014 
89. Quail MA, Frigiola A, Giardini A, Muthurangu V, Hughes M, Lurz P, Khambadkone S, 
Deanfield JE, Tsang V, Taylor AM. Impact of pulmonary valve replacement in tetralogy of 
fallot with pulmonary regurgitation: A comparison of intervention and nonintervention. Ann 
Thorac Surg. 2012;94:1619-1626 
References 
 
160 
90. Jang W, Kim YJ, Choi K, Lim HG, Kim WH, Lee JR. Mid-term results of bioprosthetic 
pulmonary valve replacement in pulmonary regurgitation after tetralogy of fallot repair. Eur 
J Cardiothorac Surg. 2012;42:e1-8 
91. Tobler D, Crean AM, Redington AN, Van Arsdell GS, Caldarone CA, Nanthakumar K, Stambach 
D, Dos L, Wintersperger BJ, Oechslin EN, Silversides CK, Wald RM. The left heart after 
pulmonary valve replacement in adults late after tetralogy of fallot repair. Int J Cardiol. 
2012;160:165-170 
92. Chen PC, Sager MS, Zurakowski D, Pigula FA, Baird CW, Mayer JE, Jr., Del Nido PJ, Emani SM. 
Younger age and valve oversizing are predictors of structural valve deterioration after 
pulmonary valve replacement in patients with tetralogy of fallot. J Thorac Cardiovasc Surg. 
2012;143:352-360 
93. Chen XJ, Smith PB, Jaggers J, Lodge AJ. Bioprosthetic pulmonary valve replacement: 
Contemporary analysis of a large, single-center series of 170 cases. J Thorac Cardiovasc Surg. 
2013;146:1461-1466 
94. Ovcina I, Knez I, Curcic P, Ozkan S, Nagel B, Sorantin E, Puchinger M, Tscheliessnigg K. 
Pulmonary valve replacement with mechanical prostheses in re-do fallot patients. Interact 
Cardiovasc Thorac Surg. 2011;12:987-991; discussion 991-982 
95. Lindsey CW, Parks WJ, Kogon BE, Sallee D, 3rd, Mahle WT. Pulmonary valve replacement 
after tetralogy of fallot repair in preadolescent patients. Ann Thorac Surg. 2010;89:147-151 
96. Tsang FH, Li X, Cheung YF, Chau KT, Cheng LC. Pulmonary valve replacement after surgical 
repair of tetralogy of fallot. Hong Kong Med J. 2010;16:26-30 
97. Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh EP. Pulmonary valve 
replacement in tetralogy of fallot: Impact on survival and ventricular tachycardia. Circulation. 
2009;119:445-451 
98. Henkens IR, van Straten A, Schalij MJ, Hazekamp MG, de Roos A, van der Wall EE, Vliegen 
HW. Predicting outcome of pulmonary valve replacement in adult tetralogy of fallot 
patients. Ann Thorac Surg. 2007;83:907-911 
99. Ghez O, Tsang VT, Frigiola A, Coats L, Taylor A, Van Doorn C, Bonhoeffer P, De Leval M. Right 
ventricular outflow tract reconstruction for pulmonary regurgitation after repair of tetralogy 
of fallot. Preliminary results. Eur J Cardiothorac Surg. 2007;31:654-658 
100. Kleinveld G, Joyner RW, Sallee D, 3rd, Kanter KR, Parks WJ. Hemodynamic and 
electrocardiographic effects of early pulmonary valve replacement in pediatric patients after 
transannular complete repair of tetralogy of fallot. Pediatr Cardiol. 2006;27:329-335 
101. van Straten A, Vliegen HW, Lamb HJ, Roes SD, van der Wall EE, Hazekamp MG, de Roos A. 
Time course of diastolic and systolic function improvement after pulmonary valve 
replacement in adult patients with tetralogy of fallot. J Am Coll Cardiol. 2005;46:1559-1564 
102. Vliegen HW, van Straten A, de Roos A, Roest AA, Schoof PH, Zwinderman AH, Ottenkamp J, 
van der Wall EE, Hazekamp MG. Magnetic resonance imaging to assess the hemodynamic 
effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. 
Circulation. 2002;106:1703-1707 
103. Gengsakul A, Harris L, Bradley TJ, Webb GD, Williams WG, Siu SC, Merchant N, McCrindle 
BW. The impact of pulmonary valve replacement after tetralogy of fallot repair: A matched 
comparison. Eur J Cardiothorac Surg. 2007;32:462-468 
104. Khambadkone S, Bonhoeffer P. Percutaneous pulmonary valve implantation. Semin Thorac 
Cardiovasc Surg Pediatr Card Surg Annu. 2006:23-28 
105. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, Cooper J, Muthurangu 
V, Hegde SR, Razavi RS, Pellerin D, Deanfield J, Bonhoeffer P. Percutaneous pulmonary valve 
implantation in humans: Results in 59 consecutive patients. Circulation. 2005;112:1189-1197 
106. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, 
Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, 
References 
 
161 
Bonhoeffer P. Percutaneous pulmonary valve implantation: Impact of evolving technology 
and learning curve on clinical outcome. Circulation. 2008;117:1964-1972 
107. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, Taylor AM, Lock JE, 
Bonhoeffer P. Risk stratification, systematic classification, and anticipatory management 
strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 
2007;115:1392-1397 
108. Nordmeyer J, Coats L, Lurz P, Lee TY, Derrick G, Rees P, Cullen S, Taylor AM, Khambadkone S, 
Bonhoeffer P. Percutaneous pulmonary valve-in-valve implantation: A successful treatment 
concept for early device failure. Eur Heart J. 2008;29:810-815 
109. Puranik R, Muthurangu V, Celermajer DS, Taylor AM. Congenital heart disease and multi-
modality imaging. Heart Lung Circ. 2010;19:133-144 
110. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules 
JW, Graham Jr TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh 
EP, Webb GD. Acc/aha 2008 guidelines for the management of adults with congenital heart 
disease: A report of the american college of cardiology/american heart association task force 
on practice guidelines (writing committee to develop guidelines on the management of 
adults with congenital heart disease). Circulation. 2008;118:e714-833 
111. Wessel HU, Paul MH. Exercise studies in tetralogy of fallot: A review. Pediatr Cardiol. 
1999;20:39-47; discussion 48 
112. Sarubbi B, Pacileo G, Pisacane C, Ducceschi V, Iacono C, Russo MG, Iacono A, Calabro R. 
Exercise capacity in young patients after total repair of tetralogy of fallot. Pediatr Cardiol. 
2000;21:211-215 
113. Giardini A, Specchia S, Tacy TA, Coutsoumbas G, Gargiulo G, Donti A, Formigari R, Bonvicini 
M, Picchio FM. Usefulness of cardiopulmonary exercise to predict long-term prognosis in 
adults with repaired tetralogy of fallot. Am J Cardiol. 2007;99:1462-1467 
114. Martelle RR, Linde LM. Cerebrovascular accidents with tetralogy of fallot. American journal 
of diseases of children. 1961;101:206-209 
115. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, 
Danielson GK. Long-term outcome in patients undergoing surgical repair of tetralogy of 
fallot. N Engl J Med. 1993;329:593-599 
116. Kilner PJ. Pulmonary resistance in cardiovascular context. Int J Cardiol. 2004;97 Suppl 1:3-6 
117. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: Not a benign lesion. Eur Heart J. 
2005;26:433-439 
118. Abd El Rahman MY, Abdul-Khaliq H, Vogel M, Alexi-Meskishvili V, Gutberlet M, Lange PE. 
Relation between right ventricular enlargement, qrs duration, and right ventricular function 
in patients with tetralogy of fallot and pulmonary regurgitation after surgical repair. Heart. 
2000;84:416-420 
119. Laneve SA, Uesu CT, Taguchi JT. Isolated pulmonic valvular regurgitation. The American 
journal of the medical sciences. 1962;244:446-458 
120. Schamberger MS, Hurwitz RA. Course of right and left ventricular function in patients with 
pulmonary insufficiency after repair of tetralogy of fallot. Pediatr Cardiol. 2000;21:244-248 
121. Bove EL, Byrum CJ, Thomas FD, Kavey RE, Sondheimer HM, Blackman MS, Parker FB, Jr. The 
influence of pulmonary insufficiency on ventricular function following repair of tetralogy of 
fallot. Evaluation using radionuclide ventriculography. J Thorac Cardiovasc Surg. 
1983;85:691-696 
122. Jarmakani JM, Nakazawa M, Isabel-Jones J, Marks RA. Right ventricular function in children 
with tetralogy of fallot before and after aortic-to-pulmonary shunt. Circulation. 1976;53:555-
561 
References 
 
162 
123. Borow KM, Keane JF, Castaneda AR, Freed MD. Systemic ventricular function in patients with 
tetralogy of fallot, ventricular septal defect and transposition of the great arteries repaired 
during infancy. Circulation. 1981;64:878-885 
124. Miura T, Nakano S, Shimazaki Y, Kobayashi J, Hirose H, Sano T, Matsuda H, Kawashima Y. 
Evaluation of right ventricular function by regional wall motion analysis in patients after 
correction of tetralogy of fallot. Comparison of transventricular and nontransventricular 
repairs. J Thorac Cardiovasc Surg. 1992;104:917-923 
125. d'Udekem Y, Ovaert C, Grandjean F, Gerin V, Cailteux M, Shango-Lody P, Vliers A, Sluysmans 
T, Robert A, Rubay J. Tetralogy of fallot: Transannular and right ventricular patching equally 
affect late functional status. Circulation. 2000;102:III116-122 
126. Frigiola A, Redington AN, Cullen S, Vogel M. Pulmonary regurgitation is an important 
determinant of right ventricular contractile dysfunction in patients with surgically repaired 
tetralogy of fallot. Circulation. 2004;110:II153-157 
127. Oosterhof T, Tulevski, II, Vliegen HW, Spijkerboer AM, Mulder BJ. Effects of volume and/or 
pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary 
stenosis) on right ventricular function using cardiovascular magnetic resonance and b-type 
natriuretic peptide levels. Am J Cardiol. 2006;97:1051-1055 
128. Eyskens B, Brown SC, Claus P, Dymarkowski S, Gewillig M, Bogaert J, Mertens L. The 
influence of pulmonary regurgitation on regional right ventricular function in children after 
surgical repair of tetralogy of fallot. Eur J Echocardiogr. 2010;11:341-345 
129. Gatzoulis MA, Elliott JT, Guru V, Siu SC, Warsi MA, Webb GD, Williams WG, Liu P, McLaughlin 
PR. Right and left ventricular systolic function late after repair of tetralogy of fallot. Am J 
Cardiol. 2000;86:1352-1357 
130. Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JC, Smith GC, Tat T, Pennell DJ, 
Gatzoulis MA. Right ventricular function in adults with repaired tetralogy of fallot assessed 
with cardiovascular magnetic resonance imaging: Detrimental role of right ventricular 
outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll 
Cardiol. 2002;40:2044-2052 
131. Koestenberger M, Nagel B, Halb V, Gamillscheg A. Correlation of pulmonary regurgitation 
fraction and right ventricular ejection fraction in patients with tetralogy of fallot. Clinical 
research in cardiology : official journal of the German Cardiac Society. 2011;100:713-714 
132. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, Williams WG, Webb G, Gatzoulis MA. 
Impact of pulmonary valve replacement on arrhythmia propensity late after repair of 
tetralogy of fallot. Circulation. 2001;103:2489-2494 
133. Harrison DA, Harris L, Siu SC, MacLoghlin CJ, Connelly MS, Webb GD, Downar E, McLaughlin 
PR, Williams WG. Sustained ventricular tachycardia in adult patients late after repair of 
tetralogy of fallot. J Am Coll Cardiol. 1997;30:1368-1373 
134. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, 
Pennell DJ, Gatzoulis MA. Ventricular fibrosis suggested by cardiovascular magnetic 
resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers 
of clinical outcome. Circulation. 2006;113:405-413 
135. Tsai SF, Chan DP, Ro PS, Boettner B, Daniels CJ. Rate of inducible ventricular arrhythmia in 
adults with congenital heart disease. Am J Cardiol. 2010;106:730-736 
136. Vogel M, Sponring J, Cullen S, Deanfield JE, Redington AN. Regional wall motion and 
abnormalities of electrical depolarization and repolarization in patients after surgical repair 
of tetralogy of fallot. Circulation. 2001;103:1669-1673 
137. Weidemann F, Eyskens B, Mertens L, Dommke C, Kowalski M, Simmons L, Claus P, Bijnens B, 
Gewillig M, Hatle L, Sutherland GR. Quantification of regional right and left ventricular 
function by ultrasonic strain rate and strain indexes after surgical repair of tetralogy of fallot. 
Am J Cardiol. 2002;90:133-138 
References 
 
163 
138. Menteer J, Weinberg PM, Fogel MA. Quantifying regional right ventricular function in 
tetralogy of fallot. J Cardiovasc Magn Reson. 2005;7:753-761 
139. Cullen S, Shore D, Redington A. Characterization of right ventricular diastolic performance 
after complete repair of tetralogy of fallot. Restrictive physiology predicts slow 
postoperative recovery. Circulation. 1995;91:1782-1789 
140. Gatzoulis MA, Clark AL, Cullen S, Newman CG, Redington AN. Right ventricular diastolic 
function 15 to 35 years after repair of tetralogy of fallot. Restrictive physiology predicts 
superior exercise performance. Circulation. 1995;91:1775-1781 
141. Helbing WA, Niezen RA, Le Cessie S, van der Geest RJ, Ottenkamp J, de Roos A. Right 
ventricular diastolic function in children with pulmonary regurgitation after repair of 
tetralogy of fallot: Volumetric evaluation by magnetic resonance velocity mapping. J Am Coll 
Cardiol. 1996;28:1827-1835 
142. Norgard G, Gatzoulis MA, Moraes F, Lincoln C, Shore DF, Shinebourne EA, Redington AN. 
Relationship between type of outflow tract repair and postoperative right ventricular 
diastolic physiology in tetralogy of fallot. Implications for long-term outcome. Circulation. 
1996;94:3276-3280 
143. Gatzoulis MA, Norgard G, Redington AN. Biventricular long axis function after repair of 
tetralogy of fallot. Pediatr Cardiol. 1998;19:128-132 
144. Mandinov L, Eberli FR, Seiler C, Hess OM. Diastolic heart failure. Cardiovascular research. 
2000;45:813-825 
145. Sachdev MS, Bhagyavathy A, Varghese R, Coelho R, Kumar RS. Right ventricular diastolic 
function after repair of tetralogy of fallot. Pediatr Cardiol. 2006;27:250-255 
146. Jarmakani JM, Graham TP, Jr., Canent RV, Jr., Jewett PH. Left heart function in children with 
tetralogy of fallot before and after palliative or corrective surgery. Circulation. 1972;46:478-
490 
147. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a 
risk factor for sudden cardiac death in adults late after repair of tetralogy of fallot. J Am Coll 
Cardiol. 2002;40:1675-1680 
148. Kempny A, Diller GP, Orwat S, Kaleschke G, Kerckhoff G, Bunck A, Maintz D, Baumgartner H. 
Right ventricular-left ventricular interaction in adults with tetralogy of fallot: A combined 
cardiac magnetic resonance and echocardiographic speckle tracking study. Int J Cardiol. 
2012;154:259-264 
149. Anderson RH, Ho SY, Redmann K, Sanchez-Quintana D, Lunkenheimer PP. The anatomical 
arrangement of the myocardial cells making up the ventricular mass. Eur J Cardiothorac 
Surg. 2005;28:517-525 
150. Corno AF, Kocica MJ, Torrent-Guasp F. The helical ventricular myocardial band of torrent-
guasp: Potential implications in congenital heart defects. Eur J Cardiothorac Surg. 2006;29 
Suppl 1:S61-68 
151. Ho SY, Nihoyannopoulos P. Anatomy, echocardiography, and normal right ventricular 
dimensions. Heart. 2006;92 Suppl 1:i2-13 
152. Helbing WA, Roest AA, Niezen RA, Vliegen HW, Hazekamp MG, Ottenkamp J, de Roos A, van 
der Wall EE. Ecg predictors of ventricular arrhythmias and biventricular size and wall mass in 
tetralogy of fallot with pulmonary regurgitation. Heart. 2002;88:515-519 
153. Weyman AE, Wann S, Feigenbaum H, Dillon JC. Mechanism of abnormal septal motion in 
patients with right ventricular volume overload: A cross-sectional echocardiographic study. 
Circulation. 1976;54:179-186 
154. James FW, Kaplan S, Schwartz DC, Chou TC, Sandker MJ, Naylor V. Response to exercise in 
patients after total surgical correction of tetralogy of fallot. Circulation. 1976;54:671-679 
References 
 
164 
155. Reybrouck T, Weymans M, Stijns H, Van der Hauwaert LG. Exercise testing after correction of 
tetralogy of fallot: The fallacy of a reduced heart rate response. Am Heart J. 1986;112:998-
1003 
156. Rowe SA, Zahka KG, Manolio TA, Horneffer PJ, Kidd L. Lung function and pulmonary 
regurgitation limit exercise capacity in postoperative tetralogy of fallot. J Am Coll Cardiol. 
1991;17:461-466 
157. Norgard G, Bjorkhaug A, Vik-Mo H. Effects of impaired lung function and pulmonary 
regurgitation on maximal exercise capacity in patients with repaired tetralogy of fallot. Eur 
Heart J. 1992;13:1380-1386 
158. Mulla N, Simpson P, Sullivan NM, Paridon SM. Determinants of aerobic capacity during 
exercise following complete repair of tetralogy of fallot with a transannular patch. Pediatr 
Cardiol. 1997;18:350-356 
159. Fredriksen PM, Therrien J, Veldtman G, Ali Warsi M, Liu P, Thaulow E, Webb G. Aerobic 
capacity in adults with tetralogy of fallot. Cardiol Young. 2002;12:554-559 
160. Samman A, Schwerzmann M, Balint OH, Tanous D, Redington A, Granton J, Siu SC, Silversides 
CK. Exercise capacity and biventricular function in adult patients with repaired tetralogy of 
fallot. Am Heart J. 2008;156:100-105 
161. Kipps AK, Graham DA, Harrild DM, Lewis E, Powell AJ, Rhodes J. Longitudinal exercise 
capacity of patients with repaired tetralogy of fallot. Am J Cardiol. 2011;108:99-105 
162. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas 
B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult 
congenital heart disease: Comparative severity, correlates, and prognostic implication. 
Circulation. 2005;112:828-835 
163. Burchill LJ, Wald RM, Harris L, Colman JM, Silversides CK. Pulmonary valve replacement in 
adults with repaired tetralogy of fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg 
Annu. 2011;14:92-97 
164. Cheung EW, Wong WH, Cheung YF. Meta-analysis of pulmonary valve replacement after 
operative repair of tetralogy of fallot. Am J Cardiol. 2010;106:552-557 
165. Eyskens B, Reybrouck T, Bogaert J, Dymarkowsky S, Daenen W, Dumoulin M, Gewillig M. 
Homograft insertion for pulmonary regurgitation after repair of tetralogy of fallot improves 
cardiorespiratory exercise performance. Am J Cardiol. 2000;85:221-225 
166. Yemets IM, Williams WG, Webb GD, Harrison DA, McLaughlin PR, Trusler GA, Coles JG, 
Rebeyka IM, Freedom RM. Pulmonary valve replacement late after repair of tetralogy of 
fallot. Ann Thorac Surg. 1997;64:526-530 
167. Bove EL, Kavey RE, Byrum CJ, Sondheimer HM, Blackman MS, Thomas FD. Improved right 
ventricular function following late pulmonary valve replacement for residual pulmonary 
insufficiency or stenosis. J Thorac Cardiovasc Surg. 1985;90:50-55 
168. Warner KG, Anderson JE, Fulton DR, Payne DD, Geggel RL, Marx GR. Restoration of the 
pulmonary valve reduces right ventricular volume overload after previous repair of tetralogy 
of fallot. Circulation. 1993;88:II189-197 
169. Niezen RA, Helbing WA, van der Wall EE, van der Geest RJ, Rebergen SA, de Roos A. 
Biventricular systolic function and mass studied with mr imaging in children with pulmonary 
regurgitation after repair for tetralogy of fallot. Radiology. 1996;201:135-140 
170. Meadows J, Powell AJ, Geva T, Dorfman A, Gauvreau K, Rhodes J. Cardiac magnetic 
resonance imaging correlates of exercise capacity in patients with surgically repaired 
tetralogy of fallot. Am J Cardiol. 2007;100:1446-1450 
171. Diller GP, Dimopoulos K, Okonko D, Uebing A, Broberg CS, Babu-Narayan S, Bayne S, Poole-
Wilson PA, Sutton R, Francis DP, Gatzoulis MA. Heart rate response during exercise predicts 
survival in adults with congenital heart disease. J Am Coll Cardiol. 2006;48:1250-1256 
References 
 
165 
172. Davos CH, Davlouros PA, Wensel R, Francis D, Davies LC, Kilner PJ, Coats AJ, Piepoli M, 
Gatzoulis MA. Global impairment of cardiac autonomic nervous activity late after repair of 
tetralogy of fallot. Circulation. 2002;106:I69-75 
173. Ohuchi H, Suzuki H, Toyohara K, Tatsumi K, Ono Y, Arakaki Y, Echigo S. Abnormal cardiac 
autonomic nervous activity after right ventricular outflow tract reconstruction. Circulation. 
2000;102:2732-2738 
174. Schulze-Neick IM, Wessel HU, Paul MH. Heart rate and oxygen uptake response to exercise 
in children with low peak exercise heart rate. European journal of pediatrics. 1992;151:160-
166 
175. Rhodes J, Dave A, Pulling MC, Geggel RL, Marx GR, Fulton DR, Hijazi ZM. Effect of pulmonary 
artery stenoses on the cardiopulmonary response to exercise following repair of tetralogy of 
fallot. Am J Cardiol. 1998;81:1217-1219 
176. Sutton NJ, Peng L, Lock JE, Lang P, Marx GR, Curran TJ, O'Neill JA, Picard ST, Rhodes J. Effect 
of pulmonary artery angioplasty on exercise function after repair of tetralogy of fallot. Am 
Heart J. 2008;155:182-186 
177. Therrien J, Fredriksen P, Walker M, Granton J, Reid GJ, Webb G. A pilot study of exercise 
training in adult patients with repaired tetralogy of fallot. Can J Cardiol. 2003;19:685-689 
178. Babu-Narayan SV, Diller GP, Gheta RR, Bastin AJ, Karonis T, Li W, Pennell DJ, Uemura H, 
Sethia B, Gatzoulis MA, Shore DF. Clinical outcomes of surgical pulmonary valve replacement 
after repair of tetralogy of fallot and potential prognostic value of preoperative 
cardiopulmonary exercise testing. Circulation. 2014;129:18-27 
179. Boening A, Scheewe J, Paulsen J, Regensburger D, Kramer HH, Hedderich J, Cremer JT. 
Tetralogy of fallot: Influence of surgical technique on survival and reoperation rate. Thorac 
Cardiovasc Surg. 2001;49:355-360 
180. Hickey EJ, Veldtman G, Bradley TJ, Gengsakul A, Manlhiot C, Williams WG, Webb GD, 
McCrindle BW. Late risk of outcomes for adults with repaired tetralogy of fallot from an 
inception cohort spanning four decades. Eur J Cardiothorac Surg. 2009;35:156-164; 
discussion 164 
181. Katz NM, Blackstone EH, Kirklin JW, Pacifico AD, Bargeron LM, Jr. Late survival and 
symptoms after repair of tetralogy of fallot. Circulation. 1982;65:403-410 
182. Rosenthal A, Behrendt D, Sloan H, Ferguson P, Snedecor SM, Schork A. Long-term prognosis 
(15 to 26 years) after repair of tetralogy of fallot: I. Survival and symptomatic status. Ann 
Thorac Surg. 1984;38:151-156 
183. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in 
patients with repair of tetralogy of fallot: 36-year follow-up of 490 survivors of the first year 
after surgical repair. J Am Coll Cardiol. 1997;30:1374-1383 
184. Harrison DA, Siu SC, Hussain F, MacLoghlin CJ, Webb GD, Harris L. Sustained atrial 
arrhythmias in adults late after repair of tetralogy of fallot. Am J Cardiol. 2001;87:584-588 
185. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, 
and gender of patients with atrial fibrillation. Analysis and implications. Archives of internal 
medicine. 1995;155:469-473 
186. Khairy P, Dore A, Poirier N, Marcotte F, Ibrahim R, Mongeon FP, Mercier LA. Risk 
stratification in surgically repaired tetralogy of fallot. Expert Rev Cardiovasc Ther. 
2009;7:755-762 
187. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, Fernandes SM, 
Beauchesne L, Therrien J, Chetaille P, Gordon E, Vonder Muhll I, Cecchin F. Implantable 
cardioverter-defibrillators in tetralogy of fallot. Circulation. 2008;117:363-370 
188. van Huysduynen BH, van Straten A, Swenne CA, Maan AC, van Eck HJ, Schalij MJ, van der 
Wall EE, de Roos A, Hazekamp MG, Vliegen HW. Reduction of qrs duration after pulmonary 
References 
 
166 
valve replacement in adult fallot patients is related to reduction of right ventricular volume. 
Eur Heart J. 2005;26:928-932 
189. Oosterhof T, Vliegen HW, Meijboom FJ, Zwinderman AH, Bouma B, Mulder BJ. Long-term 
effect of pulmonary valve replacement on qrs duration in patients with corrected tetralogy 
of fallot. Heart. 2007;93:506-509 
190. Hamada H, Terai M, Jibiki T, Nakamura T, Gatzoulis MA, Niwa K. Influence of early repair of 
tetralogy of fallot without an outflow patch on late arrhythmias and sudden death: A 27-
year follow-up study following a uniform surgical approach. Cardiol Young. 2002;12:345-351 
191. Deanfield JE, McKenna WJ, Presbitero P, England D, Graham GR, Hallidie-Smith K. Ventricular 
arrhythmia in unrepaired and repaired tetralogy of fallot. Relation to age, timing of repair, 
and haemodynamic status. Br Heart J. 1984;52:77-81 
192. Cullen S, Celermajer DS, Franklin RC, Hallidie-Smith KA, Deanfield JE. Prognostic significance 
of ventricular arrhythmia after repair of tetralogy of fallot: A 12-year prospective study. J Am 
Coll Cardiol. 1994;23:1151-1155 
193. Dore A, Santagata P, Dubuc M, Mercier LA. Implantable cardioverter defibrillators in adults 
with congenital heart disease: A single center experience. Pacing and clinical 
electrophysiology : PACE. 2004;27:47-51 
194. Russo G, Folino AF, Mazzotti E, Rebellato L, Daliento L. Comparison between qrs duration at 
standard ecg and signal-averaging ecg for arrhythmic risk stratification after surgical repair 
of tetralogy of fallot. Journal of cardiovascular electrophysiology. 2005;16:288-292 
195. Villafane J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM, Geva T, Towbin JA, 
Cohen MS, Fraser C, Dearani J, Rosenthal D, Kaufman B, Graham TP, Jr. Hot topics in 
tetralogy of fallot. J Am Coll Cardiol. 2013 
196. Kind T, Mauritz GJ, Marcus JT, van de Veerdonk M, Westerhof N, Vonk-Noordegraaf A. Right 
ventricular ejection fraction is better reflected by transverse rather than longitudinal wall 
motion in pulmonary hypertension. J Cardiovasc Magn Reson. 2010;12:35 
197. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an 
incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985;131:700-708 
198. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098 
199. Lurz P, Puranik R, Nordmeyer J, Muthurangu V, Hansen MS, Schievano S, Marek J, 
Bonhoeffer P, Taylor AM. Improvement in left ventricular filling properties after relief of 
right ventricle to pulmonary artery conduit obstruction: Contribution of septal motion and 
interventricular mechanical delay. Eur Heart J. 2009;30:2266-2274 
200. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of 
risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll 
Cardiol. 1998;32:245-251 
201. van der Hulst AE, Roest AA, Delgado V, Holman ER, de Roos A, Blom NA, Bax JJ. Relationship 
between temporal sequence of right ventricular deformation and right ventricular 
performance in patients with corrected tetralogy of fallot. Heart. 2011;97:231-236 
202. Hochberg Y. A sharper bonferroni procedure for multiple tests of significance. Biometrika. 
1988;75:800-802 
203. Shimazaki Y, Blackstone EH, Kirklin JW. The natural history of isolated congenital pulmonary 
valve incompetence: Surgical implications. Thorac Cardiovasc Surg. 1984;32:257-259 
204. Redington AN, Oldershaw PJ, Shinebourne EA, Rigby ML. A new technique for the 
assessment of pulmonary regurgitation and its application to the assessment of right 
ventricular function before and after repair of tetralogy of fallot. Br Heart J. 1988;60:57-65 
205. Marie PY, Marcon F, Brunotte F, Briancon S, Danchin N, Worms AM, Robert J, Pernot C. Right 
ventricular overload and induced sustained ventricular tachycardia in operatively "repaired" 
tetralogy of fallot. Am J Cardiol. 1992;69:785-789 
References 
 
167 
206. Giardini A, Specchia S, Coutsoumbas G, Donti A, Formigari R, Fattori R, Oppido G, Gargiulo G, 
Picchio FM. Impact of pulmonary regurgitation and right ventricular dysfunction on oxygen 
uptake recovery kinetics in repaired tetralogy of fallot. Eur J Heart Fail. 2006;8:736-743 
207. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and 
right ventricular dimensions for mri as assessed by turbo gradient echo and steady-state free 
precession imaging sequences. J Magn Reson Imaging. 2003;17:323-329 
208. Ginns J, Lewis M, Rosenbaum M. Change in rv size and function over time by serial mri in 
repaired tetralogy of fallot [abstract]. Circulation. 2012;126:A18101 
209. Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. Pulmonary valve 
replacement in adults late after repair of tetralogy of fallot: Are we operating too late? J Am 
Coll Cardiol. 2000;36:1670-1675 
210. Oosterhof T, Meijboom FJ, Vliegen HW, Hazekamp MG, Zwinderman AH, Bouma BJ, van Dijk 
AP, Mulder BJ. Long-term follow-up of homograft function after pulmonary valve 
replacement in patients with tetralogy of fallot. Eur Heart J. 2006;27:1478-1484 
211. Nordmeyer J, Tsang V, Gaudin R, Lurz P, Frigiola A, Jones A, Schievano S, van Doorn C, 
Bonhoeffer P, Taylor AM. Quantitative assessment of homograft function 1 year after 
insertion into the pulmonary position: Impact of in situ homograft geometry on valve 
competence. Eur Heart J. 2009;30:2147-2154 
212. O'Meagher S, Munoz PA, Alison JA, Young IH, Tanous DJ, Celermajer DS, Puranik R. Exercise 
capacity and stroke volume are preserved late after tetralogy repair, despite severe right 
ventricular dilatation. Heart. 2012;98:1595-1599 
213. Cordina RL, O'Meagher S, Karmali A, Rae CL, Liess C, Kemp GJ, Puranik R, Singh N, Celermajer 
DS. Resistance training improves cardiac output, exercise capacity and tolerance to positive 
airway pressure in fontan physiology. Int J Cardiol. 2012 
214. Lurz P, Muthurangu V, Schievano S, Nordmeyer J, Bonhoeffer P, Taylor AM, Hansen MS. 
Feasibility and reproducibility of biventricular volumetric assessment of cardiac function 
during exercise using real-time radial k-t sense magnetic resonance imaging. J Magn Reson 
Imaging. 2009;29:1062-1070 
215. Roest AA, Kunz P, Lamb HJ, Helbing WA, van der Wall EE, de Roos A. Biventricular response 
to supine physical exercise in young adults assessed with ultrafast magnetic resonance 
imaging. Am J Cardiol. 2001;87:601-605 
216. Meyns B, Jashari R, Gewillig M, Mertens L, Komarek A, Lesaffre E, Budts W, Daenen W. 
Factors influencing the survival of cryopreserved homografts. The second homograft 
performs as well as the first. Eur J Cardiothorac Surg. 2005;28:211-216; discussion 216 
217. Tang D, Yang C, Geva T, Del Nido PJ. Right ventricular local longitudinal curvature as a 
marker and predictor for pulmonary valve replacement surgery outcome: An initial study 
based on preoperative and postoperative cardiac magnetic resonance data from patients 
with repaired tetralogy of fallot. J Thorac Cardiovasc Surg. 2013 
218. O'Connor DS, Ginns J, Quaegebeur J, Bacha E, Rosenbaum M. Resection of right ventricular 
outflow tract patch during pulmonary valve replacement improves right ventricular volumes 
and ejection fraction in patients with tetralogy of fallot. Journal of the American College of 
Cardiology. 2013;61 (S10):E481 
219. Alexiou C, Mahmoud H, Al-Khaddour A, Gnanapragasam J, Salmon AP, Keeton BR, Monro JL. 
Outcome after repair of tetralogy of fallot in the first year of life. Ann Thorac Surg. 
2001;71:494-500 
220. Bacha EA, Scheule AM, Zurakowski D, Erickson LC, Hung J, Lang P, Mayer JE, Jr., del Nido PJ, 
Jonas RA. Long-term results after early primary repair of tetralogy of fallot. J Thorac 
Cardiovasc Surg. 2001;122:154-161 
References 
 
168 
221. Horneffer PJ, Zahka KG, Rowe SA, Manolio TA, Gott VL, Reitz BA, Gardner TJ. Long-term 
results of total repair of tetralogy of fallot in childhood. Ann Thorac Surg. 1990;50:179-183; 
discussion 183-175 
222. Van Arsdell G, Yun TJ. An apology for primary repair of tetralogy of fallot. Semin Thorac 
Cardiovasc Surg Pediatr Card Surg Annu. 2005:128-131 
223. Karl TR, Sano S, Pornviliwan S, Mee RB. Tetralogy of fallot: Favorable outcome of 
nonneonatal transatrial, transpulmonary repair. Ann Thorac Surg. 1992;54:903-907 
224. Nollert GD, Dabritz SH, Schmoeckel M, Vicol C, Reichart B. Risk factors for sudden death 
after repair of tetralogy of fallot. Ann Thorac Surg. 2003;76:1901-1905 
225. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: 
A population-based study. J Am Coll Cardiol. 2007;50:1263-1271 
226. O'Meagher S, Choudhary P, Duflou J, Puranik R, Celermajer DS. Causes of death in tetralogy 
of fallot in adults--an autopsy study. Int J Cardiol. 2013;168:1547-1548 
227. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander 
ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable 
cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am 
Coll Cardiol. 2008;51:1685-1691 
228. Silka MJ, Kron J, Dunnigan A, Dick M, 2nd. Sudden cardiac death and the use of implantable 
cardioverter-defibrillators in pediatric patients. The pediatric electrophysiology society. 
Circulation. 1993;87:800-807 
229. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thilen U, Kaemmerer H, Moons 
P, Meijboom F, Popelova J, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B. The 
spectrum of adult congenital heart disease in europe: Morbidity and mortality in a 5 year 
follow-up period. The euro heart survey on adult congenital heart disease. Eur Heart J. 
2005;26:2325-2333 
 
 
